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Abstract
The human brain is arguably one of the most complex structures known to humankind. To
understand the development, function, and dysfunction of this organ, both historical and
modern neurological research methods have intrinsic limitations. Modern functional
imaging and electrophysiological techniques obtain important data on the structural and
functional aspects of specific brain regions but are unable to accumulate biomolecular
information, whereas animal models of brain development allow for complete molecular
interrogation, but show intrinsic morphological differences compared to native human
brain tissue. In vitro modelling of human brain tissue through the differentiation of induced
pluripotent stem cells (iPSCs) offers a completely novel method of studying human brain
development. iPSCs can differentiate into any somatic cell derived from the three germ
layers, and as such, can form cells of specific neural lineages from multiple brain regions.
Furthermore, this differentiation in vitro follows the same principles of in utero brain
development, and so can be used to model specific genetically-linked neurodevelopmental
pathologies such as the epilepsies.
Neural cell differentiation within three-dimensional cell culture scaffolds offers a
way of replicating a more in vivo-like microenvironment compared to standard planar
culture. Therefore, the generation and optimisation of cytocompatible biomaterials to form
these three-dimensional scaffolds will be integral for the future of in vitro neural tissue
engineering.
This thesis focuses on the combination of both biomaterial engineering and iPSCbased neurological development to assess the synergy of targeted neuronal cell
differentiation within three-dimensional hydrogel environments.
Comparisons between alginate-based and collagen type I-based hydrogel scaffolds
(with stiffness moduli comparable to that of native brain tissue) demonstrated both
scaffold types retained high cell viability of encapsulated neural cells. However, only
collagen-based scaffolds were shown to be conducive to neurite extension, whereas neural
cells within alginate scaffolds displayed no neuritogenesis under differentiating conditions.
Alginate hydrogels modified with matrix metalloproteinase-cleavable and laminin-binding
epitopes were also non-conducive to neurite extensions but did induce changes in neuralmarker protein expression profiles of encapsulated neural cells relative to those within
unmodified alginate and collagen hydrogels.
v

Human iPSCs (hiPSCs) were successfully differentiated into dorsal forebrain
(excitatory) and ventral forebrain (inhibitory) neural lineages. Biomolecular analyses over
the timeline of differentiation uncovered differences in the speed of neural differentiation
and expression of maturation markers. Neurons derived from ventral differentiation
pathways displayed enhanced functional profiles relative to neurons generated through
dorsal differentiation strategies.
Neural differentiation of hiPSCs in three-dimensional collagen-based hydrogel
environments enabled extensive neuritogenesis throughout the constructs. Gene
expression analyses during neural induction and differentiation demonstrated significant
differences in the maturation rates of hiPSC-derived neurons in three-dimensional
environments relative to two-dimensional planar culture.
Finally, in order to generate more complex three-dimensional neural tissue
structures using bioprinting methodologies; optimisation strategies to improve the
printability of candidate biomaterials were developed. A coaxial bioprinting system was
utilised by which to achieve a low stiffness “core” bioink that maintained neural
differentiation and neuritogenesis, and a supportive “shell” hydrogel that generated
enough structural integrity by which to bioprint multi-layered free-standing neural
constructs.
In combination, the work presented in this thesis demonstrates the necessary
biological assays for measuring positive markers of neural differentiation in candidate
three-dimensional hydrogels and applies this knowledge to better understanding neural
differentiation of hiPSCs within these environments. It also establishes a 3D coaxial
bioprinting system by which to scale-up and tailor neural tissue construct design to
generate in vitro neurological models more representative of native neural tissue.
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Chapter 1: General Introduction
1.1 Background and Potential of Induced Pluripotent Stem
Cells in Neurological Research

1.1.1 Neurons Ex Machina
The human brain is arguably one of the most complex structures known to humankind.
Recent estimations of its cellular content put the total neuronal number at approximately
86 billion cells, with estimated numbers of synaptic connections between these cells well
into the trillions (Pakkenberg et al., 2003; Azevedo et al., 2009). Studies of human brain
development, function, and disease have historically been undertaken through an array of
methodologies including: posthumous observation, utilising electrophysiological & noninvasive imaging techniques, and/or with the use of animal models. However, intrinsic
differences between animal and human models of neurological diseases have resulted in
poor rates of clinical translation and development of novel therapeutics (Matthews et al.,
2005; Kelava and Lancaster, 2016; Mungenast, Siegert and Tsai, 2016). To overcome this
species gap in vitro models of brain development and disease derived from human stem
cell populations offer more clinically-representative models from which to generate healthy
and disease-state neural tissue for study.
Induced pluripotent stem cells (iPSCs) have revolutionised and rejuvenated the
field of stem cell science since their inception just over a decade ago (Takahashi and
Yamanaka, 2006). Broadly speaking, stem cells all share two basic properties; the first is the
ability to self-renew through cell division and the second is to differentiate into other cell
types. The number of cell types a stem cell can differentiate into is based on their
“potency”. For example, bone marrow, in basic terms, is a large pool of multipotent stem
cells that replenish the diverse subtypes of blood and immune cell lineages. Pluripotent
stem cells (PSCs) can turn into any cell type derived from the three germ layers, and as such
in nature primarily exist at the very early developmental stages of viable embryos.
Extraction of cells from human blastocysts and their successful culture in vitro was the first
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stepping stone into the long term culture and use of PSCs as models of understanding
pluripotency, human tissue development, and potential uses in regenerative medicine
(Thomson et al., 1998). These embryonic stem cells (ESCs), were and still are, an incredibly
powerful type of stem cell that remain as the benchmark for in vitro pluripotency research.
However, the necessity of harvesting them from early human embryos offered a logistical
and ethical challenge to their widespread use.
ESCs remained the gold standard for in vitro PSC research, until a seminal paper
from Takahashi and Yamanaka in 2006 showed the first induction of pluripotency in
differentiated murine somatic cells through ectopic expression of four pluripotency-related
factors (Takahashi and Yamanaka, 2006). From an initial twenty-four candidate genes the
authors found that a combination of the factors; Oct4, Sox2, c-Myc, and Klf4 was sufficient
to induce a state of pluripotency in formerly differentiated murine fibroblasts. These cells
were termed induced pluripotent stem cells (iPSCs). This research was later repeated with
human cell sources with the same “ Yamanaka factors” (Takahashi et al., 2007), and with a
different cocktail of factors (Oct4, Sox2, Nanog, and Lin28) (Yu et al., 2007). These human
iPSCs (hiPSCs) represented an incredible breakthrough in the field of stem cell research and
disseminated a logistically simple way of reprogramming somatic cell types into PSCs
without the ethical concerns of utilising ESC-derived cell lines. Another striking advantage
to the use of hiPSCs is the ability to induce pluripotency in cells that are genetically
identical to the cell source donor, creating the potential for rejection-free tissue
regenerative therapies, genetically-linked disease modelling, developmental biology
studies, and pharmacological testing on a patient-specific basis in vitro. This wide array of
possible applications has resulted in a large volume of research in only a few years
In short, the advent of this technology stands to remove a number of hurdles that
had plagued stem cell research; namely issues of immune rejection, ethical concerns
associated with utilising embryo-derived ESCs, and those of limited stem cell potency of
somatic stem cell populations. The promise of iPSCs therefore lies in the relative ease of
their generation from a spectrum of adult tissues, the promise of autologous regenerative
therapies, and the lack of ethical concern with their derivation. In essence, they have the
capacity to combine the advantages of both somatic stem cells and ESCs.
The advantages discussed above have also spearheaded the use of hiPSCs in
neurological research. The desire to develop in vitro patient-specific models of
neurodevelopmental and neurodegenerative disease has resulted in vast swathes of
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research for dozens of disorders (Mattis and Svendsen, 2011; Israel et al., 2012; Dajani et
al., 2013; Imaizumi and Okano, 2014; Okano and Yamanaka, 2014). In parallel to this,
research into human-specific neurodevelopment from “healthy” hiPSCs has begun to shed
light on how brain tissue and regional brain structures form in utero and allow an
unprecedented view into the regulation of these processes in vitro (Petros, Tyson and
Anderson, 2011; Anderson and Vanderhaeghen, 2014; Kelava and Lancaster, 2016). As this
field of research continues to refine and expand, the potential scope for understanding
numerous aspects of human neurobiology is remarkable.
That being said, no current iPSC-based neurological model is perfect, and potential
limitations or problems with iPSC technology such as line-to-line differentiation variability
(Hu et al., 2010), epigenetic or lineage memory (K. Kim et al., 2011), and chromosomal
aberrations (Mayshar et al., 2010) are well documented. Even so, numerous usable and
statistically sound models of neurological disease have been already documented from
disease-specific iPSCs (Israel et al., 2012; Lancaster et al., 2013; Duan et al., 2014; Okano
and Yamanaka, 2014; Mariani et al., 2015). Care must be therefore taken to ensure that
robust, reproducible and ultimately representative iPSC-derived neural cell cultures are
generated for each aspect of neurobiology under scrutiny.
Each stage of iPSC-technology can be tailored to the needs of the study being
undertaken. This includes the source of somatic cells for reprogramming (e.g. fibroblasts,
peripheral blood progenitors or epithelial-like cells from urine samples) and the type of
reprogramming vectors used to either improve reprogramming efficiency or maintain
genomic integrity. Neural induction and differentiation methodologies vary from study to
study, utilising diverse morphogen signalling and/or forced neuronal transcription factor
expression. Each method yielding differentially heterogeneous pools of cells that can be
demonstrative of the in vivo processes these protocols aim to mirror. Finally, culture in
biomimetic 2D or 3D environments can allow enhancement of neural differentiation,
promotion of neural outgrowth and modulation of cell-cell synaptic activity. Each level of
this process can help to build reproducible and physiologically relevant neurological models
to help elucidate the true goal of iPSC-neural modelling: unearthing the processes of
neurodevelopment and the aberrations leading to neurological disease.
The ability to derive a patient-specific pluripotent cell line opens an entirely new
pathway for dissecting the pathology of diseases that were either impractical or impossible
to study extensively in vivo. This is especially true in the field of neuroscience, and most
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notably in the study of neurodegenerative and neurodevelopmental conditions (Marchetto
et al., 2011; Mattis and Svendsen, 2011; Okano and Yamanaka, 2014). The ability to have a
continuous, genetically relevant supply of neurons from patients with a specific
neurological condition offers the chance to study the pathology of genetically-linked
disorders throughout development in vitro; an impossibility in patients with late-onset
conditions such as Parkinson’s Disease, Alzheimer’s Disease and Huntington’s Disease
(Imaizumi and Okano, 2014).
As well as degenerative conditions, iPSCs offer the chance to study early in utero
developmental pathways and formation of embryological neural structures, such as human
corticogenesis, which show inherent differences to animal models (Anderson and
Vanderhaeghen, 2014). Understanding the formation (or malformation) of particular brain
regions with the associated cytoarchitecture and neuronal diversity, will shed light on the
temporal and spatial control of tissue generation, and offer insights into treatments of
developmental disorders as well as human brain evolution.

1.1.2 Somatic Cell Sources and Methods of iPSC Reprogramming
This section will focus on iPSC reprogramming methodologies necessary for successful
neurological development and disease modelling. Primarily, the generation of integrationfree and genomically “clean” iPSC lines as well as concerns for cell type selection for
reprogramming; an area often overlooked in iPSC studies but an important consideration
when long term and multiple clinical samples are to be processed. A large collection of
general iPSC-derivation reviews are present throughout the literature (Maherali and
Hochedlinger, 2008; González, Boué and Izpisúa Belmonte, 2011; Bayart and CohenHaguenauer, 2013), this section will therefore represent a targeted review of the abundant
sources available.
Reprogramming vectors can be broadly classified into 2 types: viral and non-viral
(Fig 1-1). Viral vectors can then be sub-classified into integrating vectors, such as gammaretroviruses (Takahashi and Yamanaka, 2006; Takahashi et al., 2007; Yu et al., 2007) &
lentiviruses (Carey et al., 2009; Chang et al., 2009), and non-integrating (or transient)
vectors such as adenoviruses (Stadtfeld et al., 2008; Zhou and Freed, 2009) & Sendai virus
(Fusaki et al., 2009). Although reported reprogramming efficiencies for viral integrating
vector types are higher than the non-integrating vectors, they result in random integration
4

of the reprogramming factors into the target genome. This has implications for
neurological-focused iPSC-derived modelling where genomic integrity may be key for
understanding complex neurological pathologies: ensuring no genes are disrupted for
certain lineage specifications and to make certain no oncogenic gene transformations have
been generated (Bayart and Cohen-Haguenauer, 2013). For any regenerative applications,
the presence of tumourigenic mutations or the in vivo reactivation of integrated
pluripotency factors could be catastrophic. Some groups have tried to reduce the impact of
integrative reprogramming elements by generating an excisable vector system that after
generating a stable pluripotency shift within the target cells, can then be excised from the
genome (Chang et al., 2009; Soldner et al., 2009). While this methodology would in theory
excise potentially oncogenic effects (through over-expression of genes such as c-Myc), it
would still risk the generation of unforeseen recombination events that, in and of
themselves, may damage the overall genomic stability of the target cell.

Fig 1-1: Representation of strategies used for iPSC reprogramming of somatic cell
types. Illustration from Bayart & Cohen-Haguenauer 2013.
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Non-viral vectors offer an alternative transient system of delivery for the
reprogramming factors. Such vectors include the transfection of the factors encoded in
plasmids (Okita et al., 2008) or more stable episomal vectors (Yu et al., 2009). These
vectors would generate the advantageous genomically “clean” iPSC lines, but reportedly do
so at a lower efficiency than retroviral vectors (Yu et al., 2009). More recently, techniques
have been developed to generate insertion-free iPSC lines without using DNA-based
vectors. Instead they utilise either synthetic messenger RNA (mRNA) constructs of each
pluripotency factor (Warren et al., 2010) or the reprogramming proteins themselves (Kim
et al., 2009; Zhou et al., 2009). The relatively high reprogramming efficiency of the mRNAbased technique makes them an appealing non-viral option for iPSC derivation. However,
for multiple and ongoing iPSC banking projects, the cost of obtaining high amounts of
synthetic mRNA may be a consideration. Reprogramming via use of the reprogramming
proteins themselves as proof of principle is a very interesting result, however the very low
efficiency of iPSC generation would not make them an ideal go-to methodology for general
de novo iPSC banking and modelling projects (Fig 1-1).
Another concern for deriving de novo iPSC lines is the choice of adult cell type to
undergo reprogramming. For many disease modelling studies this is a commonly
overlooked consideration, with the majority (approximately 80%) of published de novo iPSC
lines generated from dermal fibroblasts (González, Boué and Izpisúa Belmonte, 2011). This
is obviously of little concern in animal studies where tissue selection does not need to
represent a clinically relevant situation. However, it should be a factor for research groups
hoping to generate multiple disease-specific iPSC lines from human patients. Ideally, the
harvesting of cells should be relatively non-invasive and generate a large enough pool of
starting cells which can be easily cultured and stored. Fibroblasts have been heavily utilised
in iPSC studies because they are a robust and easily expandable cell type. To obtain human
dermal fibroblasts a skin punch biopsy must be performed by a trained clinician. Although
this procedure is relatively non-invasive it must be performed under local anaesthetic and
is still associated with a low risk of nerve injury and infection. Minimising the discomfort of
patients while maximising the speed and ease of cell collection should be a principle
concern for iPSC-based disease modelling research groups. Especially when studying
idiopathic and familial conditions where multiple iPSC-lines need to be generated
simultaneously for broad and statistically significant experimental analysis.
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Since the seminal iPSC-generation research was first published, many studies have
now looked at iPSC-reprogramming of a whole host of somatic cell types, some more
clinically useful than others, for obtaining a starting cell pool. Human bone marrow-derived
mesenchymal stem cells (BM-MSCs) (Park et al., 2008) and hepatocytes (Liu et al., 2010)
have been reprogrammed into iPSCs, but with the obvious disadvantage of a much more
invasive harvesting process than simple skin biopsies. Dental pulp stem cells (harvested
from deciduous or “baby teeth”) are another source of cells that have been used in iPSC
generation (Beltrão-Braga et al., 2011). This may not a viable or desirable option in adult
patients where the harvesting of this tissue would involve the extraction of teeth (Tamaoki
et al., 2010). A promising starting somatic cell pool may be keratinocytes. Although
harvested in multiple studies from foreskin, keratinocytes have also been harvested and
reprogrammed from hair follicles (Aasen et al., 2008). Cell harvesting in this instance would
simply involve a single plucked hair from which to expand the keratinocyte population. A
possible issue would be the very limited starting cell number, but may be offset by the
much higher reprogramming efficiency of keratinocytes - reportedly up to one hundredfold more efficient and two-fold faster than fibroblast-reprogramming methodologies
(Aasen et al., 2008). This is also mirrored by reprogramming of dermal papillae cells (also
from hair follicles) which have a reported three-fold increase in reprogramming efficiency
relative to dermal fibroblasts (Muchkaeva et al., 2014).
Another promising minimally-invasive method of somatic cell harvest is via
peripheral blood collection (Mack et al., 2011; Okita et al., 2013). The obvious advantage to
this methodology being that it is widely used in clinical practice for a whole spectrum of
diagnostic tests. Within this framework peripheral blood could be collected from patients
with no additional harvesting procedure necessary and with minimal discomfort. However,
a caveat to this procedure must be the removal of mature immune cells that have
undergone V(D)J rearrangements. This genomic rearrangement, although limited to
adaptive immunity genes, is not ideal for production of genomically representative iPSClines. Hence the peripheral blood-based methodologies tend to selectively make use of
CD34+ cells within the blood as a marker of a progenitor cell type that has not undergone
this rearrangement.
Finally, another intriguing source of cells for iPSC generation may be those
collected from urine samples (Zhou et al., 2012; Xue et al., 2013). Epithelial-like cells
obtained through centrifugation of urine offer a completely non-invasive method of cell
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harvesting. iPSC-lines derived in this way are still a recent development and as such has not
been widely adopted by many research groups, however at least one research group has
generated neural progenitors (and consequently mature neurons) from urine-derived
somatic cells (Wang et al., 2013).

1.2 Differentiation Strategies for iPSC-derived Neurons
Differentiation protocols to derive neuronal and glial cell subtypes from iPSCs have largely
been based on methodologies developed from ESC-differentiation, although differences in
neural lineage differentiation efficiency have been documented between the two PSC types
(Hu et al., 2010). Multiple varied protocols can be seen throughout the literature that result
in neuronal differentiation (or more specific neuronal subtype generation) with varying
efficiencies. The time frame for differentiation and neuronal maturation strategies also
differs from protocol to protocol and depend on the target-cell-type.
Broadly speaking, the two main methodologies of deriving neurons from iPSCs can
be defined as those that utilise developmental morphogens to trigger a step-wise
differentiation into neuronal lineages, and those that employ the transfection, and
consequent expression, of known neurogenic genes. An overview of the basis for
morphogen-derived neuronal patterning and direct transfection of neurogenic genes are
outlined below.

1.2.1 In Vivo Neural Tube Patterning Factors as a Basis for In Vitro
Differentiation
Differentiation protocols based around neural tube morphogen patterning take cues from
known neurodevelopmental processes and attempt to recapitulate the in vivo system by
sequential addition of signalling factors in vitro to direct specific pathways of
differentiation.
The neural tube is an embryonic structure that is the precursor of the central
nervous system (CNS). Patterning factor gradients within this structure during development
primarily form two axes; the dorsal-ventral axis and anterior-posterior axis (also referred to
as the rostral-caudal axis) (Briscoe and Ericson, 2001; Petros, Tyson and Anderson, 2011; Le
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Dréau and Martí, 2012). Signalling molecules form gradients within the neural tube that
then act to define a precursor cell’s neural fate by way of its spatial and temporal location.
Different neuronal and glial subtypes will then be generated dependent on the precursor
cell’s location and therefore its exposure to relative amounts of specific morphogens along
the two axes (Fig 1-2). Dorsal-ventral patterning is primarily derived from the interplay of
three signalling pathways: Sonic Hedgehog (SHH), members of the Bone Morphogenetic
Protein (BMP) family, and the Wingless-type MMTV integration site (Wnt) family. SHH is a
ventralising ligand secreted from the floor plate of the neural tube and the notochord
(Jessell, 2000), whereas BMPs and Wnts are released from the roof plate and trigger a
dorsalising response in target cells (Le Dréau and Martí, 2012). In simple terms SHH
signalling can be seen as a mechanism to derive ventral neural tube identity (and therefore
ventrally-derived neuronal cell types) while BMP and Wnt signalling drive dorsal neural
tube identity (and conversely a dorsally-derived neuronal lineage differentiation) (Briscoe
and Ericson, 2001; Le Dréau and Martí, 2012).

Figure 1-2: Representation of morphogen gradients in the neural tube during
embryological development of the central nervous system. Combinations of factors
generate a dorsal-ventral (DV) axis and anterior-posterior (AP) axis. The spatial
“coordinates” derived from these gradients trigger development of specific brain areas
and neural cell types. BMPs, Bone Morphogenetic Proteins; WNTs, Wingless-type MMTV
integration site; RA, Retinoic Acid; FGF8, Fibroblast Growth Factor 8; SHH, Sonic
Hedgehog.

The anterior-posterior axis is established predominantly by retinoic acid (RA) which is
secreted from the surrounding somitic mesoderm and notochord precursors (Pierani et al.,
1999). Higher RA concentrations denote a posteriorising (or caudalising) signal within the
neural tube and hence are associated with hindbrain and spinal neuron positional
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specification of the putative CNS (Maden, 2006). Another key signalling molecule in the
formation of the anterior-posterior axis is the induction of fibroblast growth factor-8 (FGF8) signalling from the isthmic organiser. This region of the neural tube denotes the
midbrain-hindbrain boundary and its signalling is integral to the formation of dopaminergic
and serotonergic neurons (Goridis and Rohrer, 2002; Brodski et al., 2003).
Strictly defined roles for these factors are still being elucidated and the above
explanations are more of a crude overview by which in vitro differentiation strategies have
been derived. Indeed, some of these inductive signals appear to have multiple roles: Wnt
signalling has also been implicated as a posteriorising signal in developmental studies (as
well as the dorsalising role explained above) (Yamaguchi, 2001). RA in differentiation
studies in murine ESCs has also shown it to be a dorsalising signal as well as a posteriorising
one (Okada et al., 2004). Retinoids have also been shown to help induce dorsal forebrain
cortical lineages from iPSCs with high efficiency (Shi et al., 2012; Shi, Kirwan and Livesey,
2012).
In vitro differentiation of iPSCs into neuronal lineages using these morphogens can
be broken down into a series of steps that sequentially restrict the potency of the starting
iPSC colonies. Firstly, with the generation of neural precursors, then patterning these
precursors to recapitulate the positional specificity of a neural subtype within the neural
tube, and finally to mature and enrich the desired neuronal lineage into functional
networks that can undergo further in vitro study.

1.2.2 Neural Induction of iPSCs In Vitro
The first step in the in vitro differentiation pathway is to trigger a neural induction within
the iPSCs to generate a patterning-competent pool of neuroepithelial progenitors. Multiple
strategies have been used across iPSC and ESC lines that generate neural progenitors that
show consistent gene expression markers regardless of their starting PSC cell type (Falk et
al., 2012). There are three main strategies to induce this effect, namely; embryoid body
formation, dual SMAD inhibition, and stromal cell-derived inducing activity (SDIA). As with
the majority of this research, the seminal papers deal with a range of PSC types but
ultimately have been utilised in iPSC differentiation strategies across the literature. It is also
worth noting that not only do methodologies for neural induction vary greatly between
studies, but also the nomenclature for the progenitor cell type that is initially generated
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and the time course over which this cell type is propagated and matured. Studies have
referred to this pool of cells as neural precursor/progenitor cells (NPCs), neuroepithelia
(NE) or neuroepithelial progenitors (NEPs), neuroepithelial stem cells (NESs), and neural
stem cells (NSCs). This may be a point of confusion, as although cultures of these
progenitors will indeed alter their properties over time, the markers used to identify them
tend to be the same across the bulk of studies, namely Nestin, Pax6 and Musashi-1 [for
example (Watanabe et al., 2005; Shin et al., 2006; Nemati et al., 2011)]. Another point of
possible misunderstanding is to equate the progenitor pool derived from iPSCs to primary
culture NSCs. Primary NSCs harvested from foetal or adult brain are believed to be derived
from radial glia-like stem cells which when cultured as neurospheres form a renewable
source of NSCs (Reynolds and Rietze, 2005). However, these primary-NSCs lack many of the
characteristics of iPSC-NPCs such as intrinsic neural architecture formation and differing
marker expression (Elkabetz et al., 2008; Falk et al., 2012; Karus, Blaess and Brüstle, 2014).
iPSC-NPCs should then be seen as a more developmentally early-stage stem cell than
primary NSCs and care should be taken not to confuse the two types by name alone.
Therefore, for the purpose of consistency this thesis will refer to PSC-derived pools of
neural precursor cells as NPCs.

1.2.3 Embryoid Body-Based Neural Induction
The first technique that will be discussed is that of neural induction via embryoid body (EB)
formation, also referred to as serum-free floating culture of embryoid body-like aggregates
(SFEB). This is achieved through the culture of PSC-colony fragments in suspension. The
cellular aggregates self-form into tightly packed EBs which if left in iPSC media will develop
markers of all three germ layer lineages. However, when the growth media is exchanged
for a serum-free media, the differentiation within the EBs becomes biased towards a
neuroectodermal lineage (Okabe et al., 1996; Watanabe et al., 2005). An improvement on
this basic protocol termed SFEBq was reported by Eiraku et al., by using U-shaped wells to
accelerate the formation of PSC aggregates from single cell suspensions within a few hours
rather than the days needed for reaggregation in basic suspension culture (Eiraku et al.,
2008). When plated onto adhesive substrates these primed cells form structures termed
“neural rosettes”. These can be mechanically separated and cultured independently to
form a pool of multipotent NPCs which form the basis of further neural differentiation
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strategies. The rosettes themselves are a self-organised two-dimensional recapitulation of
the neural tube and not simply artefacts of in vitro NPC culture. They display apical-basal
polarity (Falk et al., 2012), express specific early markers of iPSC-NPCs (Elkabetz et al.,
2008), and even more remarkably display neural crest cell generation developing at the
periphery of the rosettes; similar to the spatial separation seen in vivo (Karus, Blaess and
Brüstle, 2014).

1.2.4 Dual SMAD Inhibition
SMAD proteins are the principal signal transducers of the Transforming Growth Factor-β
(TGF-β) signalling receptor superfamily. Dual SMAD inhibition is a technique that allows for
monolayer induction of NPCs from iPSCs without the need for embryoid body formation.
This restriction of lineage differentiation is achieved through the selective inhibition of both
BMP and Activin/Nodal/TGF-β signalling pathways. The blocking of these pathways
individually had previously been shown to aid neuronal differentiation of ESCs through the
use of the protein Noggin for BMP-signalling inhibition (Lee et al., 2007; Elkabetz et al.,
2008) and the small-molecule SB431542 for inhibition of the Nodal/Activin/TGF-β pathway
(Smith et al., 2008). The seminal paper that brought both of these strands together showed
that the dual inhibition of these pathways was sufficient to induce NPC differentiation and
subsequent neuronal maturation in completely defined conditions (Chambers et al., 2009).
Multiple studies have used different compounds to elicit the inhibition of each
pathway. For instance, BMP signalling can be inhibited using the recombinant protein
Noggin, but also by the synthetic compounds Dorsomorphin (Shi, Kirwan and Livesey, 2012;
Naujock et al., 2014; Stanslowsky et al., 2014) and LDN193189 (Kriks et al., 2011; Prè et al.,
2014). In general terms the NPC induction by dual SMAD inhibition is reportedly faster than
that derived from the EB-based induction (Muratore et al., 2014) and is generally stated to
work with high efficiency. However, a recent study looking at direct comparisons of neural
induction from EB-based and dual SMAD inhibition approaches in iPSCs reported a lower
neural induction with the dual SMAD inhibition technique (Muratore et al., 2014).
It should also be noted that these two techniques are not strictly mutually exclusive.
Recent studies have reported successful neuronal differentiation via induction of NPCs
through a combination of dual SMAD inhibition during EB formation (Stanslowsky et al.,
2014; Qian et al., 2016). This is a clear demonstration that although vague divisions can be
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made between stages of various differentiation protocols, this is a highly changeable
sphere of frontier research and slight modifications and alterations to existing protocols are
the rule and not the exception.

1.2.5 Stromal Cell-Derived Inducing Activity (SDIA)
The method of neural induction via SDIA is derived from the co-culture of iPSCs with
specific stromal cell lines. These stromal cells (as a replacement for fibroblastic feeder cells
in classical PSC culture) supply factors to the iPSCs that directly induce the generation of
NPCs. The stromal cell lines used to trigger neuronal lineage differentiation are
predominantly the PA6 (Kawasaki et al., 2000) and MS-5 (Lee et al., 2007) lines. Although
this is still a widely used and completely valid technique, it does come with some
disadvantages when applied to modern iPSC research. Firstly, it involves the use of an
animal cell line, which for human iPSC regenerative research may make this technique
difficult to apply clinically. Secondly, the system of induction is an undefined one and the
factors necessary to drive this induction are not completely known or understood.
However, some progress has been made by screening the stromal cells for elevated factors,
and protocols do exist for neural induction using these so-called SPIE factors (Stromal cellDerived Factor-1, Pleiotrophin, Insulin-like Growth Factor-2 and Ephrin-B1) (Vazin et al.,
2009). As with all these techniques described above, extensive characterisation of NPCs
must be undertaken to ensure reproducibility between separate induction experiments.
This will be integral to in vitro studies into disease-modelling that may hinge on subtle
differences in neuronal maturation between healthy and disease-specific iPSC lines. Any
irregularities in the induction of neural subtypes could therefore mask or negate any
phenotypic changes present between healthy and disease-specific lines. Therefore,
undefined or stochastic NPC induction protocols may result in irreproducible downstream
assays or therapeutic outcomes.

1.3 Specific Neuronal Subtype Differentiation
The next step in the chain of in vitro neuronal differentiation is the patterning of NPCs and
subsequent maturation of the desired neural subtype. As stated above, these protocols
take general cues from the in vivo patterning of the neural tube. That being said, the time
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of exposure to patterning morphogens, the combinations & concentrations of signalling
molecules or agonists, and the time of maturation before experimental analysis of postmitotic neurons differs greatly from study to study (Compagnucci et al., 2014). This chapter
will therefore try to bring together an overall demonstrative consensus of many neuronal
differentiation studies to obtain a broad picture of subtype specific factors (Fig 1-3).
The stages of neuronal specification can be crudely broken down into; the neural
induction step (covering the generation of pattern-competent NPCs); the patterning step,
(in which suitable morphogens are used to recapitulate spatial location in the neural tube
and therefore trigger lineage restriction); and the maturation step (where neurons are
matured in media conducive to terminal differentiation and synaptogenesis) (Petros, Tyson
and Anderson, 2011). This is not always the case, however, and some protocols throughout
the literature do not use a pool of unpatterned NPCs, instead utilising a “pre-patterning”
step that combines patterning factors with the early stages of neural induction. These
protocols add patterning factors directly or soon after the start of neural induction of iPSCs
and attempt to pre-determine neuronal lineage specification simultaneously with NPC
generation [for example (Hartfield et al., 2014)]. However, it should be noted that reported
efficiencies will vary from study to study and no definitive protocols exist for subtype
differentiation. An overview of specific neural subtype differentiation protocols for
forebrain, midbrain and hindbrain lineages is outlined below.
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Figure 1-3: In vitro methods of generating Neural Progenitor Cells (NPCs) and specific
neural cell lineages from iPSCs. The morphogens used are predominantly derived from
known in vivo signalling events. Solid blue lines indicate patterning of NPCs after neural
induction. Dashed red lines indicate patterning during the NPC induction step. SHH,
Sonic Hedgehog; WNT, Wingless-type MMTV Integration site; FGF, Fibroblast Growth
Factor; EGF, Epidermal Growth factor; RA, Retinoic Acid; BMP, Bone Morphogenetic
Protein; CNTF, Ciliary Neurotrophic Factor; JAG-1, Jagged-1; GDNF, Glial-cell Derived
Neurotrophic Factor; BDNF, Brain-derived Neurotrophic Factor; TGF-β, Transforming
Growth Factor-Beta; GDF, Growth Differentiation Factor; SDIA, Stromal-cell Derived
Inducing Activity.
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1.3.1 Forebrain Lineages
NPCs generated via the majority of neural induction pathways listed above and cultured in
a basic neural maintenance media free of any morphogens, will differentiate into mature
neuronal lineages (Hansen, Rubenstein and Kriegstein, 2011). More specifically this
“default pathway” directs a neural lineage specific to dorsal forebrain cortical neurons
(Zeng et al., 2010; J.-E. Kim et al., 2011; Shi, Kirwan and Livesey, 2012). This is true across
neural induction strategies in murine ESCs (mESCs), human ESCs (hESCs) and human iPSCs
(hiPSCs). Therefore an “uncontrolled” or “un-patterned” differentiation will create a
neuronal culture rich in glutamatergic (excitatory) and, to a lesser extent, γ-aminobutyric
acid (GABA)ergic (inhibitory) neurons (Gaspard et al., 2008; Li et al., 2009; Espuny-Camacho
et al., 2013). This is an interesting point of fact as it displays a developmental bias to form
anterior dorsal neural cell types in the absence of other neural tube patterning factors, and
not simply a random assortment of neuronal cell lineages. This default dorsalisation effect
can be further strengthened by the use of the SHH-signalling antagonist Cyclopamine,
which near abolishes the presence of ventral/inhibitory neuronal subtypes (Gaspard et al.,
2008), or with the application of the dorsalising signalling molecule WNT-3A (Li et al.,
2009). This is also seen functionally where the electrophysiological properties of these
“default” dorsal cultures do not alter firing properties under antagonism of GABA
signalling, showing their low presence within these neural cultures (Kirwan et al., 2015).
In general terms, neuronal cultures with a high proportion of glutamatergic
neurons are said to have dorsal forebrain characteristics (mirroring the spatial coordinates
of the neural tube from which they would be derived in vivo), whereas cultures with a high
proportion of GABAergic neurons are said to be derived from ventral forebrain or
“ventralised”.
It has also been shown that the use of dorsal-ventral patterning factors can alter
the percentage of excitatory and inhibitory neurons in this forebrain lineage pathway.
Forebrain GABAergic interneurons account for about 20% of the neocortical neuronal cell
number and develop from ventral in vivo structures termed the ganglionic eminences,
namely the lateral ganglionic eminence (LGE), the caudal ganglionic eminence (CGE), and
the medial ganglionic eminence (MGE) (Danjo et al., 2011; Arber and Li, 2013; Yan Liu et al.,
2013). The latter also containing progenitors of forebrain cholinergic neurons (Crompton et
al., 2013). In utero these interneurons then undergo a large tangential migration into the
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dorsal cortical tissues. Very high patterning concentrations of SHH (or purmorphamine – a
SHH pathway agonist) have been shown to trigger GABAergic interneuron differentiation in
in vitro PSCs (Maroof et al., 2010; Danjo et al., 2011; Goulburn et al., 2012; Ma et al., 2012;
Arber and Li, 2013; Yan Liu et al., 2013; DeRosa et al., 2015) sometimes combined with
antagonists of Wnt-based dorsalising pathways such as Dickkopf-1 (DKK-1) (Li et al., 2009).
Through regulation of the concentration of ventralising signalling molecules it is
possible to derive not only crude measures of GABAergic interneurons, but also define
particular subsets of inhibitory NPCs derived from each of the ganglionic eminences. High
concentrations of SHH (or its pathway agonists) generate pools of ventral NPCs displaying
markers of the MGE and CGE neuraxis regions, whereas lower amounts instead generate
medium spiny neuronal NPCs of the LGE (Danjo et al., 2011; Ma et al., 2012). These
divisions can be further tailored by the addition of FGF-8 which increases the population of
MGE-specific precursors, but is inhibited through the addition of FGF-15/19, while
conversely CGE-specific precursor induction efficiencies are increased with FGF-15/19
treatment and suppressed by FGF-8 (Danjo et al., 2011). Other GABAergic differentiation
protocols have also found an enhancing effect of FGF-8 treatment when paired with a SHHagonist and IWP-2 (an antagonist of the dorsalising Wnt-signalling pathway) (Kim et al.,
2014). Interneurons derived in this way have been successfully transplanted into murine
models of induced-epilepsy and display functional integration to a level that ameliorated
the seizure activity (Cunningham et al., 2014). LGE-specific GABAergic NPC induction can be
initiated through strict control and reduction of SHH or SHH-agonist concentration, to a
level lower than is necessary for MGE and CGE differentiation, and therefore generate
pools of NPCs with different marker compositions distinct from other GE and dorsal
precursor cell types (Ma et al., 2012).
Interestingly, similar differentiation strategies have generated cultures enriched
with forebrain cholinergic neurons (Crompton et al., 2013). Other strategies have combined
SHH with the midbrain marker FGF-8, and further treatment with BMP-9, to generate high
induction efficiencies of forebrain cholinergic neurons (Bissonnette et al., 2011).
Surprisingly, other studies have reported GABAergic lineage differentiation based
on NPC treatment with all-trans-retinoic acid (Chatzi et al., 2009; Addae et al., 2012) as a
single factor that generates the specific ventral subtype, as well as in combination with
FGF-2 (Goulburn et al., 2011) although the authors postulate these cells arise from a
diencephalic rather than telencephalic origin. RA, as was discussed in the context of neural
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tube patterning, is used as a posteriorising signal and is predominantly associated with
hindbrain and spinal cord neuronal development. The majority of motor neuron and
hindbrain neuron differentiation strategies discussed below (Section 1.3.3) utilise RA as a
caudalising patterning signal. It is therefore intriguing how forebrain lineages may be
formed from this treatment. The concentration and timing of treatment does however
differ between protocols and indeed certain levels of RA and retinoids may encourage
cortical induction without caudalising the NPCs to a noticeable extent (Shi et al., 2012; Shi,
Kirwan and Livesey, 2012). Even FGF-2 treatment (as will be discussed below) utilised in a
subset of GABAergic differentiation strategies and also a major component in many
proliferation media for NPC propagation, can have caudalising effects on the NPCs
themselves and can therefore generate more caudal neural subtypes (Falk et al., 2012;
Zhou et al., 2016).
Even more surprising is the report that treatment with Activin (a member of the
TGF-β signalling family) could induce the differentiation of Calretinin-expressing CGEspecific interneurons through the downregulation of SHH signalling and the upregulation of
RA signalling events (Cambray et al., 2012). Both components of this result appear counterintuitive, but nevertheless highlight the esoteric nature of neural lineage differentiation
both in vivo and in vitro.
Hippocampal dentate gyrus (DG) neurons are derived in vivo from the most
dorsomedial region of the telencephalon (Yu, Marchetto and Gage, 2014). Protocols
focused on the differentiation of DG neurons from PSCs are quite sparse in the literature
but successful attempts have utilised a combination of WNT-3A dorsalising morphogen
together with brain-derived neurotrophic factor (BDNF) (Yu et al., 2014), as well as a
combination of the dorsalising factors CHIR99021 (a Wnt-signalling agonist) and BMP-4
(Sakaguchi et al., 2015).
It is worthy of note, that although a multitude of differentiation protocols exist for
the generation of human neural subtypes through morphogen patterning as outlined
above, the speed of differentiation and maturation of each cell type follows an intrinsic
timeline that closely mimics that of in utero brain development (Espuny-Camacho et al.,
2013). Consequently PSC-derived cortical neural models derived from murine cell types will
differentiate and mature on a much more compressed timeline than for human PSCderived cortical neural cultures (Van den Ameele et al., 2014; Kelava and Lancaster, 2016)
(Fig 1-4 A). This intrinsic timing of cellular differentiation and maturation of human NPCs
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also reveals in vitro temporal recapitulation of markers of corticogenesis indicative of in
utero cortical lamination events (Hansen, Rubenstein and Kriegstein, 2011; Anderson and
Vanderhaeghen, 2014).
Development of the human cortex into a highly organised multi-layered laminar
structure generated from the pre-plate primordium occurs in a regulated temporal and
spatial manner, with each neuronal layer having distinct gene expression markers. The
timing of this series of precursor differentiation and maturation events of each layer
identity is preserved in in vitro PSC differentiation studies, allowing for an exquisite view in
vitro of the protracted time of cortical layer development (Hansen, Rubenstein and
Kriegstein, 2011; Espuny-Camacho et al., 2013; Anderson and Vanderhaeghen, 2014;
Kelava and Lancaster, 2016). This faithful recapitulation of the inside-out nature of cortical
lamination from early deep-layer neurons to later upper-layer neurons, followed by glial
cell differentiation can form the basis of studying human-specific brain structures that may
not be present or markedly reduced in brains of other animal models, such as the outer
subventricular zone (Kelava and Lancaster, 2016) (Fig 1-4 B). Even implantation of human
cortical NPCs into developing mouse brains did not accelerate the sequential maturation
profile of the human cortical neurons, suggesting a level of tight control on these timing
and maturation events that are not easily swayed by the cellular environment (EspunyCamacho et al., 2013). Other implantation studies of human cortical NPCs into embryonic
murine cortex do show robust migration and integration into the post-natal brain, showing
that even if intrinsic maturation timing is different, the human cells will still develop
faithfully in an in vivo environment (Nagashima et al., 2014).
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Fig 1-4: (A) The in vitro cortical differentiation of human and murine PSCs follows
the same pattern of layer-specific development and intrinsic timing as is seen in
utero. (B) Each cortical layer contains neurons of specific gene expression profiles
that develop sequentially during the formation of the cytoarchitecture. Gliogenesis
follows after the bulk of neurogenesis. Figures adapted from Anderson &
Vanderhaeghen 2014; Hansen et al. 2011

1.3.2 Midbrain Lineages
A very high proportion of PSC-neural differentiation studies are based around midbrain
dopaminergic neuron generation, compared to other neural lineages. Dopaminergic
neuronal subtypes are strongly affected in Parkinson’s disease (PD) pathology, and hence
many research groups have focused on its lineage specification as a basis to better
understand the mechanisms of PD-related neurodegeneration. These neurons in vivo are
specified from the developing midbrain (Brodski et al., 2003). A large amount of FGF-8
signalling denotes the midbrain-hindbrain boundary (the isthmic organiser) and as such,
20

FGF-8 treatment is a constant factor in almost all in vitro dopaminergic neuron
differentiation strategies, together with the ventralising effect of SHH (Petros, Tyson and
Anderson, 2011). Treatment with SHH triggers a strong ventralising signal which mirrors the
in vivo discovery that true midbrain dopaminergic neurons develop from the floor plate
(the most ventral mid-line portion) of the neural tube (Ono et al., 2007). Successful
combinations of these factors to generate neurons with dopaminergic markers have been
shown in hESCs (Koch et al., 2009; Kriks et al., 2011) and hiPSCs (Swistowski et al., 2010;
Zeng et al., 2010; Kikuchi et al., 2011; Kriks et al., 2011; Stanslowsky et al., 2014) and have
also been shown to be electrophysiologically active (Hartfield et al., 2014). These protocols
include the use of patterning and pre-patterning (or “pre-rosette”) treatments with SHH
and FGF-8 to obtain the target dopaminergic lineage. One of these studies showed
improved in vivo dopaminergic marker presence and improved in vivo grafting of the
generated neuronal pool when FGF-8 and SHH treatment was paired with canonical Wntsignalling (Kriks et al., 2011). The initial step used high amounts of SHH to ventralise the
NPCs during induction into a floor-plate-like cell type which was then patterned with FGF-8
and the Wnt-signalling activator CHIR99021. As with forebrain patterning methodologies,
the use of Wnt-signalling was linked with dorsalisation of the NPCs, and hence in this
method the timing and use of both ventralising and dorsalising signals is necessary for
improving specific dopaminergic differentiation. This then reinforces the concept of the
strong interplay between morphogen gradients within the neural tube in vivo and the fine
tuning that is capable in vitro to derive neuronal subtype specificity.
A large portion of dopaminergic differentiation methodologies also report
successful differentiation when utilising solely the stromal cell co-culture neural induction
strategy (SDIA) outlined previously (Kawasaki et al., 2000; Zeng et al., 2004; Parmar and Li,
2007). This leads to the conclusion that although neural induction is indeed possible with
SDIA, the generated NPCs would in effect be patterned or at least biased for
midbrain/hindbrain lineage differentiation. This pro-dopaminergic patterning of NPCs by
SDIA has been utilised by other studies in conjunction with treatment of the patterning
factors SHH and FGF8 (Perrier et al., 2004), while another study showed successful
dopaminergic differentiation of hESCs using the SPIE factors (Section 1.2.5) as a neural
inductive signal to trigger not only patterned NPCs but also dopaminergic lineage
differentiation (Vazin et al., 2009).
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It is also interesting to note that NPCs propagated in long term culture in the
presence of FGF-2 and epidermal growth factor (EGF), will default to a midbrain/hindbrain
specification instead of forebrain lineages (Falk et al., 2012). This is probably due to the
effect of FGF-2 which is a known caudalising signal in NPC patterning (Shi, Kirwan and
Livesey, 2012; Karus, Blaess and Brüstle, 2014; Zhou et al., 2016). Under these conditions,
the continuously propagated NPCs will be biased towards a midbrain or hindbrain lineage
specification during maturation and not the “default” cortical lineage as in protocols that
involve neural induction and maturation in a single continuous process from iPSCs
(Anderson and Vanderhaeghen, 2014).

1.3.3 Hindbrain and Spinal Lineages
As with in vivo patterning of the neural tube, the specification of hindbrain and spinal
lineages in vitro is dependent on the presence of midbrain and/or caudalising signalling
molecules during or after neural induction. Serotonergic neurons in vivo are generated in
an area of the rostral (or anterior) hindbrain (Goridis and Rohrer, 2002) and as with
dopaminergic neuron development the midbrain-hindbrain organiser is integral for this
specification (Brodski et al., 2003). Neural tube explant studies highlighted the necessity of
not only SHH and FGF-8 signalling, but also pre-patterning with FGF-4 (probably derived
from the primitive streak in vivo) as an inductive cocktail to drive serotonergic neuron
differentiation ex vivo (Ye et al., 1998). These factors have since been shown to successfully
generate serotonergic neurons from various PSCs in vitro (Barberi et al., 2003; Alenina,
Bashammakh and Bader, 2006). Interestingly, higher serotonergic induction was reported
using the MS5 SDIA induction method than with the EB-based neural induction (Alenina,
Bashammakh and Bader, 2006). Another recent method of serotonergic neuronal
differentiation employed a “single-step” induction of ESCs and iPSCs using only a
monolayer culture of PSCs on a thick layer of Matrigel (a murine sarcoma-derived
extracellular matrix product) and treatment with Noggin (a BMP-signalling antagonist)
(Shimada et al., 2012). It is surprising that serotonergic differentiation was derived without
the exogenous use of a separate neural induction step, nor any of the classical midbrainhindbrain signalling factors or FGF-4. A possible explanation for this may be the undefined
nature of Matrigel, in terms of growth factor composition, directly influencing lineage
selection.
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Successful cerebellar granule neuron differentiation protocols in the literature are
predominantly based around more complex and sequential addition and removal of
patterning factors throughout neural induction and maturation. One of the first studies
reported in the literature, using mESCs, generated Math1+ cerebellar precursor cells and
L7+ Purkinje cells. The ESCs underwent a SDIA neural induction followed by treatment with
BMP-4 and WNT3a resulting in the formation of cerebellar precursors. Additional
treatment with FGF-8 resulted in more Purkinje cells being generated (Su et al., 2006).
Mature granule neurons have also been generated from mESCs through a stepwise
exposure to a much wider array of morphogens through the EB-based induction method:
Addition of WNT1, WNT3a, FGF-2, FGF-4, FGF-8, and RA trigger initial patterning. This in
turn is followed by BMP-6, BMP-7 and Growth Differentiation Factor-7 (GDF-7) for further
maturation, and then finally SHH and Jagged-1 (JAG-1) (Salero and Hatten, 2007).
Functional cerebellar neurons from hESCs have also been generated with efficiencies over
75% using the same array of morphogens listed above but in a five-step sequential process
over the first thirty days of induction (Erceg et al., 2012). Cerebellar neural induction in
vitro therefore seems to require tightly controlled midbrain, caudalising, early dorsalising
and late ventralising signals by which to specify developmental identity.
Motor neuron (MN) lineage specification tends to rely on a strong caudalising
signal (namely RA) and ventralising signal (either SHH or Purmorphamine) to promote
specific differentiation. This basic concept of MN induction works consistently in mESCs
(Barberi et al., 2003; Soundararajan et al., 2007), hESCs (Lee et al., 2007; Li et al., 2008;
Koch et al., 2009) and hiPSCs (Hu and Zhang, 2009; Karumbayaram et al., 2009; Zeng et al.,
2010; Corti et al., 2012). Successful MN differentiation with these factors does not seem
dependant or inhibited by any particular method of neural induction and positive MN
differentiation is seen from SDIA-based protocols (Barberi et al., 2003; Lee et al., 2007) and
EB-based inductions (Hu and Zhang, 2009; Karumbayaram et al., 2009; Zeng et al., 2010).
hiPSC-derived MNs differentiated in this way are reportedly electrically active and
functional after 10 weeks in vitro (Hu and Zhang, 2009; Karumbayaram et al., 2009) and
have been successfully engrafted in murine models of Spinal Muscular Atrophy (Corti et al.,
2012).
It is also worthy of note that unlike forebrain lineage differentiation which may be
inhibited in NPCs kept in long-term culture due to the caudalising effect of FGF-2, MNs can
still be differentiated easily from long-term extended culture of NPCs (Koch et al., 2009).
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1.3.4 Glial Cell Differentiation
Glial cell differentiation, migration and maturation in vivo occurs predominantly after that
of neuronal development and continues to do so postnatally (Barateiro and Fernandes,
2014). This pattern of delayed glial differentiation also holds true for in vitro neural
differentiation studies (Gaspard et al., 2008; Krencik et al., 2011; Emdad et al., 2012; Gorris
et al., 2015). There are many reasons why the generation of glial cell subtypes
independently from neuronal lineages would be advantageous. Firstly, for improved
neurological modelling, astroglial cell subtypes are known to have pro-synaptogenic
properties and may aid with generating more mature and in vivo-like neuronal networks
(Christopherson et al., 2005; Hu et al., 2007; Hughes, Elmariah and Balice-Gordon, 2010;
Kucukdereli et al., 2011; Clarke and Barres, 2013). Secondly, for disease-modelling studies,
the role of glial cells may have an integral role in the pathology of the neurological
condition and therefore could be studied in isolation or in tandem with neuronal
populations: such as the toxic effects on hESC-derived motor neurons seen when cocultured with astroglial cells carrying an amyotrophic lateral sclerosis-related (ALS)
mutation (Di Giorgio et al., 2008). Finally, for regenerative therapies, certain glial subtypes
such as oligodendrocytes could be transplanted to generate autologous therapies for
multiple sclerosis (Grade, Bernardino and Malva, 2013) or other CNS trauma (Nistor et al.,
2005), also demonstrated through astroglial-rich NPC transplantations into ALS-affected
mice (Kondo et al., 2014). Because of the intrinsic delayed nature of gliogenesis from PSCs
undergoing neural induction, many protocols to generate both astroglial and
oligodendrocyte cell types in the literature do so over a longer time frame than for
neuronal subtype differentiation.
For astroglial differentiation of PSCs in vitro, many protocols utilise treatment with
ciliary neurotrophic factor (CNTF) which has been shown to enrich Glial Fibrillary Acidic
Protein-positive (GFAP+) cells (a marker of astroglial identity) in embryonic murine NSCs
(Kanski et al., 2014), although not as a single factor within differentiation formulations.
Such an example used treatment with both CNTF and FGF-2 by which to generate astroglial
cell types from PSC-derived NPCs (Emdad et al., 2012). Other protocols utilise a
combination of leukaemia inhibitory factor (LIF) and BMP-4 which has been shown in
primary NSC culture to promote the differentiation of astroglial cells (Bonaguidi et al.,
2005) and which has also been successful in generating astrocyte lineages in vitro from
hESC-derived NPC populations (Gupta et al., 2012; Kondo et al., 2014). A combination of
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BMP-2 and CNTF was utilised in another study in the differentiation of astroglial lineages
from PSCs, which also recognised heregulin (an alternative splice variant of neuregulin and
member of the EGF-like ligands) as a strong inducer of astroglial cell phenotypes (Shaltouki
et al., 2013). Long term culture of “patterned” NPC types with individual or combinations of
the dorsal-ventral and rostral-caudal morphogens FGF-8, SHH, and RA results in astroglial
subtypes from various developmental regions of the neural tube and that further
treatment with CNTF at later time points in differentiation can aid to increase the presence
of astroglial cell types, albeit over months of differentiation (Krencik et al., 2011).
Early oligodendrocyte differentiation studies employed the use of insulin and
Triiodothyronine (T3) as morphogens to induce oligodendroglial lineages during extended
proliferation of NPCs generated by EGF & FGF-2, which all followed NPC induction via RA
treatment of hESCs (Nistor et al., 2005). A similar protocol to the one above, together with
a temporally controlled addition of Noggin (a BMP-signalling antagonist) increased the
presence of cells displaying oligodendrocyte lineage markers (Izrael et al., 2007). Yet
another study utilising long term NPC expansion through FGF-2 and EGF based media,
enhanced oligodendroglial precursors through the early addition of platelet derived growth
factor (PDGF-AA) with a later maturation triggering signal of T3 (Kang et al., 2007). The
derivation of oligodendroglial cells from other patterned regions of the neural tube have
also been investigated. Ventral spinal oligodendrocytes were successfully generated after
patterning of hNPCs with both ventralising and caudalising morphogens; SHH and RA, prior
to the addition of the oligodendrocyte maturation cytokines; PDGF-AA, insulin-like growth
factor 1 (IGF-1), and T3 (B.-Y. Hu et al., 2009; Hu, Du and Zhang, 2009). Interestingly, the
authors show a role for FGF-2 inhibiting motor neuron generation and instead favouring
the formation of early oligodendroglial precursors, but that extended FGF-2 treatment
inhibits the maturation of these precursors. This further demonstrates that tailoring the
temporal exposure of the same morphogen, can have stark effects on downstream NPC
differentiation. This again reinforces that these processes are both biochemical and
temporal in nature, and that both have equal weight in development of these protocols.
Other oligodendrocyte differentiation methodologies have used similar induction cytokines
as listed above (FGF-2, EGF, PDGF-AA, IGF-1, and T3), together with further glial inductive
signals; CNTF (as is used in astroglial differentiation protocols), ascorbic acid (AA) (Sundberg
et al., 2010), and neurotrophin-3 (NT-3) (Czepiel et al., 2011) but each morphogen
exposure controlled via specific temporal exposure.
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As a method of further refining and enriching the NPC pool from neural lineage
induced PSCs, some studies have employed a fluorescence-activated cell sorting (FACS)
step within the protocol. After initial neural induction, NPCs cultured in the presence of T3,
RA, EGF, and FGF-2 triggered a radial glial-NPC identity, before FACS separation of cells
displaying a CD133+ (prominin) plasma membrane marker. Final oligodendroglial
maturation was prompted through exposure to PDGF, AA, T3, and Noggin (Gorris et al.,
2015).

1.4 Transcription Factor-Induced Neuronal Differentiation
Apart from the use of developmentally related morphogens to derive mature
neuronal lineages from PSCs, some research groups have utilised forced expression of
specific neural transcription factors (TFs) to induce precise neuronal subtype differentiation
(Velasco et al., 2014). The transcription factors used are ones that are known to be
functional in developmentally-early neural tissue patterning and can be thought of as
downstream effectors of soluble morphogen patterning. Numerous neuronal cell types
from forebrain to hindbrain lineages have already been generated from these TF-based
methodologies (Allodi and Hedlund, 2014).
Generally speaking, the neuronal cultures developed with this methodology
reportedly have a much quicker neural identity induction time, in the scale of weeks until
yielding electrophysiologically functional neurons, compared to morphogen-based
protocols which may be in the scale of months (Kirwan et al., 2015; Odawara et al., 2016).
Induction efficiencies are also consistently reported as much higher when direct forced
expression of TFs drives neural differentiation; generally over 90% (Bissonnette et al., 2011;
Zhang et al., 2013).
Some neural subtypes seem to only require one neural TF to show lineage
determination, such as Neurogenin-2 (Ngn-2) which can drive PSCs and PSC-derived NPCs
to an almost completely pure cortical excitatory neuronal lineage (Zhang et al., 2013; Ho et
al., 2016). Ascl1 alone has also been shown to convert human fibroblasts into functional
neurons as a single exogenous factor, although this process can be enhanced when other
concurrent factors are also transfected (Chanda et al., 2014). Other neuronal induction
protocols require multiple neural TFs to trigger an efficient specific induction, such as
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neurogenesis from hiPSCs through forced expression of both neurogenin-1 (Ngn-1) and
Ngn-2 (Busskamp et al., 2014). Excitatory cortical neurons have also been induced and from
murine fibroblasts using forced expression of the three factors Ascl1, Brn2 and Myt1l
(Vierbuchen et al., 2010) and together with NeuroD triggered neuronal induction in human
fibroblasts (Pang et al., 2011).
Midbrain dopaminergic neurons differentiated from hiPSCs required the synergistic
co-transfection of the Ascl1, Nurr1 and Lmx1a TFs (Theka et al., 2013). For spinal neural
lineages, a combination of Ngn2, Isl1 and Lhx3 induced spinal motor neuron differentiation
in mESCs. Interestingly, the replacement of Lhx3 with Phox2a generated a pool of cranial
motor neurons (Mazzoni et al., 2013). This synergistic overlap between TFs is indicative of a
system by which no one particular TF purely denotes each neural subtype (e.g. Ngn2 has
been used both in excitatory cortical and motor neuron differentiation) or developmental
location but instead neural tube signalling works in concert with multiple TFs in order to
differentiate specific neural subtypes (Imayoshi and Kageyama, 2014).
This is also evident when TF transfections are used in conjunction with soluble
morphogen patterning to try and enhance the induction efficiency of particular neural
lineages. The combination of forced expression of single or multiple TFs and different
patterning morphogen compositions has potent effects on the subtype and homogeneity of
neural subtypes during neural induction and differentiation. Patterning of hESC-NPCs with
FGF-8 and SHH, during forced expression of Lhx8 and Gbx1, generates basal forebrain
cholinergic neurons (Bissonnette et al., 2011; Duan et al., 2014). Similar patterning
morphogen treatment with FGF-8, SHH and FGF-2 but with forced expression of Lmx1a will
produce dopaminergic neurons from hESCs (Friling et al., 2009), but not to the high
efficiency recorded in multi-TF transfection protocols. A similar protocol with the same
soluble factors (but without FGF-2) and Lmx1a, expressed from a Nestin-enhancer,
generated dopaminergic neurons from mESCs (Panman et al., 2011). FGF-8 and SHH
priming with the forced expression of Phox2a or Phox2b instead of Lmx1a in mESCs will
trigger differentiation into visceral motor neurons (Panman et al., 2011; Mong et al., 2014),
however, replacing SHH with BMP-7 but retaining forced Phox2b expression, instead
generated dorsal hindbrain noradrenergic neurons (Mong et al., 2014).
Patterning with both ventralising (SHH) and caudalising (RA) signals can aid with
other forced expression of single TFs in ESCs. For example, Nkx2.2 expression generates
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high levels of serotonergic neurons, while Olig2 expression with the same morphogens will
trigger somatic motor neuron differentiation (Panman et al., 2011).
While the results of these TF-based studies are striking in terms of apparent
induction efficiency, subtype specificity, and speed of neuronal functionality; they must be
weighed against the possible disadvantages of forced gene expression and effects related
to developmental genes activated out of order, or not in correct synergy with other
associated genes. This is of course not to say that neural cultures generated in this way
would be unsuitable for disease modelling or developmental applications; indeed
cholinergic neurons produced from TF forced expression have already been used in an
Alzheimer’s disease model (Duan et al., 2014). Experimental methodologies that would
require quick differentiation and electrophysiological analysis from a very pure and
reproducible iPSC-derived neuronal subtype may very well prefer TF-based methods to
slower developmentally-based morphogen protocols.
Even more intriguing is the finding that transdifferentiation of fibroblasts to neural
subtypes can be achieved without ectopic expression of neural-associated TFs, and instead
is possible purely from chemical induction. Induced neural stem cell-like cells (iNSLCs) were
generated from murine fibroblasts after treatment with nine separate chemical factors
alone (M. Zhang et al., 2016).

1.5 Neuronal Subtype Enrichment
Heterogeneous cell populations are often generated when utilising neural induction
protocols from hPSCs. For developmental studies this may not be an issue as the native
mixed generation, maturation and connectivity of neuronal and glial cell types are the basis
of the assays being undertaken, and are known to follow embryological developmental
timelines (Hansen, Rubenstein and Kriegstein, 2011; Van den Ameele et al., 2014; Kelava
and Lancaster, 2016). Certain instances however, necessitate highly reproducible and highyield pools of specific neural progenitors or neuronal subtypes for study. This is most
evident in degenerative disease modelling where the pathology of the disease is limited (to
the best current knowledge) to a particular neuronal subtype, for example, dopaminergic
neurons in Parkinson’s disease and motor neurons in Spinal Muscular Atrophy.
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One study performing a FACS-based screen of cell surface markers of NPCs
differentiated from hPSCs at different stages of induction and differentiation identified a
CD184+/CD271-/CD44-/CD24+ cell population that was able to distinguish between noninduced hESCs (which do not express CD184) and non-NPC and neural crest cell
contaminants (which express CD271 and CD44) thus selecting a “true” population of NPCs.
After propagation and expansion of this cell pool into differentiation media the authors
identified cell-surface combinations for glial pools of cells (CD184+/CD44+) and neuronal
pools (CD184-/CD44-/CD15LOW/CD24+) if further cell sorting and purification was necessary
prior to terminal differentiation and maturation (Yuan et al., 2011).
As well as cell surface markers, fluorescent protein reporters can be used to
identify and sort specific neuronal lineages. When transfected either into the PSC line or
NPC pool, these reporters can be driven by cell type-specific promoters or enhancers to
ensure that the reporter is only expressed when the gene of interest is transcriptionally
active. Examples of this technique have proven effective in identifying, sorting and
enriching motor neurons via the use of a HB9-driven GFP reporter (Karumbayaram et al.,
2009), serotonergic neurons using a Pet-1 driven reporter (Shimada et al., 2012), and
GABAergic interneurons with either an Lhx6- (Maroof et al., 2010), vGAT- (DeRosa et al.,
2015), or NKX2.1-driven fluorescent reporter (Goulburn et al., 2011).
There are some important caveats to the use of these reporter constructs for
neuronal enrichment protocols, namely issues of transient gene expression, non-specific
expression and timing of cell selection during differentiation. The gene of interest used to
drive the promoter must be specific and robust enough to a particular subtype so that
other developing lineages or proliferative cells are not falsely selected. For example
tyrosine hydroxylase (TH) is a well-used marker for mature dopaminergic differentiation,
however, TH is also transiently expressed in other cell lineages during development (Allodi
and Hedlund, 2014). Thus, a purely TH-driven promoter would enrich for both
dopaminergic and non-dopaminergic cell types depending on the stage of differentiation
chosen for sorting. Other dopaminergic promoter-reporter constructs based around early(Hes5), mid- (Nurr1) and late- (Pitx3) dopaminergic markers resulted in different recovery
efficiencies and cell pool enrichments. The later and mid marker-reporters (Nurr1 and
Pitx3) had higher purity cultures of dopaminergic neurons after FACS-based sorting than
the earlier developmental marker Hes5 (Ganat et al., 2012). The trade off in using later
markers rather than earlier ones is one of cell recovery efficiency and cell survival –
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whereby more mature post-mitotic neurons will tend not to survive FACS-based sorting
protocols.

1.6 Organoids for Studying Neurological Development and
Disease
Perhaps the most striking finding in recent years within iPSC-neural modelling is the
development of tissue-specific organoid cultures. Organoids are three-dimensional (3D)
cellular aggregates in which the contained stem cells differentiate and self-organise into
structures reminiscent of in vivo tissue or functional elements of mature organs (Lancaster
and Knoblich, 2014; Huch and Koo, 2015). Human PSC-derived NPCs will differentiate into
neuronal lineages depending on patterning factors they are exposed to in vitro. Incredibly
however, if the hPSCs undergo neural induction as 3D aggregates they will begin to selforganise and recapitulate developmental structures indicative of early brain tissue (Karus,
Blaess and Brüstle, 2014). These induced-aggregates will display neural tube-like
morphology with the affiliated apical-basal polarity and gene expression patterns, and if
left to develop over time will generate forebrain layered early-cortical structures (Mariani
et al., 2012; Kadoshima et al., 2013) or cortical-spheroid structures (Paşca et al., 2015).
These are defined loosely by the homogeneity of the contained cells and the complexity of
the derived neural cytoarchitecture. The basis of this line of research was born out of the
extended SFEBq neural induction protocols used previously for PSC-based neural derivation
(Eiraku et al., 2008).
A single aggregate may contain multiple early-cortical-like structures, but when
cultured in Matrigel droplets and cultured in a spinning bioreactor, a much more
continuous neuroepithelia is generated, enabling more defined cortical regions over long
term culture (Lancaster et al., 2013) as well as discrete midbrain/hindbrain structural
markers, and with a subset even developing retinal tissue. Organoids cultured in this way
displayed discrete non-overlapping regions of cortical layering with gene expression of
early- and late-born neural markers, an outer Reelin-positive layer, and even interneuron
migration from ventral to dorsal regions of the organoid (Lancaster et al., 2013). Even
though these organoids will develop in the absence of any exogenous factors, the
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organoids themselves are responsive to neural-tube patterning morphogens that alter the
region of the CNS they are generating.
Ventralising of the organoids with a SHH pathway agonist triggered the enrichment
of GABAergic neurons and an upregulation of adjacent LGE cell populations next to corticallike tissue (as is seen in vivo) (Kadoshima et al., 2013), and higher levels of MGE-like
precursor pools, with concurrent lowering of LGE cell markers, was seen when the SHH
agonist concentration was increased further (Kadoshima et al., 2013). This follows the same
pattern as is seen in equivalent two-dimensional (2D) differentiation ventralisation
protocols (Ma et al., 2012).
In accordance with the 2D hiPSC-NPC differentiation methods – the default
development of these organoids is one of a forebrain, cortical structure. But as with the
patterning of the monolayer iPSC-NPCs, these organoids can themselves be patterned to
develop into structures from other developmentally-early brain regions. The generation of
hPSC-derived neural midbrain organoids can be triggered through the same addition of
factors necessary to generate midbrain cell identities in 2D, namely SHH and FGF-8. These
mid-brain organoids also produce neuromelanin and are functionally similar to primary
dopaminergic neuronal cells (Jo et al., 2016). Single mESCs suspended in 3D Matrigel (or a
synthetic matrix) undergoing neural induction will proliferate and form neural tube-like
structures, termed neuroepithelial cysts. These cysts respond to patterning factors that
both ventralise to floor plate identity and posteriorise the cysts to a more hindbrain or
spinal cord identity, with the affiliated gene expression profiles (Meinhardt et al., 2014).
hESC-derived organoid aggregates patterned with FGF-2, FGF-19 and SDF-1, suppressed
forebrain identity and enhanced endogenous FGF-8 and Wnt signalling (a property of the
midbrain hindbrain boundary in vivo). This in turn generated markers and organoid
morphology consistent with early cerebellar-like tissue (Muguruma et al., 2015).
These findings combine to point to the incredible discovery that not only can
individual NPCs respond to exogenous patterning to derive specific subtypes, but that early
neural aggregates can respond to similar signals and self-organise into a multitude of
neurodevelopmentally relevant structures. This opens the door to an incredible tool by
which to analyse human brain development in a completely in vitro and highly reproducible
way.
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As well as the implications for studies on brain tissue development these organoids
have already shown that they can shed light on neurological disease on a patient-specific
basis. hiPSC-derived organoids from patients with a CDK5RAP2-dependent pathogenic form
of microcephaly also display neural hypoplasia and generate smaller organoids than nonpatient iPSC-organoids (Lancaster et al., 2013). Another study generated neural organoids
from patients with an idiopathic Autism Spectrum Disorder that displayed differing neural
subtype compositions to control organoids. The authors even managed to track this
difference down to specific aberrant gene upregulations (Mariani et al., 2015). A multifaceted approach of using forebrain, midbrain and hypothalamic organoids has recently
been used to model Zika virus infection and disease pathology in vitro (Qian et al., 2016),
showing that the use of these organoids goes beyond genetically-linked neurological
diseases and show promise in studying exogenous factors of brain disease and trauma.
The fact that these organoid structures have now begun to help analyse and
recapitulate developmental pathways and disorders show the true power of iPSC-based
neural modelling and are paving the way for future 3D neurological research. Single cell
transcriptome analysis of forebrain cerebral organoids show high fidelity to expression
profiles from foetal neocortex (Camp et al., 2015) which further supports the paradigm of
faithful recapitulation of developmental processes from these 3D in vitro models.
All of the models discussed in this section contain inherent technical challenges and
idiosyncrasies that will need to be resolved before wide-scale implementation and
translation of PSC-based brain modelling projects (Brennand et al., 2015). Nevertheless, a
vast amount of research has been undertaken to refine and improve both 2D and 3D neural
differentiation protocols and models over a relatively short time-scale, and this is a source
of optimism for the field. The combination of both stem cell biology and 3D growth
environments is a fascinating area of research with untold potential for understanding
embryological processes, degenerative or malformative disorders, and in unprecedented
detail uncover how the brain builds itself.

1.7 Biomaterials for Neural Culture
The concept of disease modelling, or “disease in a dish”-technology, hinges on the faithful
recapitulation of in vivo conditions in an in vitro model. The factors needed for accurate
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neuronal maturation and survival must, by definition, recreate the in vivo
microenvironment for disease phenotypes to be measurable. Many neurodegenerative
conditions have undefined genetic components and unknown early-stage pathologies. The
difference between a healthy neuronal state and a diseased one may begin as a subtle
aberration. Also, measurable differences between control and disease-specific neurons
may be present at the level of gene expression, synaptogenesis or detectable only with
functional network formation. To simply have iPSC-derived neural cultures in a dish may
not be enough to elucidate disease pathologies nor to study healthy neural development.
Instead, techniques for accurately recreating in vivo environments by use of biomimetic
constructs, may be integral for generation of pseudo-neural tissue and therefore complete
disease and developmental modelling. Cell culture environments themselves can have
profound effects on differentiation of stem cells, neurite outgrowth & axonogenesis, and
ultimately the cytoarchitecture of neural cultures through modulation of cell-cell and cellmatrix interactions. A wide variety of methods to modulate and enhance in vitro neural
cultures are outlined and discussed below.

1.7.1 Two-Dimensional Culture Conditions
Planar neuronal differentiation and maturation of PSC-derived NPCs requires a plating
substrate conducive to cell adhesion and promotion of neurite outgrowth. Throughout the
literature the most frequently used substrates are Matrigel (a murine sarcoma-derived
extracellular matrix product) or a combination of poly-ornithine & laminin (POL). Both
Matrigel and POL have been used successfully in many PSC-neural differentiation studies
with successful NPC differentiation on both substrates (Gaspard et al., 2008; Shi, Kirwan
and Livesey, 2012; Naujock et al., 2014). A recent side-by-side study, however, reported
that when using the EB method of iPSC-neural induction, Matrigel yielded higher
percentages of MAP2-positive neurons after differentiation than aggregates plated on POL
(>90% vs 56%) (Muratore et al., 2014). Other studies utilise non-biological growth
substrates that have been modified to promote neuronal attachment and outgrowth.
Poly(ester carbonate) functionalised with a laminin-derived peptide sequence resulted in
higher levels of neural cell viability, neurite length and number of neurites per cell than
growth on tissue culture plastic (Xing, Ma and Gao, 2014). A mix of native and synthetic
elements in a hydrogel substrate composed of covalently linked Heparin and star-
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polyethylene glycol (PEG), functionalised with a fibronectin-derived peptide and FGF2,
enhanced murine NSC survival compared to growth on a poly-lysine substrate
(Freudenberg et al., 2009).
Substrate composition can also be modulated to generate growth surfaces of
differing degrees of stiffness which have been shown to have strong effects on cell
attachment, differentiation, and maturation (Discher, Janmey and Wang, 2005).
Mesenchymal stem cells (MSCs) will favour neural differentiation when grown on soft
substrates that have an elastic modulus similar to that of in vivo brain tissue; typically
below 1kPa (Engler et al., 2006). More recently, a study has reported that hPSCs cultured
on soft rather than stiff substrates (700Pa vs 75kPa) will show a bias for neuronal
progenitor formation and mature neuronal differentiation (Keung et al., 2012). These
findings are not in isolation; rat embryonic NSCs cultured on polydimethylsiloxane (PDMS)
with a stiffness similar to brain tissue will extend longer neurites and have enhanced
expression of pre-synaptic markers than stiffer PDMS substrates (Teixeira et al., 2009), and
these cultures also enhanced astrocytic differentiation. Intriguingly, another study found
that cortical neurons cultured on polyacrylamide or fibrin gels of varying stiffness show
strong neurite extension regardless of stiffness, but that astrocytic growth and cell
spreading was inhibited on soft substrates (Georges et al., 2006). The discrepancy between
these two results may be due to the synergistic interplay of neural cells on equivalent
stiffness of substrates but differing substrate compositions. Even though numerous studies
implicate softer substrates in the promotion of neurite outgrowth and neural
differentiation it has conversely been reported that synaptogenesis, voltage-gated calcium
channel currents and neuronal networking of murine hippocampal neurons were all
enhanced on stiffer rather than softer substrates (Q.-Y. Zhang et al., 2014).
As well as the choice of substrate on which to differentiate neural progenitors,
many studies have shown the importance of topographical features of 2D surfaces that can
modulate, and to some extent control, neurite extension, arborisation and ultimately the
networks formed on these surfaces (Hoffman-Kim, Mitchel and Bellamkonda, 2010). These
topographies can be in the micro- to nano-scale and can be anisotropic (such as grooved
surfaces or aligned fibres) or isotropic (such as nano-rough surfaces or geometrically
spaced pillars) (Fig 1-5 A).
Electrospun polymer fibres are widely used to generate aligned or randomly
orientated nano-scale fibres for cell-topography interaction studies (Xie et al., 2010). It is
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well documented that many neuronal cultures will tend to align and extend neurites in the
direction of aligned fibres (Yang et al., 2005; Kim et al., 2008; Bourke et al., 2014; Xia et al.,
2014). However, different neuronal subtypes will display differing outgrowth patterns
depending on the level of alignment and diameter of the polymer fibre. Murine NSCs will
differentiate and extend neurites along both micro- and nano-scale polylactic acid (PLA)
fibres but this effect is accelerated on smaller fibre diameters (300nm vs 1.5um) (Yang et
al., 2005). Dorsal root ganglion (DRG) cells will tend to exclusively follow fibre alignment in
a parallel fashion (Kim et al., 2008; Xia et al., 2014) (Fig 1-5 B) and will extend longer
neurites than when grown on the same polymer in a smooth film (Mukhatyar et al., 2011).
This alignment becomes less strict with smaller fibre diameters (300nm) which causes a
more frequent perpendicular movement of the neurite (Wang et al., 2010). By contrast,
embryonic rat hippocampal neurons will tend to extend processes both in a parallel fashion
to the fibres, but also with regular perpendicular branching (Bourke et al., 2014). Polymer
fibres can be further modified to enhance substrate-cell interaction, such as mixing the preformed polymer with gelatin (a hydrolysed product of collagen type I) to enhance
hydrophilicity and cell adhesion on the fibre mats (Alvarez-Perez et al., 2010).
The results of neuronal outgrowths seen on fibre-based substrates is reflected
when cells are cultured on micro-grooved surfaces. Embryonic rat hippocampal neurons
grown on micro-grooved quartz will tend to extend processes parallel to wide grooves but
perpendicular to narrow ones (of approximately 1μm) (Rajnicek, Britland and McCaig,
1997). However, this pattern of contact guidance differed when hippocampal cells were
harvested at different stages of development: Later embryonic neural cells favoured
parallel alignment to the grooves, whereas cells from developmentally earlier embryos had
an increased tendency for neurite outgrowth perpendicular to grooved topography. Similar
patterns were seen on micro-grooved polypyrrole (PPy, an electrically conducting polymer)
surfaces; neurons polarized and defined axons faster on grooved PPy than the smooth film
and orientation was both parallel and perpendicular to the grooved topography (Gomez et
al., 2007). Combinations of nano-rough and micro-grooved substrates also increase focal
adhesion and human NSC differentiation and maturation compared to flat surfaces or each
topographic feature alone (Yang et al., 2014).
Isotropic micro-pillar topographies elicit differing effects on neuronal
differentiation and outgrowth strictly depending on their size and spacing. Embryonic
hippocampal neurons grown on micro-scale pillars will show greatest fidelity to the
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geometry of the posts when the gaps between them are minimal, and generate a striking
neurite growth pattern almost exclusively in strict right-angled trajectories (Dowell-Mesfin
et al., 2004) (Fig 1-5 C). This effect was also seen when hippocampal neurons were cultured
on micro-scale PDMS conical posts (Hanson et al., 2009).
As mature neural cell types are electrically active, it has long been postulated that
electrical stimulation of differentiating neural cultures will have positive and enhancing
effects on neuritogenesis and maturation pathways. Electrical stimulation of neuronal
cultures via the electrically conducting polymer polypyrrole (PPy) was demonstrated by
Schmidt et al. about 20 years ago. PC12 cells, a neural-like cell line, showed similar cell
attachment to the PPy substrate and tissue culture plastic, but after electrical stimulation
of the PPy substrate, generated neurite lengths double that of cells cultured on
unstimulated PPy (Schmidt et al., 1997). Electrical stimulation of PPy before cell attachment
has also been shown to increase protein adsorption to the substrate from the surrounding
growth media and therefore increase cell attachment and neurite outgrowth (Kotwal and

Fig 1-5: (A) An overview of topographies utilised on two-dimensional surfaces to
modulate neural cell morphology and maturation in vitro. (B) Aligned electrospun
fibres, as an example of anisotropic surface topography, trigger neurite outgrowth and
alignment of dorsal root ganglion-derived cells in the direction of the fibre alignment
(scale bar = 100μm). (C) Micro-scale pillar topography causes perpendicular patterns of
neurite extension and arborisation from primary hippocampal neurons [scale bars =
4μm (black) and 100μm (white)]. Figure adapted from Hoffman-Kim et al. 2010, Xia et
al. 2014, and Dowell-Mesfin et al. 2004
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Schmidt, 2001). Electrical stimulation of this material may therefore aid outgrowth and
attachment via direct interaction with the cells and the positive modulation of the basal
PPy substrate through protein adsorption.
In addition, electrical stimulation of neural cells cultured on electrospun fibres
coated with PPy induce longer and more abundant neural processes than either factor
alone (Lee et al., 2009), in a method that combines both topographical and electrical cues.
Further functionalization of PPy has also been tested with either the direct covalent
attachment of neurotrophic factors (Gomez and Schmidt, 2007) or the doping of PPy with
neurotrophic factors during polymerisation, in order to release them over time during
neuronal culture (Thompson et al., 2010). In both of these cases, electrical stimulation was
used synergistically with the biological effect of these growth factors to promote neuronal
maturation. It has also been shown that extracellular electric fields can also promote and
orientate neurites. Accelerated outgrowth and higher numbers of neurites were found on
the cathodal side of neurons exposed to an extracellular electric field (Patel and Poo, 1982).
Taken together; the tailored combination of biochemical, mechanical,
topographical and electrical cues to a wide variety of neuronal subtypes and progenitors
can generate strong, reproducible neurotrophic effects in 2D: modifying cell migration,
axonal sprouting, dendritic arborisation, and even how and where neuronal networks form.
The potential of combining iPSC-derived NPCs and programmable biomaterials is a
powerful tool in engineering neural constructs that truly reflect more in vivo-like
conditions, be they developmental or disease-state.

1.7.2 Three-Dimensional culture conditions
Although the level of customisation of 2D planar culture conditions is incredibly varied, it
can be argued that neural cell encapsulation and growth in three-dimensional (3D)
environments promote a more in vivo-like physiological setting. Cell-cell and cell-matrix
interaction in 2D systems are confined to a single plane, with neural process outgrowths
limited to two-axes and with the majority of cell surfaces exposed to the growth media. 3D
cultures (with cells encapsulated within biocompatible scaffolds) allow for cell-cell contacts
& neurite outgrowths in all directions, as well as complete interaction with the scaffold
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matrix. Cell density can be modulated as can the composition of the matrix in order to
generate a cell culture that has cytoarchitecture more representative of living tissue.
Hydrogels are a class of 3D scaffolds generated from networks of hydrophilic
polymer chains. When hydrogels undergo sol-gel transitions they retain water content
above 90% of their mass, and as such are highly suited to model in vivo-like cellular
microenvironments.
The diverse list of hydrogel biomaterials used for 3D neural differentiation or
maturation of progenitors includes purified proteins or extracellular matrix (ECM) protein
mixes such as Matrigel (Irons et al., 2008), laminin/entactin gels (Meinhardt et al., 2014),
collagen type I (O’Connor et al., 2001), fibrin scaffolds (Montgomery et al., 2015; Robinson,
Douglas and Michelle Willerth, 2017), and even decellularised porcine brain (DeQuach et
al., 2011). Synthetic self-assembling peptides (SAPs) such as PuraMatrix have also shown
promising recent use in 3D hESC-derived neural cultures (Ylä-Outinen et al., 2014) and
primary neural cultures (Kaneko and Sankai, 2014). As well as peptide-derived matrices the
literature is also filled with polysaccharide-based hydrogels that use both mammalian
polysaccharides, such as the glycosaminoglycan hyaluronic acid (HA) (Wang and Spector,
2009; Z.-N. Zhang et al., 2016), and non-mammalian substrates such as chitosan (Li,
Wijekoon and Leipzig, 2014), alginate (Banerjee et al., 2009) and agarose (Balgude et al.,
2001). Results from material to material can be varied and depend on substrate
composition, cell density and any modifications to the material, but as a very general rule;
protein-based scaffolds tend to be more inherently conducive to neuronal differentiation
and allow for more in vivo-like cell morphologies and cell-cell contacts than unmodified
polysaccharide scaffolds.
As well as being highly used as a 2D cell adhesion matrix, Matrigel has been used
extensively and successfully in 3D neuronal cell culture for neural cell lines (McMurtrey,
2014), primary cells (Irons et al., 2008), NSCs (Gelain et al., 2006; Koutsopoulos and Zhang,
2013) and hESC- and hiPSC-derived NPCs (Lancaster et al., 2013; Moreno et al., 2015). It
has also formed the cell-laden structural basis for high-density 3D neural cell cultures in
large-scale perfusion devices (Cullen et al., 2007) and microfluidic 3D “lab-on-a-chip”
perfusion devices (Moreno et al., 2015). Electrophysiological analysis of neurons cultured
within Matrigel scaffolds confirmed the presence of abundant cell-cell synaptic events and
mature network formation (Irons et al., 2008); a crucial property of biomaterials for use in
neural tissue engineering.
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SAPs are short synthetic peptides (usually based around a repeating core ArginineAlanine-Aspartate-Alanine “RADA” motif) that can self-assemble under physiological pH
and salt concentrations. The resulting hydrogel maintains a nanofibrous structure and
porosity comparable with naturally occurring ECM structural proteins (Gelain et al., 2006).
Unmodified SAP-scaffolds (i.e. containing only the repeat self-assembling motif) have been
shown to generate a pro-neuronal biomimetic scaffold even without native protein binding
motifs: hESC-NPCs differentiated in PuraMatrix (a commercially available SAP) display more
branching events and thicker dendritic processes than the same cells grown on 2D Laminin
cultures (Ylä-Outinen et al., 2014). Also, dopaminergic differentiation of mESCs and miPSCs
was enhanced in 3D SAP scaffolds compared to 2D laminin culture and 3D Matrigel
scaffolds (Ni et al., 2013). This specific dopaminergic neuron increase may be due to the
non-animal-derived nature of the SAP, whereby undefined growth factors within the
Matrigel may promote general cell viability and neuronal differentiation [as seen in (Gelain
et al., 2006; Koutsopoulos and Zhang, 2013)], but may interfere to a certain degree with
the patterning factors necessary for specific neuronal subtype lineage differentiation. As
with 2D growth substrates, biomaterials for use in 3D scaffolds can be modified with
peptide motifs with the aim of increasing cell-matrix interactions and therefore generating
a truer in vivo-like microenvironment. SAPs have been synthesised with binding epitopes of
native proteins such as laminin, fibronectin, collagens or other sequences (e.g. neuronal
anti-apoptotic protein motifs) (Gelain et al., 2006; Li and Chau, 2010; Koutsopoulos and
Zhang, 2013; Li, Chow and Chau, 2014). These functionalised SAPs have reportedly higher
neuronal differentiation efficiencies of ESCs and NSCs than basal SAP scaffolds. A different
format of SAPs based around a stacking aromatic fluorenylmethyloxycarbonyl (Fmoc) group
covalently functionalised with laminin-binding moieties, has shown promise in rat models
of ischemic stroke recovery (Somaa et al., 2017). The combination of this form of SAP
together with hESC-derived NPCs allowed for an injectable delivery system into an in vivo
model of cortical damage, that resulted in functional neural integration.
Collagen Type I (herein referred to as collagen) scaffolds are widely used
throughout the literature as a go-to cell encapsulation material for numerous cell types,
including neurons (Antoine, Vlachos and Rylander, 2014). Embryonic rat hippocampal
neurons will show extensive neurite outgrowths and higher cell viability in collagen
scaffolds than in parallel experiments with the same cell type encapsulated in agarose
(O’Connor et al., 2001). In contrast to this, there are examples in the literature of positive
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DRG neurite outgrowth in low concentration agarose, but this finding is quite rare (Balgude
et al., 2001). As with SAP scaffolds, collagen can also be functionalised by covalent addition
of protein-binding epitopes. DRGs cultured in collagen modified with both laminin and
fibronectin motifs resulted in significantly higher MAP2 expression than unmodified
collagen, the fibronectin motif alone, or a scrambled binding motif (Hosseinkhani et al.,
2013). Also, covalent modification of collagen with native laminin subunits resulted in
greater cell survival of embedded NSCs (Nakaji-Hirabayashi, Kato and Iwata, 2012).
An interesting use of collagen scaffolds was to determine neurite outgrowth when
cells were exposed to 3D stiffness or mechanical gradients. Encapsulated DRGs extend
longer neurites down a stiffness gradient rather than up one. This effect is greater than
when neural cells were grown in uniform stiffness (Sundararaghavan et al., 2009). Also,
overall DRG neurite extensions are longer in hydrogels of low collagen concentration than
in higher concentration (and therefore stiffer) collagen hydrogels (Swindle-Reilly et al.,
2012). Collagen composite scaffolds containing a porous silk sponge as a model of corticallike white/grey matter layering allow for more brain-like cytoarchitecture with neurons
retaining function and network formation (Tang-Schomer et al., 2014; Chwalek et al.,
2015), that was further enhanced with the addition of foetal ECM components into the
collagen hydrogel (Sood et al., 2016).
Neural cell electrophysiological activity is preserved in cells differentiated within
collagen hydrogel matrices (O’Connor et al., 2000; Ma et al., 2004) and embryonic
hippocampal neurons within collagen scaffolds show comparable electrophysiological
profiles to those grown on 2D substrates (Xu et al., 2009). By segregating cell-seeded
collagen hydrogels and connecting blank-hydrogels over a multielectrode array (MEA),
pathways of synaptic functionality were traced throughout a layered neural structure in
vitro (Odawara, Gotoh and Suzuki, 2013). All of which demonstrates that collagen
hydrogels are inherently conducive to neural network formation and function, and that
composites or structural cues within the hydrogels can even enhance the level of these
formations.
Composite scaffolds containing both Collagen and HA (either through covalent
crosslinking or simply a blending of material prior to cell encapsulation) show reportedly
improved results for 3D neural culture, purely from a cell morphology and neurite
outgrowth point of view (Brännvall et al., 2007; Wang and Spector, 2009). Also, HA
scaffolds with embedded polycaprolactone (PCL) electrospun fibres (coated with laminin)
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enhanced neurite lengths of SH-SY5Y cells (a human neuronal cell-line) when compared to
the same fibres in 2D culture. Interestingly this increase was not found when the same
fibres were utilised in a Matrigel equivalent scaffold (McMurtrey, 2014). A covalentlymodified form of HA that enables UV-driven crosslinking; HA-methacrylate (HAMA), has
also been shown to enable iPSC-derived neural differentiation and migration assays (Z.-N.
Zhang et al., 2016).
Direct comparisons between 3D NSC cultures composed of collagen, Matrigel, SAPs
(RADA scaffold), and SAPs with functionalised peptide motifs, show significant differences
in cell viability, differentiation and neurite outgrowth. Over long term culture, collagen
scaffolds have been shown to have the lowest retention of cell viability, followed by
Matrigel and then SAP scaffolds (Koutsopoulos and Zhang, 2013). Interestingly, even
though long term viability was lower in Matrigel, the rate of NSC differentiation over the
first 2 weeks was higher than in any of the SAP scaffolds. This may be due to the presence
of undefined growth factors in this ECM-derivative promoting early cell responses
(Koutsopoulos and Zhang, 2013).
As well as protein-based biomaterials for deriving scaffolds matrices, numerous
polysaccharide hydrogels have shown promise in generating 3D neural cultures in vitro.
Alginate (sodium alginate or alginic acid) is an anionic polysaccharide derived from brown
algae that undergoes sol-gel transition through ionic crosslinking with divalent cations.
Alginate hydrogels are a well characterised means to encapsulate cells in 3D with no
significant cytotoxic effects (Andersen, Auk-Emblem and Dornish, 2015) and through
generation of composite scaffolds are amenable to bioprinting technologies (Chung et al.,
2013). Rat NSCs encapsulated in alginate with an elastic modulus comparable to that of
brain tissue show a twenty-fold higher level of β-III-tubulin expression than when
differentiated in stiffer scaffolds (Banerjee et al., 2009) which mirrors the known 2D effect
of substrate stiffness directly affecting stem cell differentiation pathways (Engler et al.,
2006). Typical neuronal morphology was not directly observed in this study and cells
tended to form aggregates within alginate hydrogels. This finding is not in isolation; rat
DRGs embedded in alginate will show little to no neurite outgrowths, but when embedded
in Matrigel show neurite outgrowths seventeen-fold longer (Novikova et al., 2006).
Alginate concentration and the concentration of the ionic crosslinker of each scaffold
however can have stark effects on neural adhesion and morphology within the hydrogel
scaffolds. For instance, “ultrasoft” alginate hydrogels, with sub-stoichiometric amounts of
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calcium ion crosslinker, will allow for neurite extension in 3D scaffolds (Palazzolo et al.,
2015). Even on 2D alginate hydrogel substrates, neural attachment and extension are
heavily dependent on lower overall calcium ion concentration and therefore the degree of
crosslinking of the gel (Matyash et al., 2012, 2014).
Even though mature neuronal networking is sometimes limited in unmodified
alginate it has still been used as a platform for 3D neural induction protocols from mESCs
(Li et al., 2011; Bozza et al., 2014), and hESCs & hiPSCs (Lu et al., 2012; Kim, Sachdev and
Sidhu, 2013) and used as a scaffold in high throughput 3D hNSC toxicity arrays (Meli et al.,
2014). Neural induction efficiencies are reportedly higher in these 3D structures than direct
terminal differentiation in suspension culture (Lu et al., 2012). It is telling however that cell
aggregation and clustering are prominent in these 3D scaffolds and extensive networking
beyond the boundaries of each cluster (despite having strong neural marker
immunostaining) are infrequent, if present at all. Covalent functionalisation of alginate with
full length-laminin or a laminin-derived binding peptide does seem to improve neural
outgrowths of both hippocampal primary neurons and glial cell lines (Frampton et al.,
2011). A caveat may be the impressive cell densities in these constructs, which are much
higher than those seen in other 3D scaffold studies. Other modified alginate constructs
functionalised with an integrin-binding motif (Arginine-Glycine-Aspartate “RGD”) did show
enhanced adhesion and differentiation of MSCs to neural lineages within the peptidemodified alginate, but with cell seeding only after freeze-drying of the construct to
generate anisotropic channels throughout the structure (Lee et al., 2015).
Chitosan is a deacetylated form of chitin; a polysaccharide found within the
exoskeletons of crustaceans. Its high abundance and relatively low cost make it an
appealing biomaterial for tissue engineering studies. However, primary cortical cells
cultured in 3D chitosan hydrogels (with elastic moduli similar to that of brain tissue) will
tend to maintain a rounded cell body and extend only a single neurite. The number of cells
with neurites is increased when the chitosan is functionalised with poly-lysine (Crompton et
al., 2007). Photo-crosslinkable methacrylamide chitosan (MAC) 3D scaffolds show poor
induction of neuronal markers from rat NSCs even after functionalization with fibronectinderived binding motifs, but can be increased through the addition of soluble or immobilized
interferon-gamma (IFN-γ). As with many alginate constructs, the morphological analysis of
embedded neural cells via immunostaining for neuritogenesis is not overly convincing
(Leipzig et al., 2011). This was also not improved by increasing the porosity of the scaffolds
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by using mannitol crystals during crosslinking (Li, Wijekoon and Leipzig, 2012) or
conjugation with perfluorocarbons to enhance oxygen release in the core of the gels (Li,
Wijekoon and Leipzig, 2014). In both cases, NSCs displayed a rounded morphology lacking
in prominent neurite extensions, even though neuronal markers were still present via
immunocytochemistry. This leads to an almost counterintuitive conclusion, by which neural
differentiation is still initiated in the cells throughout these scaffolds (leading to positive
neuronal marker expression) but the cells themselves seem unable to generate extensive
cell-cell connections outside of aggregates formed within the matrix, perhaps due to an
intrinsic steric hindrance or lack of native adhesion moieties.
An intriguing solution to the lack of neurite outgrowth when neural progenitors are
encapsulated in non-native matrices is the addition of protease cleavable peptides into the
structure of a synthetic hydrogel (McKinnon, Kloxin and Anseth, 2013). mESC-derived
motor neuron progenitors seeded in polyethylene glycol (PEG) hydrogels covalently
crosslinked with matrix metalloproteinase (MMP) cleavable peptide sequences and
functionalised with other binding epitopes (with moduli around 350Pa) showed robust
neurite outgrowth and retained high cell viability, while stiffer moduli (>2kPa) induced
almost uniform cell death. Scaffolds without the MMP-cleavable sequence showed no
axonal outgrowth. This is a good demonstration that for 3D neural culture, simply having
biomimetic binding motifs may not be enough to induce a true in vivo-like neuronal
morphology and the ability for the cell to manipulate the surrounding matrix is integral to
tissue-like recapitulation and development.
This directed assembly of 3D growth cultures, rather than simple scaffold-based
cell encapsulation, may be able to pre-form necessary cytoarchitecture relevant for
particular areas of neural tissue modelling and in vivo-like recapitulation. Assembly of cellladen hydrogel “building blocks” already has precedent in the literature and can combine
processes such as emulsification, photolithography, microfluidics, micromoulding, and
bioprinting (Kachouie et al., 2010). As well as being able to accurately arrange cell types in
3D environments it also allows the possibility of developing pseudo-vasculature in the
derived 3D culture and perhaps even targeted delivery of trophic factors (Kang et al., 2016).
A bio-printable scaffold material formulated from alginate, carboxymethyl-chitosan, and
agarose has been demonstrated to support hiPSC-derived neural differentiation within in
silico-designed construct architectures (Gu et al., 2017). Similarly, a hand-held bio-printing
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technique with a peptide-functionalised gellan gum “bioink” has been able to recapitulate
printed laminar structures representative of layered cortical tissue (Lozano et al., 2015).
3D environments can also be generated from colloidal layering of cell-coated silica
beads (45μm in diameter). Different neural subtypes attached to separate “pools” of beads
will self-assemble into arrays when added into a growth chamber. In essence, each layer of
beads can be tailored in composition to form highly controlled 3D arrangements, with
functional synaptic connections measurable between multiple layers of cell-laden beads
(Pautot, Wyart and Isacoff, 2008) that showed asynchronous patterns and differential burst
firing timings than seen from basic 2D neural network formation (Frega et al., 2015).
Taken all together, the array of biomaterials and fabrication technologies available
for processing both 2D and 3D growth substrates for neural tissue engineering is vast (Fig 16). Covering all aspects of intrinsic biomaterial properties, binding moieties, substrate
stiffness, topographical patterning, and functionalisation; the ability to completely tailor in
vitro environments for any conceivable aspect of neurological modelling and combine them
with additive fabrication technologies, electrode arrays and microfluidic devices will be at
the forefront of the next generation of neural tissue modelling.
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Figure 1-6: Overview of the possible material and cellular components of in vitro
iPSC-derived neural cultures. Growth material selection may be in two- or threedimensions and be of biological or synthetic sources. Modifications of materials can
be through covalent functionalisation or the formation of composites, and can be
processed into differing shapes and topographies. iPSC-derived neural cells can be
patterned to specific subtypes and be combined with other neural cell lineages to
develop brain-like architecture when combined with the 2D/3D scaffold materials.

1.8 Thesis Aims and Structure
Modern neurological research into human neurodevelopmental and neurodegenerative
pathologies has been revitalised with the advent of induced pluripotent stem cell
technology. The generation of genomically-clean, patient-specific and developmentally
representative neural models in vitro has broad promise for not only understanding brain
development and dysfunction, but to also act as a foundation stone for full regenerative
therapies and drug efficacy & toxicology studies.
In addition to this, the rise of additive fabrication technologies such as 3D
bioprinting within the biomedical field, holds great promise for generating more
representative tissue-like constructs from an ever-increasing array of synthetic and
biological materials.
The ideal in vitro modelling system would therefore involve the combination of
iPSC-derived neural cultures differentiated within tailored 3D matrices allowing for the
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development of a highly representative in vivo-like tissue constructs that contain specific
neural cell subtypes from particular brain regions, in the appropriate cytoarchitecture, to
create developmental- or disease-related network formations.
For this holistic approach to modelling brain biology to work fully and faithfully “inthe-dish”, each element of its construction must be assayed; to ensure reproducible and
developmentally representative neural cell differentiation from iPSCs; and to develop the
appropriate assays of biomaterials from which to build the 3D in vivo-like environments for
the derived cell types to interact with and form native cellular architecture and function.
Broadly speaking, this body of work will focus on achieving the following aims:


To assay an array of candidate biomaterials for use as the basis for threedimensional neural tissue scaffolds by focusing primarily on the biomolecular and
biophysical responses that the matrices induce in embedded neural cells.



To generate forebrain-specific excitatory and inhibitory neural cell populations
from human iPSCs. The development of both of these cell types in vitro is integral
for modelling not only true human forebrain development but also as the basis for
disease-specific modelling of forebrain-derived pathologies such as the epilepsies.



To compare the effect of iPSC-neural differentiation within the most promising 3D
biomaterial candidate and to compare this to differentiation on 2D planar culture,
in order to ascertain how differentiation strength, speed and efficiency is affected
through 3D culture.



To determine the biomaterial characteristics that maintain potential for neural cell
maturation and differentiation in vitro, but also allow for 3D bioprinting processes
that would enable more complex neural tissue-model architecture to be formed,
beyond the capability of currently available bioinks.

Chapter 2 focuses on the development and assaying of candidate biomaterials for 3D
neural cell culture using a neural cell-line as a proxy for hiPSC-derived neural cell cultures.
The materials under investigation are alginate and collagen type I, both with and without
the formation of composite gels with a Matrigel-equivalent ECM mix termed “ECL”.
Alginate scaffolds with covalent peptide-functionalisation with matrix metalloproteinase
(MMP) cleavable motifs and laminin-derived binding moieties are also generated and
tested in parallel to unmodified scaffolds. The majority of assay techniques focus on
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biomaterial properties through the lens of cellular responses, and therefore positive and
negative results of each scaffold are based on; retention of cell viability, conduciveness to
neurite extension and native morphology, gene & protein expression of differentiationassociated markers, and comparisons to 2D differentiation benchmarks.

Chapter 2 Hypotheses:
1. The neuritogenic potential of embedded neural cells in unmodified alginate
hydrogels is low in comparison to collagen scaffolds, and this morphological
difference is reflected in neuronal gene and protein expression.
2. Modification of alginate hydrogels with MMP-cleavable and laminin-binding
peptide motifs will attenuate the morphologically restrictive nature of the
hydrogel.
3. Candidate biomaterials for neural tissue engineering can be assessed through
changes in neural gene and protein expression in synergy with morphological
assessment of neuritogenesis
Chapter 2 Findings:


Using aqueous carbodiimide chemistry; double-ended MMP-cleavable and lamininbinding peptide motifs can be covalently bonded to alginate polymers with high
efficiency.



Collagen type I, alginate and peptide-modified alginate hydrogels all allow for high
retention of metabolic activity/cell viability of encapsulated neural cells during scaffold
gelation, as well as over the time course of neural differentiation.



Collagen type I hydrogels (both with and without ECM protein components) allow for
neurite extension of encapsulated PC12 neural cells over the same time course as 2D
planar differentiation.



Low concentration alginate hydrogels are non-conducive to neuritogenesis of
encapsulated differentiating PC12 neural-like cells. This effect is not ameliorated by the
addition of extracellular matrix proteins.



Peptide-modified alginate hydrogels also do not allow for neuritogenesis of
encapsulated neural cells.



The canonical neuronal protein markers β-III-Tubulin and GAP43 increase in expression
over the time course of neural differentiation in 2D and 3D culture. These increases do
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not reflect the neuritogenic potential of the hydrogel scaffolds and are highly
expressed in alginate and alginate-peptide scaffolds which restrict neurite formation.


Other neuronal protein markers MAP2, P-MAP2, NF-H, and NF-L do show stark
differences in expression profiles during neural differentiation in the various
biomaterial scaffolds. These markers therefore represent more reliable measures of
neuritogenic potential of candidate biomaterials.

Chapter 3 focuses on the development of differentiation strategies of human iPSCs into
both excitatory and inhibitory forebrain neuronal cell populations using neural tube
patterning factors in 2D. These distinct cell populations develop separately embryologically,
but following pre-natal migration, form complete forebrain-cortical structures and
networks. This chapter follows the molecular timings and comparisons between distinct
neural developmental pathways from hiPSCs in vitro and tracks the timings of subtype
development, loss of pluripotency, neuronal maturation markers, synaptic machinery, and
neurotransmitter receptor apparatus. As well as biomolecular markers of maturation and
development, this chapter also studies the functionality of the cells through assaying of
intra- and extra-cellular electrophysiological recordings of derived neural cell types. By
tracking the generation of these cell types in parallel will allow for the formation of more
complete and representative forebrain/cortical models.

Chapter 3 Hypotheses:
1. hiPSCs can be efficiently differentiated into mature neural cells over 60 days of
differentiation and display markers of subtype specificity, forebrain regionalisation,
and pre- & post-synaptic machinery.
2. Neural cell cultures can be efficiently patterned into dorsal (excitatory) and ventral
(inhibitory) neuronal subtypes over a parallel time course.
3. Both dorsal and ventral neural cultures mature at equivalent rates and display
equivalent molecular and functional markers of maturity.
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Chapter 3 Findings:


hiPSCs undergoing neural induction via dual-SMAD inhibition pathways generate NPCs
with high efficiency over 7-14 days.



Further maturation of NPCs without exogenous signalling morphogens will derive
neuronal cells with extensive neuritogenesis after 28 days of differentiation and both
neuronal and glial-lineage cell types by Day 60 of maturation.



Neural cell cultures differentiated for 60 days will express markers of; cortical and
forebrain localisation; excitatory glutamatergic neuronal subtype; pre- & post-synaptic
components; and glutamate- & GABA-sensitive neurotransmitter subunits.



Ventral patterning of NPCs, through the use of a sonic hedgehog-pathway agonist,
generates mature neurons of a predominantly inhibitory GABAergic cell type after 60
days of differentiation and show heavily reduced cortical marker expression.



Ventral-patterned neural cells show slight enrichment of neuronal associated markers
at the gene and protein level in comparison to the default (dorsal) induction pathway.



Both dorsally- and ventrally-patterned matured neuronal cells can fire an action
potential under intracellular current stimulation. Multiple action potentials can be
evoked from ventrally-patterned neuronal cells depending on the current stimulus
level, demonstrative of a more mature phenotype than is seen in dorsally-patterned
neurons.



Transient sodium and potassium currents are both present after stimulation of
dorsally- and ventrally-derived neurons. Both current levels are higher in ventrallypatterned cultures, indicative of a more mature ion channel composition phenotype.
However, potassium currents in neurons from both patterning methodologies are low,
showing an overall immature phenotype for all neurons assayed.

Chapter 4 will combine the differentiation pathways outlined in Chapter 3 and compare
them to iPSCs differentiated within the top candidate biomaterial scaffold determined from
Chapter 2. This chapter will elucidate the morphology of iPSC-derived neural cells within
the scaffold and determine the rate of maturation of the 3D neural cultures when directly
comparing to differentiation in 2D planar culture, using gene expression profiling. This
chapter will also ascertain whether scaffold composition has an influence on the
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morphogen patterning of embedded NPCs (either positively or negatively) as this may be
an important factor when generating mixed neural subtype-specific 3D scaffolds.

Chapter 4 Hypotheses:
1. Differentiation of hiPSC-derived neural cells within 3D collagen type I hydrogels will
enhance the speed and strength of neuronal differentiation and maturation
compared to 2D culture.
2. The 3D hydrogel environment does not negatively impact the dorsal-ventral
patterning of encapsulated hiPSC-derived NPCs during differentiation.

Chapter 4 Findings:


hiPSC-derived NPCs differentiating within 3D collagen type I scaffolds undergo
neuritogenesis in all three axes throughout the hydrogel over 60 days of
differentiation.



3D encapsulated neural cultures express protein markers of post-mitotic neuronal
generation as well as pre-synaptic machinery.



Enhanced NPC marker expression was seen within ventrally-patterned neural cells but
not with dorsally-patterned neural cultures when encapsulated in 3D hydrogel
environments.



3D Ventral cultures show early peak expression of neuronal and synaptic markers
significantly above the levels of 2D cultures and 3D Dorsal neural cultures.



By later time points of differentiation: neuronal, axonal and synaptic marker expression
are lower in 3D microenvironments than in 2D planar culture, suggesting an inhibition
of maturation.



Excitatory and inhibitory neuronal subtype marker expression are preserved in
dorsal/ventral patterning in 3D environments, but with lower levels of expression than
is seen in planar differentiation.



Dorsal cortical localisation markers are observed in both 2D and 3D Dorsal neural
cultures. In 3D scaffolds however, early-cortical markers (REELIN, TBR1) display
expression profiles lower than in 2D differentiation, and late-cortical markers (CTIP2,
SATB2) show enhanced expression relative to 2D Dorsal cultures.
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3D Ventral neural cultures show significantly high expression spikes of GABABR1,
NMDAR1 and AMPAR1 neurotransmitter receptor subunits, not seen in 3D Dorsal
differentiation. By later time points of maturation, these markers tend to show lower
expression in 3D cultures compared to 2D differentiation.



Neuronal generation is not limited within 3D hydrogel scaffolds, but functional
maturation does appear to be restricted under these experimental conditions.



Astrocytic gliogenesis is enhanced in 3D differentiation environments compared to 2D
cultures.

Chapter 5 will focus on aspects of bioprinting neural tissue and the biomaterial
considerations that maintain positive neural differentiation and network formation, but
balancing this with the constraints of developing bioinks that are conducive to additive
fabrication technologies. Modifications and methodologies of printing neural tissue
constructs from existing biomaterials utilised in Chapters 2 and 4 will be explored.

Chapter 5 Hypotheses:
1. Unmodified alginate or collagen hydrogel compositions will demonstrate low
intrinsic bioprintability.
2. Combining a pro-neuritogenic collagen-based “core” bioink and a structurally
robust cytocompatible alginate “shell” bioink will allow for self-supporting coaxial
bioprinting suitable for neural tissue-modelling.
3. Segregation of the core and shell bioinks will be maintained under physiological
conditions and maintain cell viability and neuritogenesis of encapsulated neural
cells.

Chapter 5 Findings:


Low concentration collagen and alginate hydrogel solutions show poor bioprinting
traits.



Alginate and gelatin composite bioinks show differential printing characteristics heavily
dependent on concentration and ratio to each other. A 3% alginate and 5% gelatin mix
was found to have promising properties for a bio-printable material.
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Coaxial printing of a collagen-based core material designed to be amenable to neural
cell differentiation, and an alginate-gelatin shell bioink surrounding the core adding to
the structural integrity of the scaffold, was developed.



Core/shell separation was conserved throughout the printing process and could form
two-layer in silico designed grid structures.



Acellular versions of the scaffold construct could be handled manually and maintained
structural integrity after storage under physiological conditions.



Separation of core and shell biomaterial components was demonstrated through
fluorescent-bead loading of the core material, which displayed continued core/shell
separation after maintenance at 37⁰C.



Neural cell encapsulation and growth within the bioprinted core component of the
coaxial scaffold demonstrated the retention of high cell viability by day four postprinting.



Neuritogenesis was prevalent by day 7 of differentiation post-print within the coaxial
scaffold. Demonstrating conduciveness to neural differentiation within the core
collagen-based bioink.

Chapter 6 is the final conclusion and discussion chapter pulling together analysis from all of
the previous chapters and to frame the work in the context of the field as it currently
stands. It will also contain speculations and recommendations for future directions of this
research as well as possible inherent limitations.

1.9 Notes on Usage
Throughout the results chapters within this thesis, the plural form of personal pronouns
(“we/our” rather than “I/my”) have been used as a stylistic preference to be more in line
with the current format of scientific reporting.
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Chapter 2: Biomaterial Optimisation for
Three-Dimensional Neural Culture

2.1 Introduction
For any in vitro modelling of human neurodevelopment to be successful, it is critical that
the growth and assay conditions of neural cell cultures accurately reflect and recapitulate
the in vivo environment as closely as possible. To this end, many studies have focused on
developing three-dimensional (3D) growth environments for neural cell differentiation and
culture rather than simple planar culture. The potential advantages of this approach
include; greater degrees of cell-cell interaction; enhanced paracrine effects (owing to a
more restrictive diffusion rate of secreted signalling molecules); increased cell-matrix
interactions allowing for cell migration, cell aggregation & self-organisation within threedimensional space; and the responsiveness of differentiating neural cells to material moduli
(and other biophysical properties) representative of native tissue (LaPlaca et al., 2010).
Scaffold matrices that allow for complete encapsulation of cells and are conducive
to neurite extension, is a prerequisite to one of the most important facets of in vitro neural
tissue engineering: that of active synaptic network formation. Candidate scaffold materials
must be selected on the basis of not only being permissive to this morphological
development of neural cells, but possibly its enhancement to a level not demonstrated in
basic two-dimensional (2D) culture.
Hydrogels are 3D scaffolds generated from networks of hydrophilic polymer chains.
When transitioning into their gelled form they can retain water content above 90% of their
mass, and as such, are highly suited to model in vivo-like cellular microenvironments (Drury
and Mooney, 2003). They have been used extensively throughout the literature as scaffolds
for tissue engineering of multiple tissue types (Kachouie et al., 2010). Many biological and
non-biological polymers can be used to form neural tissue hydrogels (see Section 1.7.2),
but this chapter will focus on two commonly used natural biomaterials; alginate and
collagen type I.
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Alginate (sodium alginate or alginic acid) is an anionic polysaccharide derived from
brown algae that undergoes sol-gel transition through divalent cation crosslinking. Alginate
hydrogels have been widely used for three-dimensional neural cell culture (Banerjee et al.,
2009; Frampton et al., 2011; Andersen, Auk-Emblem and Dornish, 2015) and as a key
biomaterial in additive fabrication technologies such as bioprinting (Chung et al., 2013). The
use of alginate scaffolds as a basis for three-dimensional neural differentiation from murine
and human pluripotent stem cells also has precedence within the literature (Li et al., 2011;
Lu et al., 2012; Kim, Sachdev and Sidhu, 2013; Kuo and Chang, 2013; Bozza et al., 2014),
with differentiation efficiencies reportedly higher in these gels than parallel neural
inductions in suspension culture (Lu et al., 2012). Although the baseline properties of
unmodified alginate hydrogels have shown promising results in upregulating levels of
neuronal markers in embedded neural stem cells (Banerjee et al., 2009; Meli et al., 2014),
the ability for neural cells within alginate scaffolds to undergo extensive neuritogenesis is
restricted without ultra-low concentrations of alginate within the hydrogel and substoichiometric amounts of the ionic crosslinker (Matyash et al., 2012, 2014; Palazzolo et al.,
2015).
Greater success on this front has been reported either through covalent
modification of the alginate itself or through the formation of composite gels containing
blends of other biomaterials to help aid cell attachment and morphological development.
For example; the enrichment of alginate hydrogels with fibronectin helped ameliorate the
lack of encapsulated dorsal root ganglion (DRG) sprouting (Novikova et al., 2006) and
composite alginate microbeads formed with gelatin (a hydrolysed product of collagen type
I) showed a higher proliferative capacity of neural stem cells (NSCs) than that seen in
standard suspension culture (Song et al., 2014).
Rather than simple blending of hydrogel components to form enhanced scaffolds,
covalent modification of alginate with peptide motifs designed from extracellular matrix
attachment epitopes can add a biomimetic element to the hydrogels not present in the
basic polysaccharide structure. The covalent addition of Arginine-Glycine-Aspartic Acid
(RGD) cell adhesion ligands to the alginate backbone using aqueous carbodiimide chemistry
was first shown by Rowley et al. as a way of promoting cell attachment to alginate hydrogel
surfaces (Rowley, Madlambayan and Mooney, 1999). This type of functionalisation with the
fibronectin-derived RGD ligand however, did not improve 3D neural culture of primary
neurons or glial cell lines, whereas functionalisation with either full-length laminin or a
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laminin-derived binding peptide did improve neural outgrowth in alginate hydrogels
(Frampton et al., 2011).
The presence of rounded-cell morphology and lack of cell spreading without
modification of alginate hydrogel environments (or using ultra-soft under-crosslinked
compositions) has been overcome by the addition of matrix metalloproteinase (MMP)cleavable motifs into the scaffold backbone for culture of mesenchymal stem cells
(Fonseca et al., 2011). Showing that not only is cell attachment integral to successful
interaction with the three-dimensional environment, but that local proteolysis and the
ability for cells to remodel their surroundings is key to morphological changes and cell
function. This is of course combined with the synergistic factors of low hydrogel modulus,
native binding epitopes, as well as overall porosity derived from limited dry mass
composition and crosslinking conditions. This concept has also been successfully shown in
3D motor neuron cultures, although through modification of a synthetic polyethylene
glycol (PEG) scaffold, rather than an alginate-based one (McKinnon, Kloxin and Anseth,
2013).
Type I collagen (referred to herein as “collagen”) is a mammalian extracellular
structural protein that can form in vitro hydrogel scaffolds. Collagen scaffolds have been
widely used for tissue engineering purposes due to their innate cell adhesion properties,
biocompatible nature and multiple hydrogel fabrication technologies (Antoine, Vlachos and
Rylander, 2014). As with alginate, multiple studies have used collagen as the basis for
three-dimensional neural tissue constructs (O’Connor et al., 2001; Sundararaghavan et al.,
2009). Functionalisation with both fibronectin and laminin binding motifs, however, results
in significantly higher neuronal marker expression in encapsulated dorsal root ganglion
cells (Hosseinkhani et al., 2013) and covalent attachment of individual laminin subunits
triggers an increase in cell survival of embedded neural stem cells (NSCs) (NakajiHirabayashi, Kato and Iwata, 2012).
Although much has been done to individually assess and modify both alginate and
collagen scaffolds, very little has been shown that directly compares the effect of each
biomaterial on the biomolecular process of neural differentiation and to directly compare
different subsets of biomaterial hydrogels to each other and to 2D culture. Positive results
for marker expression data may not reflect adequate neuronal outgrowth or cell-cell
contact generation, and conversely, the presence of neurite morphology may not
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necessarily invoke molecular changes during differentiation to a higher degree than in
planar culture.
The aims of this chapter are to contrast five candidate biomaterial hydrogels:
alginate (Alg); alginate composites with a Matrigel equivalent, termed “ECL” (Alg + ECL);
collagen (Coll); collagen composites with ECL (Coll + ECL); and a peptide-functionalised
alginate (Alg-Pep) which contains both metalloproteinase-cleavable and laminin-binding
motifs representative of native extracellular matrix. These three-dimensional hydrogelembedded neural cultures will ascertain which combination of functionalised or composite
hydrogels elicit the strongest upregulation of differentiation markers and which allow the
greatest degree of neurite extensions and in vivo-like morphology.
To streamline this process, experimental work in this chapter will be undertaken
using a pheochromocytoma (PC12) neural-like cell line as a proxy for human iPSC-derived
neural cells. The ability of the PC12s to mirror morphological changes of differentiating
neural cells as well as expression of neuronal markers is well documented (Ohuchi et al.,
2002; Das, Freudenrich and Mundy, 2004; Won et al., 2015). By using this cell line rather
than iPSC-derived or primary neurons, a much more condensed, stable and higherthroughput molecular analysis can be used to ascertain which hydrogel configuration and
composition best supports neuronal cell differentiation and thus is the most promising for
downstream hiPSC-based differentiation in three-dimensional scaffolds.
Other than basic material properties such as matching moduli to native tissues and
gelation conditions, the focus of this chapter will be one devoted to that of the neural
tissue outcome – namely; what are the effects of each biomaterial on these differentiating
neural-like cells in relation to cell viability, cell morphology, and the expression of neural
gene & protein markers.
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2.2 Materials and Methods
2.2.1 Cell Culture
Adherent PC12 cell cultures were maintained in a proliferation media composed of
Dulbecco’s Modified Eagle Media (DMEM) (Lonza), 5% Foetal Bovine Serum (FBS) (Gibco),
10% Horse Serum (Gibco), 2mM L-Glutamine (Gibco), 100U/ml Penicillin and 100μg/ml
Streptomycin (Gibco). Cultures were incubated at 37⁰C and 5% CO2. Cells were passaged
using a 0.025% Trypsin Dissociation Buffer for 5 minutes at 37⁰C before re-plating in growth
media. Differentiation of PC12s was triggered using a differentiation media composed of
DMEM (Lonza), 1% Horse Serum (Gibco), 2mM L-Glutamine (Gibco), 100U/ml Penicillin,
100μg/ml Streptomycin (Gibco), and 50ng/ml Nerve Growth Factor (NGF) (Sigma). Over the
course of differentiation, media was changed every 2 days. For expansion, cells were grown
in 75cm2 tissue-culture coated flasks, whereas for 2-dimensional differentiation
experiments; PC12s were grown on Collagen I pre-coated 75cm2 culture flasks (Corning).
After differentiation, cells were harvested using the dissociation procedure described
above and pelleted by centrifugation. Cell pellets were stored at -80⁰C prior to molecular
analyses.

2.2.2 Preparation of 3D Scaffolds
PC12s were harvested (as described above) from growth flasks at 37⁰C for 5 minutes. Cell
counts were performed using trypan blue (Thermo Fisher Scientific) staining and quantified
using a haemocytometer. The cell density for each cell-laden hydrogel was 1x106 cells/ml.
Alginate hydrogel scaffolds were formed in sterile de-ionised water at a final
concentration of 0.5% (w/v) Sodium Alginate (Sigma), 1x HEPES Buffer pH 7.4 (20mM
HEPES [Sigma], 150mM NaCl [Sigma]), 15mM CaCO3 (Sigma), and 30mM Gluconolactone
(Sigma). Scaffolds with ECL (“+ECL”) contained a final concentration of 0.05mg/ml ECL Cell
Attachment Matrix (Millipore). All components listed above were mixed by pipetting prior
to cell addition. The 1:2 CaCO3:Gluconolactone molarity ratio ensures a balanced end pH
but triggers the solubility of CaCO3. 200μl of the hydrogel solution was added per well of a
48-well tissue culture plate to form each scaffold. Scaffolds underwent gelation at 37⁰C for
15 minutes before addition of 0.5ml differentiation media per well. For peptide-
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functionalised alginate (Alg-Pep) hydrogel scaffolds the process of formation was the same
but final concentration of alginate solutions was split 1:1 between the MMP-modified
alginate (0.25% w/v final) and the Laminin-modified alginate (0.25% w/v final) creating an
overall 0.5% (w/v) alginate concentration with an even mixture of each alginate-peptide
type. The process of functionalisation and characterisation of peptide modified alginate is
outlined in sections 2.2.9 and 2.3.1.
Collagen hydrogel scaffolds were formed in sterile de-ionised water at a final
concentration of 0.4mg/ml Collagen Type I from Rat Tail (Corning). Collagen hydrogel
gelation was triggered with the addition of 0.23x of the added collagen volume of 0.1M
NaOH (Sigma), and 1x HEPES Buffer pH 7.4 (20mM HEPES [Sigma], 150mM NaCl [Sigma])
before mixing with cells. Scaffolds with ECL (“+ECL”) contained a final concentration of
0.05mg/ml ECL Cell Attachment Matrix (Millipore). Collagen and NaOH working volumes
were mixed (to trigger neutralisation) prior to addition to buffered cell suspensions. 200μl
of the hydrogel solution was added per well of a 48-well tissue culture plate to form each
scaffold. Scaffolds underwent gelation at 37⁰C for 30 minutes before the addition of 0.5ml
differentiation media per well. Approximately 70% of media volume was exchanged every
two days over the time course of differentiation for all hydrogel types.

2.2.3 Scaffold Digestion and Cell Retrieval
Cells from 3D differentiation experiments were harvested at Day 1, 3 and 7 for molecular
analyses. Media was removed from alginate scaffold wells and the scaffold was de-gelled
with the addition of 50mM Sodium Citrate (Sigma) in 1x Hank’s Buffered Saline Solution
(HBSS) (Gibco). Scaffolds were left at 37⁰C for 15 minutes prior to trituration and transfer
to centrifugation tubes. For Collagen-based scaffolds, differentiation media was exchanged
for 0.5ml DMEM containing 0.05mg/ml Collagenase Type 1 (>125U/mg, Worthington
Biochemical Corporation) per well. Scaffold digestion took place at 37⁰C for 45 minutes
prior to trituration and centrifugation of cell pellets. Cells from four scaffolds were pooled
to form one pellet from each experimental setup. Cell pellets were stored at -80⁰C.
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2.2.4 Metabolic Activity and Cell Viability
Cell viability in 3D cultures was determined with an AlamarBlue (Thermo Fisher Scientific)
metabolic assay. 50μl of AlamarBlue was added into each scaffold-well which contained
0.5ml of differentiation media. Experimental plates were incubated for 4 hours at 37⁰C.
200μl aliquots were removed from each well and transferred to opaque 96-well assay
plates (Corning/Sigma). Fluorescence readings were measured on a FLUOstar Galaxy Plate
Reader (BMG) with an excitation wavelength of 550nm and an emission filter of 590nm.
Each time point was averaged from scaffold triplicates, and each triplicate from 4 biological
repeats. Statistical analysis was completed using GraphPad Prism software (version 5). For
intra-scaffold data, a one way-ANOVA with Tukey’s post-hoc test was used to ascertain
statistical significance between time points. For inter-scaffold data, a two-way ANOVA with
Bonferroni post-test was used to determine statistical significance between scaffold types
at each time point.

2.2.5 Western Blot Assay
Cell pellets were resuspended in 100-200μl of M-PER Mammalian Protein Extraction
Reagent (Thermo Fisher Scientific) and mixed gently at room temperature for 10 minutes.
After centrifugation at 10,000xg for 15 minutes the supernatants were transferred to new
1.7ml microfuge tubes and stored at -80⁰C until needed for downstream assays.
A colourmetric Bradford assay was used for total protein quantification, calibrated
against a Bovine Serum Albumin (BSA) (Sigma) standard curve. 2μl of each protein sample
was utilised for protein quantification together with 200μl of 1:5 diluted Bradford Reagent
(Bio-Rad). Absorbance readings at 590nm were measured on a FLUOstar Galaxy plate
reader (BMG).
For SDS-PAGE; protein samples were denatured at 70⁰C for 10 minutes in the
presence of NuPAGE LDS Sample Buffer (Thermo Fisher Scientific) and NuPAGE Sample
Reducing Agent (Thermo Fisher Scientific). Protein samples were separated on BOLT 4-12%
Bis-Tris Gels (Thermo Fisher Scientific) at 150V for 45 minutes. Molecular weight estimation
was achieved with parallel loading of Precision Plus Protein Kaleidoscope Prestained
Protein Standards (Bio-Rad). Protein lanes were transferred on to nitrocellulose
membranes (GE Healthcare Life Sciences) using Semi-Dry Transfer (Bio-Rad) at 20V for 70
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minutes in Bjerrum Schafer-Nielsen buffer (48mM Tris, 39mM glycine, 1.3mM SDS, 20%
Methanol). Successful protein transfer was confirmed with Ponceau S stain (0.1% w/v) in
acetic acid, and de-stained through washing in Tris buffered saline (TBS) with 0.05% Tween20 (TBST) (50mM Tris, 150mM NaCl, pH 7.6). Membranes were blocked for 1 hour at room
temperature in either 5% (w/v) low fat milk powder in TBST or 5% (w/v) BSA in TBST.
Membranes were incubated with primary antibodies overnight in the block solution at 4⁰C
on a plate rocker: anti-TUJ1 (Covance MMS-435P, 1:2000), anti-GAP43 (Millipore AB5220),
anti-MAP2 (Cell Signaling Technology #4542, 1:2000), anti-Phospho-MAP2-Ser136 (Cell
Signaling Technology #4541, 1:2000), anti-neurofilament-H (Cell Signaling Technology
#2836, 1:2000), anti-neurofilament-L (Cell Signaling Technology #2837, 1:2000) & antiGAPDH (Cell Signaling Technology #5174, 1:5000). Membranes were washed three times in
TBST prior to addition of secondary antibodies. Membranes were incubated with secondary
antibodies in block solution for 1 hour at room temperature on a plate rocker: Goat-antiMouse-HRP (Millipore, 1:10,000), Goat-anti-Rabbit-HRP (Millipore, 1:10,000). Membranes
were washed a further three times in TBST and once in TBS prior to chemiluminescent
detection. Imaging of protein bands on membranes was achieved on a ChemiDoc MP
system (Bio-Rad) after incubation with Western Lightning® Ultra chemiluminescence
substrate (Perkin Elmer). For semi-quantitative analysis of protein expression, band
intensities were recorded using ImageJ software (NIH). Protein bands of interest were
calculated relative to the housekeeping gene band intensity in each lane. Statistical analysis
was performed using two-way ANOVA and Bonferroni post-tests in GraphPad Prism
software (Version 5). Data is shown ± standard error of the mean with significance denoted
when the p-value ≤0.05. Three biological repeats were completed for each scaffold-type at
each time point.

2.2.6 Gene Expression
Relative gene expression analysis was performed using quantitative polymerase chain
reaction (qPCR) methodology. Firstly, RNA was purified from frozen cell pellet samples
using the RNeasy Plus Mini Kit (Qiagen) as per the manufacturer’s instructions into a total
elution volume of 50μl nuclease free water. RNA concentration was determined using an
Ultraspec 2200 Pro Spectrophotometer (GE Healthcare Life Sciences) and RNA integrity was
confirmed by running samples on a 1% Agarose (w/v)-EtBR TAE gel under electrophoretic
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conditions for 40 minutes at 80V followed by imaging on a ChemiDoc MP (Bio-Rad) to show
sharp ribosomal RNA banding.
cDNA was generated from 1μg of each RNA using the Omniscript Reverse
Transcription Kit (Qiagen) with 1μM oligo dTs (Qiagen) and 1U/ml RNase Inhibitor (Qiagen).
Reverse transcription reactions took place at 37⁰C for 80 minutes in a 20μl reaction
volume. On completion of the reaction, samples were further diluted with 20μl of nuclease
free water (Integrated DNA Technologies). cDNA samples were stored at -20⁰C until used in
qPCR reactions.

Table 2-1: List of TaqMan assay probes used in PC12 gene expression analyses

qPCR analyses were completed as duplex reactions using TaqMan Gene Expression
Master Mix (Applied Biosystems) in 10μl reaction volumes. The TaqMan assay probes used
are listed in Table 2-1. Reactions were run on a RealPlex Mastercycler (Eppendorf) with the
following parameters: 50⁰C for 2 minutes, 95⁰C for 10 minutes, followed by 40 cycles of
95⁰C for 15 seconds and 60⁰C for 1 minute. Data were analysed by the ΔΔCt method in
Microsoft Excel and statistical analyses performed in GraphPad Prism (Version 5) using twoway ANOVA with Bonferroni post-test analysis. Data is shown ± standard error of the mean
with significance denoted when the p-value ≤0.05. Three biological repeats were
completed for each scaffold-type at each time point.

2.2.7 Rheological Measurements
Storage moduli were measured using an Anton Paar MCR 702 TwinDrive rheometer with a
25mm-diameter 2⁰-angle measuring cone (Anton Paar, #79039). 170μl of each scaffold
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solution was used in each measurement. Crosslinking was monitored during 1Hz
oscillations and 1% strain at 37⁰C. Final storage moduli were calculated from when the rate
of change of the moduli reached plateau. Rheological data is presented as mean ± standard
error of the mean from three separate experiments. Statistical significance was calculated
in GraphPad Prism software using one-way ANOVA with Tukey’s post-test.

2.2.8 Live Cell and Immunofluorescence Microscopy
Live cell images were taken on an EVOS XL Core Cell Imaging System (Thermo Fisher
Scientific) and processed on ImageJ software (NIH).
Three-dimensional scaffolds for immunocytochemistry were fixed for 1 hour at
room temperature in 10% neutral-buffered formalin solution (Sigma) and permeabilised for
1 hour at room temperature in 0.5% Triton-X-100 (Sigma) in phosphate buffered saline
(PBS) (137mM NaCl, 10mM Phosphate, 2.7mM KCl, pH 7.4). Samples were blocked
overnight at 4⁰C in 5% goat or donkey serum (Millipore) in PBS before incubation with
primary antibodies (also in block solution) overnight at room temperature; anti-TUJ1
(Covance MMS-435P, 1:1000). Constructs were washed three times for 1 hour each in PBS
before addition of secondary antibodies; goat-anti-mouse IgG AF488 (Invitrogen A11029,
1:2000) in block solution overnight at room temperature. Constructs were washed three
more times in PBS before addition of DAPI (Sigma) for 1 hour, for cell nuclei visualisation.
For phalloidin staining (Texas Red-X Phalloidin, Thermo Fisher Scientific), constructs
were fixed and permeabilised as described above. A working concentration of phalloidin
stain was made at 1:100 dilution with PBS. Constructs were incubated with the stain
overnight at 4⁰C, before an overnight wash in PBS at 4⁰C.
Image acquisition was performed using a Nikon Ti Eclipse microscope equipped
with a fully automated A1 confocal laser (A1R, Nikon) and processed with NIS-Elements
software (Nikon, version 4.20).

2.2.9 Synthetic Peptide Functionalisation
100mg of each crude peptide extract (>30% purity) (Wuxi Nordisk Biotech) were purified
using reversed-phase High-Performance Liquid Chromatography (HPLC) and confirmed
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using Ninhydrin stain (Sigma) and Mass Spectroscopy (see appendix 2.5.1). The purified
MMP-peptide (with sequence GGYGPVGLIGGK) and the Laminin-peptide (with sequence
GGSDPGYIGSRGGK) were then lyophilized and stored at -20⁰C prior to use.
A 1% (w/v) alginate solution (Sigma) was formed in a 2-(N-morpholino)
ethanesulfonic acid buffer (MES buffer) (0.1M MES [Sigma], 0.3M NaCl [Sigma], pH 6.5);
buffer conditions outlined in previous peptide carbodiimide-based functionalisation
protocols (Fonseca et al., 2011; Ferris et al., 2015). Under stirring conditions, the reaction
components N-Hydroxysulfosuccinimide (Sulfo-NHS, Sigma) and N-(3Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC, Sigma) were added to the
MES buffered alginate at a ratio of 31.1mg/g alginate and 27.4mg/g alginate respectively.
This resulted in a molarity ratio of 1:2 sulfo-NHS:EDC. The solution was mixed at room
temperature for 15 minutes prior to the addition of either the MMP- or Laminin-peptide at
a ratio of 10mg/g alginate. The mixture was further stirred for 20 hours at room
temperature. The reaction was quenched with the addition of hydroxylamine (Sigma) at a
final concentration of 5mM for 10 minutes. Unreacted peptide species were removed from
the reaction mix during dialysis for 4 days at room temperature using Spectra/Por 3 Dialysis
Membranes (MW3500, Spectrum Laboratories). Peptide-functionalised alginates were then
lyophilized and stored at -20⁰C until use in quantification analysis and hydrogel formation.
Quantification of the degree of peptide functionalisation utilised UV-Vis
absorbance of the tyrosine (Y) residues within each peptide sequence. A standard curve
was generated using a 2% (w/v) alginate solution in deionised water with standard dilutions
of 2.5 or 2mg/ml, 1mg/ml, 0.5mg/ml, 0.25mg/ml, and 0.0625mg/ml of each purified
peptide. Absorbance was measured from 210nm to 300nm on an Ultraspec 2200 Pro
Spectrophotometer (GE Healthcare Life Sciences) with base alginate as the blanking
solution. Peptide-functionalised alginates were also formed in 2% (w/v) solutions for
absorbance assays. The peak absorbances at 275nm of the standard curve peptides
allowed for a linear regression model to be generated in GraphPad Prism software, and
peptide-crosslinking efficiency was calculated from this model.
The peptide diagrams in Fig 2-1 were made using PepDraw online software (Tulane
University, http://www.tulane.edu/~biochem/WW/PepDraw/index.html)
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2.3 Results
2.3.1 Generation of Peptide-Functionalised Alginate
The array of both positive and negative results of unmodified alginate as a hydrogel
scaffold for neural tissue engineering throughout the literature prompted the generation of
a novel functionalised version of the biomaterial for direct experimental comparisons. The
functionalisation outlined here utilised double-ended covalent binding of peptide motifs
using aqueous carbodiimide chemistry. Two separate peptide motifs were generated, one
containing an MMP-cleavable moiety (termed “MMP-peptide”) and the other around a
laminin-derived binding epitope (termed “Laminin-peptide”) (Fig 2-1). Each peptide was
crosslinked to the alginate backbone through both the peptide’s N-terminal amine group
and the amine group on the C-terminal lysine (K) residue side chain of each peptide.

Fig 2-1: Chemical structure and amino acid sequence of the peptides used to
functionalise alginate hydrogels. The MMP-peptide contains a metalloproteinase
cleavable sequence (PVGLIG). The laminin-peptide contains a laminin-derived cell
adhesion moiety (SDPGYIGSR). Both peptides have C-terminal lysine (K) residues
(shown in green) for amine cross-linking to the alginate chains allowing for both Nand C-terminal covalent bonding. The aromatic tyrosine residues (Y, orange) allow
for UV-Vis absorbance and quantification of peptide crosslinking efficiency.
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The formation of chemical crosslinking events therefore utilised the carboxyl side chains of
alginate polymers and the terminal amine groups of the synthetic peptides.
Peptides were also designed with an internal aromatic side chain-containing amino
acid; tyrosine (Y). In the MMP-peptide this was added within a glycine spacer region to
keep it separate from the MMP-cleavable domain, whereas in the laminin-peptide the
tyrosine residue is a native component of the binding moiety.
The tyrosine residue allows for a UV-Vis absorption at approximately 280nm due to
the aromatic side chain. As a single tyrosine residue is contained within each peptide, this
then acts as a strong linear marker of peptide crosslinking and therefore of reaction
efficiency. Absorbance spectra of each peptide of differing concentrations and mixed
within alginate solutions showed both the absorbance at 230nm derived from peptide
bond absorbance and at 270-280nm derived from the tyrosine-specific absorbance (Fig2-2
A).

Fig 2-2: (A) Absorbance spectra of each peptide by which to derive concentration
standard curves. Peaks around 230nm represent peptide bond absorbance. Peaks
around 275nm represent Tyrosine side-chain specific absorbance. (B) Standard
curves of peptide absorbance at 275nm for each peptide. Linear regression analysis
shows strong linear agreement and basis for assessing peptide crosslinking
efficiencies.
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Plotting of each peptide concentration with absorbance at 275nm (the wavelength
at which peak absorbance was seen) showed a strong linear relationship between
absorbance and peptide concentration (Fig 2-2 B) with coefficient of determination (R2)
values calculated as 0.9995 and 0.9971 for the MMP-peptide curve and laminin-peptide
curve respectively.
From this, the degree of peptide functionalisation after aqueous carbodiimide
crosslinking was ascertained. For the MMP-peptide the covalent attachment conditions
resulted in a degree of functionalisation of 4.05mg of peptide per 1g of alginate. This
equates to a crosslinking reaction efficiency of 40.5% (Table 2-2). For the laminin-peptide
the carbodiimide-derived crosslinking resulted in functionalisation of 4.68mg of peptide per
1g of alginate (Table 2-2). This had a slightly higher reaction efficiency than that of the
MMP-peptide, with a calculated 46.8% crosslinking efficiency.

Table 2-2: Measures of peptide functionalisation of alginate following carbodiimide
crosslinking of each peptide. Peptide molarity is based on the final 0.25% (w/v) of
each modified alginate in final hydrogel scaffolds. Functionalisation degree is shown
in milligrams of peptide per gram of alginate. Reaction efficiency is a measure of
cross-linked peptide relative to starting peptide in the crosslinking reactions.

As well as determining mass-based figures of the crosslinking process, the overall
molarity of each peptide that would be present in the final hydrogel scaffold was
determined. The peptide modified alginate hydrogel scaffold (herein referred to as AlgPep) used in future cell experiments was formed by combining in equal measure each of
the MMP- and Laminin-alginates, generating a hydrogel solution with both cell attachment
and cell degradable motifs to ensure the greatest potential for positive neural cell
interaction with the hydrogel scaffold. Therefore, the peptide molarities listed in Table 2-2
represent the concentration of each of the peptides in the final hydrogel solution.
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2.3.2 Modulus Testing of Candidate Neural Scaffold Materials
The effect of hydrogel modulus can elicit stark morphological and biomolecular changes of
attached or embedded neural cells and their precursors. Higher levels of neural
differentiation have been recorded within hydrogels that have degrees of stiffness similar
to those of native brain tissue (<1kPa) (Banerjee et al., 2009). To ascertain whether each
hydrogel composition had comparable storage moduli, rheological measurements of each
biomaterial were undertaken (Fig 2-3).

Fig 2-3: Rheological measurements of the candidate biomaterials for 3D in vitro neural
tissue engineering. Alg, alginate; Alg + ECL, alginate composite with ECL; Coll, collagen
type I; Coll + ECL, collagen type I composite with ECL; Alg-Pep, peptide-modified
alginate. Data shown as mean ± standard error of the mean. Statistical significance is
displayed relative to; Alg (*), Alg + ECL (#), and Coll (α). *,α p≤0.05, ***,###p≤0.001

The obtained storage moduli for all hydrogels were all below 60Pa, and therefore
well within the limits of other neural hydrogel models with stiffness equivalent to brain
tissue modulus estimates (<1kPa). Alginate scaffolds showed the highest storage modulus
of 58.1Pa, which was reduced in composite gels containing the Matrigel equivalent cell
attachment matrix (ECL) to 43.2Pa. This decrease reached statistical significance, showing a
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consistent negative impact on hydrogel stiffness in alginate gels when formed with ECMderived protein mixtures. In contrast, collagen scaffolds showed much lower storage
moduli than either of the alginate composite hydrogels, with measurements of 3.1Pa.
Conversely, collagen when blended with the ECL protein mixture showed a slight increase
in scaffold modulus to 4Pa. Both of the collagen scaffolds showed significantly lower
material stiffness when compared to both the alginate and composite alginate scaffolds.
The peptide modified alginate hydrogel (Alg-Pep) displayed an intermediate
storage modulus, between the alginate and collagen constructs, of 15.4Pa. This drop in
hydrogel stiffness following the carbodiimide-based peptide-crosslinking chemistry is not
unexpected as the peptide conjugation reaction does exploit carboxylic acid groups on the
polysaccharide molecule which otherwise would be utilised in the divalent cation
crosslinking process. The recorded storage modulus of the Alg-Pep hydrogels was
significantly lower than both alginate and alginate composite scaffolds, and significantly
higher than the base collagen hydrogel.

2.3.3 Metabolic Activity and Viability of Neural Cells within 3D
Scaffolds
To ascertain whether candidate biomaterials have a negative impact upon encapsulated
cell survival both during the process of gelation and throughout cell culture is a key
assessment of the suitability of each material to form in vitro tissue-like constructs.
PC12 cells fully encapsulated in each of the biomaterials were assayed for cell
viability during the first 7 days of differentiation. Cell viability assays that rely on the
assessment of individual cell survival using multiple fluorescent dyes and microscopy
techniques are powerful tools in two-dimensional culture but become more difficult when
assaying cells encapsulated within three-dimensional hydrogels, especially with
epifluorescent microscopy techniques. Inherent biases in field selection, dye diffusion and
background fluorescence from differing field depths make quantifiable viability assays
difficult in three-dimensional constructs. To this end, this viability assay is based on
metabolic activity across the whole construct as a proxy for measuring quantifiable cell
survival and comparisons across each hydrogel scaffold type without such biases.
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The AlamarBlue viability assay was undertaken for all cell-laden hydrogel scaffolds
on the day of gelation (Day 0), and Day 1, Day 3 and Day 7 post gelation. Experiments to
ensure that no acellular hydrogel interference of the assay were also performed (data not
shown). No statistically significant differences in cell metabolic activity (viability) were
detected between the scaffold types after the initial gelation procedures on Day 0. This was
mirrored by the finding at Day 7, which also showed comparable viability levels between all
of the tested constructs (Fig 2-4 A).

Fig 2-4: Metabolic activity/viability assays of PC12s encapsulated within each
hydrogel scaffold over 7 days of differentiation. (A) Inter-scaffold analysis of cell
viability over the time course. (B) Intra-scaffold analysis of cell viability over the
time course. Data shown as mean ± standard error of the mean. Statistical
significance denoted by *p≤0.05, **p≤0.01, ***p≤0.001
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The only differences in metabolic output (as a measure of cell viability) between
the hydrogel subtypes that reached statistical significance was between 3D Alg and 3D AlgPep constructs at Day 1 and 3D Alg + ECL and 3D Alg-Pep constructs at Day 3. In both cases
the cell viability in the peptide modified hydrogel was lower than that of the base alginate
and composite alginate scaffolds. All other viability measurements at Day 1 and 3 were
comparable between all of the construct subtypes.
When looking at cell viability within the same scaffold type over the time course of
differentiation, it is clear that metabolic activity increases to a statistically significant
degree, showing that measured cell viability is not only maintained during the experimental
timeline, but also significantly increases in all cases (Fig 2-4 B).
From these data, it can be demonstrated that all of the candidate hydrogel
materials maintain comparable cell survival during each gelation protocol and that cell
survival, proliferation, and metabolic activity increases during the process of cellular
differentiation to the same degree by the end of the experimental timeline.

2.3.4 Morphological Analysis of Encapsulated Neural Cells
The success of biomaterials for use in in vitro neural tissue engineering is not only based on
maintenance of cell viability, but also its conduciveness to allow for morphological changes
such as neurite extension, cell migration and the formation of functional cell-cell contacts
such as synapses.
Successful candidate biomaterials for three-dimensional neural tissue engineering
should have the properties that promote equivalent cell morphology and neurite extension
attained in planar culture, as well as be representative of those seen in native neural tissue.
PC12s differentiated in two-dimensional culture over 7 days displayed strong
morphological changes and extensive neurite extensions increasing in length and density
over this time course (Fig 2-5). Rounded cell morphology is observed during the growth
phase of PC12 culture (Day 0), but after the addition of differentiation triggering media
PC12s rapidly undergo neuritogenesis that is visible by Day 1 with large widespread
morphological changes throughout the planar culture after 7 days of differentiation.
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Fig 2-5: Live cell imaging of PC12s differentiating over 7 days in two-dimensional
planar culture. Cell spreading and extensive neurite extensions increase during
the differentiation process from very rounded cells at Day 0 to a strong neuronal
morphology by Day 7. Inlays show more localised regions of interest. Scale bar
represents 200μm.

Live cell imaging of PC12s encapsulated in the base and composite (+ECL) hydrogel
scaffolds after differentiation showed stark contrasts between the alginate- and collagenbased scaffolds. After 7 days of differentiation within alginate hydrogels no neurite
extensions were seen with any of the encapsulated cells, instead, round cell clusters were
formed within the hydrogel that appear isolated from one another (Fig 2-6 A). This
formation of cell aggregates without neurite extensions was also seen in the alginate
composite blended scaffolds containing the ECL protein additive. In contrast, PC12s
encapsulated within collagen matrices tended to show less cell clustering than cells within
the alginate hydrogels and also allowed for the formation of neurite extensions into the
hydrogel scaffold (Fig 2-6 A, white arrow heads). This same pattern of cell growth was also
seen in the collagen composite scaffolds containing ECL.
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This stark contrast in cellular morphology was also observed when investigated
using fluorescent immunohistochemistry and confocal microscopy. β-III-Tubulin
immunostaining of cells within alginate constructs showed tightly clustered multi-nuclear
cell clusters, that although showed expression of this neuronal marker, did not display
neurite extensions. This morphology was also seen after phalloidin staining, which binds
strongly to filamentous actin (F-actin) fibres. Within the alginate hydrogels, PC12s displayed
a strong punctate phalloidin staining pattern at the plasma membrane of the cell showing
the presence of F-actin, but none that indicate neurite extension or cell morphology
changes beyond the rounded morphology seen in bright field images (Fig 2-6 B).
PC12s differentiated within collagen-based hydrogels displayed pronounced
morphological changes with less rounded cell morphology and highly prevalent neurite
extensions into the hydrogel matrix after 7 days of differentiation (Fig 2-6 B, white and
black arrow heads). β-III-Tubulin immunostaining and phalloidin staining of PC12s within
collagen scaffolds again demonstrated a strong expression of the neuronal marker protein
that displayed neurite extensions in all three axes of the hydrogel. The phalloidin stain
showed a less punctate form than was seen in alginate-embedded PC12s, and a more
continuous formation of F-actin around the cell body and within the numerous neurite
extensions (Fig 2-6 B).
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Fig 2-6: (A) Live cell images of PC12s in alginate (Alg) and Collagen (Coll) scaffolds after 7
days of differentiation, both with and without ECL addition. Scale bars represent
100μm. (B) Bright field and confocal images of PC12s embedded in alginate and collagen
hydrogels for 7 days with β-III-Tubulin (green), phalloidin (red) and DAPI (blue)
fluorescent staining. The right-most panel displays z-depth colour coding of the neural
cells and neurite extensions. Bright field scale bar represents 50μm. Confocal images are
110μm x 110μm x 30-60μm in depth. Black/white arrowheads denote examples of
neurite outgrowth.
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The above data shows that the simple blended alginate hydrogels with extracellular
matrix components were insufficient to overcome the inert nature of alginate hydrogels to
induce a true in vivo-like neuronal morphology as in planar culture and in the 3D collagen
scaffolds.
Using live cell imaging, direct comparisons of cellular morphology between PC12s
encapsulated in alginate scaffolds and those in the peptide modified alginate (Alg-Pep)
revealed similar levels of cell clustering and rounded cell morphology (Fig 2-7 A). The cell
clustering within alginate and peptide-functionalised alginate was more apparent under
fluorescent immunohistochemical staining of the neuronal marker β-III-Tubulin (Fig 2-7 B).
Even with this degree of hydrogel modification no qualitative difference could be observed
between PC12s encapsulated in the base hydrogel relative to the alginate scaffold
containing MMP-cleavable and cell-adhesion moieties.

Fig 2-7: (A) Live cell imaging of PC12s encapsulated in alginate (Alg) and peptidemodified alginate (Alg-Pep) hydrogels after 7 days of differentiation. Scale bars
represent 50μm. (B) Fluorescent immunostaining of β-III-Tubulin (green) and DAPI
(blue) of PC12s encapsulated in each of the hydrogels after 7 days of
differentiation. Scale bars represent 50μm. BF; Bright Field.

Although no gross cellular morphological changes could be seen between these
two scaffold types, it is worthy of note that some clusters within the functionalised alginate
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scaffold did show a halo-like effect around the cluster of cells with punctate structures
visible in the hydrogel, that were seen in a lesser degree in the base alginate hydrogels (Fig
2-7 A). The presence of these elements appeared stochastically and were not accompanied
with evidence of neuritogenesis, however, this phenomenon may be indicative of local
proteolysis or ostensibly an enhanced cellular interaction with the peptide-modified
alginate hydrogel.

2.3.5 Protein Analysis of Differentiating Neural Cells in ThreeDimensional Scaffolds
As well as morphological changes of cells within hydrogel scaffolds during neural
differentiation; neuronal protein markers have been used to ascertain and quantify the
strength, speed and efficacy of neural differentiation protocols and can be directly
compared between two- and three-dimensional neural cell culture.
As the morphological differences were so stark between the subsets of threedimensional scaffolds it was reasonable to assume that these differences would be
reflected in molecular analyses of the PC12s during differentiation and allow for a more
directly quantifiable system of elucidating the biomaterials most conducive to neuronal
differentiation and directly compare this to planar differentiation.
When looking at the canonical neuronal markers β-III-Tubulin and Growth
Associated Protein 43 (GAP43) from PC12s differentiated in two-dimensional culture over
the course of 7-days, the relative amounts of these proteins mirrored the morphological
changes induced within the cells and increased over time (Fig 2-8). It was also noticeable
that a baseline constitutive expression of these markers could be seen within PC12s
(expression at Day 0) even without induced differentiation and while still in a proliferative
state (Fig 2-8). Surprisingly, this same pattern was seen in all five hydrogel scaffold
formulations over the course of differentiation. Intriguingly, the level of expression within
the alginate-based scaffolds was higher than that of the collagen hydrogels, showing
upregulation of these proteins does not necessarily follow that of morphological changes
and neuritogenesis, and instead are triggered via the induction of differentiation even in a
sterically restrictive biomaterial scaffold.
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Semi-quantitative analysis of the protein levels for these markers revealed strong
differences between the differentiation of PC12s in planar culture and those differentiated
in each of the hydrogel subtypes. β-III-Tubulin protein levels in PC12s from both alginate
and alginate + ECL scaffolds showed a statistically significant increase in expression in
comparison to two-dimensional planar differentiation and differentiation within collagen
scaffolds by Day 1 (Fig 2-9). This difference lessened as time in culture increased but was
still present to a statistically significant degree between the base alginate and both
collagen-type scaffolds by Day 7.

Fig 2-8: Western Blot expression data of neuronal protein markers of PC12s
differentiated in two-dimensional culture (2D) and within the five hydrogel threedimensional scaffolds (Alg, Alg+ECL, Coll, Coll+ECL, and Alg-Pep) at Day 1, 3 and 7.

It is also interesting to note that the protein expression of β-III-Tubulin from cells
within Alg-Pep hydrogels more closely resembled the lower levels seen within collagen
constructs, rather than the unmodified alginate hydrogels, and this difference was
statistically significant at both Day 1 and Day 3 of differentiation (Fig 2-9).
A similar pattern was also observed when looking at GAP43 protein expression
which showed close agreement between protein levels from planar PC12 cultures and the
three-dimensional alginate ±ECL hydrogels over all time points of differentiation (Fig 2-9).
These GAP43 levels showed either a strong trend or statistically significant lower intensity
value in both subtypes of collagen hydrogels. As with the levels of β-III-Tubulin; GAP43
protein expression in Alg-Pep scaffolds more closely mirrored the lower levels seen in
76

collagen hydrogels (±ECL) rather than the expression seen in the alginate gels in the earlier
time points of differentiation. This effect is reversed by Day 7, by which time the GAP43
expression level in Alg-Pep scaffolds was comparable to alginate scaffolds and statistically
higher than in the collagen gels (Fig 2-9).

Fig 2-9: Semi-quantitative analysis of Western Blot data for β-III-Tubulin and GAP43
from PC12 cells differentiated in 2D planar culture and in 3D hydrogel scaffolds over 7
days. Data is shown as means ± S.E.M. Statistical significance is displayed relative to; 2D
(*), 3D Alg (#), 3D Alg + ECL (α), 3D Coll (φ), and 3D Coll + ECL (ψ). *,#,α,φ,ψ p≤0.05,
**,##,αα,φφ,ψψ p≤0.01, ***,###,ααα,φφφ,ψψψ p≤0.001

While the protein expression patterns of both β-III-Tubulin and GAP43 showed
similar expression patterns during the course of differentiation, but with a difference in the
strength of expression for each scaffold type; other neuronal-associated proteins showed
large differences between neural cells differentiated within hydrogel scaffold subtypes and
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planar culture and offered more direct analysis of protein expression relating to neural cell
morphological changes.
Microtubule-associated protein 2 (MAP2) is a dendritic protein involved in the
regulation of microtubule assembly and neuritogenesis (Sánchez, Díaz-Nido and Avila,
2000). The expression pattern of the MAP2 (C/D) isoform appeared to differ strongly
between neural cells differentiated in two-dimensional planar culture and those within
differing hydrogel scaffolds (Fig 2-8). In planar culture, the pattern of MAP2 protein level
decreased over the course of differentiation with a constitutively high expression in
proliferative (Day 0) PC12s. This pattern was directly mirrored by the signal of PhosphoMAP2-Ser136 (P-MAP2), a phosphorylated form of the MAP2 protein, with high initial
protein expression that declined during culture. Differential expression of both MAP2 and
P-MAP2 in alginate (±ECL) versus collagen (±ECL) hydrogel scaffolds is striking, with PC12s
differentiating in collagen scaffolds showing a similar but slower pattern of MAP2 and PMAP2 decline during the time course. Neural cells within alginate scaffolds however,
showed almost no expression of MAP2 or P-MAP2 from Day 1 onwards. This is the first
sharp divide in protein expression seen between neural differentiation within the two
scaffold types so far. Interestingly, the pattern of MAP2 and P-MAP2 expression in the
peptide-functionalised alginate again followed the pattern of collagen scaffold expression
rather than that of the base or ECL-composite alginate scaffolds.
Stark differences in neuronal protein marker expression between differentiating
cells within hydrogel subtypes continued when looking at the regulation of the neuronspecific intermediate filaments Neurofilament-Light (NF-L) and Neurofilament-Heavy (NFH). In the case of PC12 differentiation in two-dimensional culture, the levels of NF-L
diminished over time relative to the Day 0 signal, whereas NF-H expression increased over
the course of differentiation, suggestive of differential timings and roles of these filaments
during the differentiation process (Fig 2-8). The collagen (±ECL) and alginate (±ECL)
hydrogel cell scaffolds had clear and contrasting expression patterns of these proteins over
the course of differentiation. Cells within alginate hydrogels, both with and without ECL
composites, displayed a low level of NF-L signal over 7 days that increased over time, with a
double-banded positive signal at Day 7. Conversely no NF-L signal was seen in cells
differentiated in collagen hydrogels at any time point during the differentiation (Fig 2-8).
Intriguingly, the expression pattern of NF-L from cells differentiated within Alg-Pep
scaffolds showed a semi-consistent expression pattern with the double banding seen from
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late time points from alginate derived samples at all time points during differentiation. So
even when previous marker expression from Alg-Pep constructs more closely resembled
those of collagen-derived samples, the presence of this NF-L signal was more similar to that
of an alginate (±ECL) derived cell protein sample.
In contrast to NF-L protein expression, no NF-H signal was seen within
differentiating PC12s within base or composite alginate scaffolds at any time point,
whereas strong banding was seen from neural cells differentiated in the collagen hydrogels.
The expression pattern derived from collagen scaffold samples however, did not follow the
same pattern as is seen from planar differentiated samples, and instead had a peak
intensity at Day 1 that declined during differentiation.
The NF-H protein expression in cells differentiated in the Alg-Pep matrices diverged
from the pattern seen in the alginate and collagen scaffolds and instead displayed the
pattern seen from cells in two-dimensional culture; with an increase in expression over the
7-day time course.

2.3.6 Gene Expression Analysis of Differentiating Neural Cells in
Three-Dimensional Scaffolds
The large differences seen in protein expression patterns for the array of neuronal markers
from PC12s differentiating in two-dimensional and three-dimensional environments seen
above, raise the question of how these protein levels are regulated. Whether the
regulation of these proteins expressed in environments conducive to neuritogenesis occur
at the gene expression level or post-transcriptionally will allow for a better insight into how
these genes and proteins work in concert over the course of neural cell differentiation.
qPCR analysis of the genes β-III-tubulin, Gap43, Map2, Nf-l, and Nf-h was
completed for 7-day differentiation of PC12s in each of the five three-dimensional hydrogel
scaffolds and two-dimensional planar culture to make it directly comparable to the protein
expression analysis completed above.
Gene expression levels of these neuronal markers in general showed a relatively
high level of constitutive expression which, for the majority of genes, showed limited up- or
down-regulation when looking at fold changes of mRNA expression (Figs 2-10, 2-11).
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β-III-tubulin mRNA expression displayed a general trend of slight upregulation over
the time course of differentiation for the majority of 2D and 3D differentiation conditions
(with the exception of Alg-Pep encapsulated PC12s, which showed a slight downregulation
at Day 1). Although this upregulation never reached a 2-fold increase in expression and
showed no statistically significant differences between any of the two- and threedimensional growth conditions at any stage of differentiation.

Fig 2-10: Inter-scaffold quantitative PCR (qPCR) analysis of β-III-Tubulin, Gap43, Map2,
Nf-l and Nf-h mRNA expression in PC12 cells during differentiation in two-dimensional
culture (2D), alginate hydrogels (3D Alg), alginate and ECL protein mix composite
hydrogels (3D Alg + ECL), collagen hydrogels (3D Coll), collagen and ECL protein mix
composite hydrogels (3D Coll + ECL), and peptide-functionalised alginate hydrogels (AlgPep). Data is shown as mean values ± standard error of the mean of three independent
experiments. Statistical significance is denoted by * p≤0.05, ** p≤0.01, *** p≤0.001.

A similar pattern was seen for Gap43 gene expression during differentiation, albeit
with overall higher fold-changes than the Day 0 constitutive expression. In early stages of
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differentiation (Days 1-3) the level of Gap43 mRNA was highest in the two-dimensionally
differentiated neural cells, followed by cells in the collagen scaffolds and then lower levels
in cells from the alginate and peptide-alginate hydrogels, although none of these trends
reached statistical significance (Fig 2-10). These early stage differences were also not
present by Day 7 of differentiation where expression levels of Gap43 were comparable
across all 2D and 3D differentiation conditions.

Fig 2-11: Intra-scaffold quantitative PCR (qPCR) analysis of β-III-Tubulin, Gap43, Map2,
Nf-l and Nf-h mRNA expression in PC12 cells during differentiation in two-dimensional
culture (2D), alginate hydrogels (3D Alg), alginate and ECL protein mix composite
hydrogels (3D Alg + ECL), collagen hydrogels (3D Coll), collagen and ECL protein mix
composite hydrogels (3D Coll + ECL), and peptide-functionalised alginate hydrogels (AlgPep). Data is shown as mean values ± standard error of the mean of three independent
experiments. Statistical significance is denoted by * p≤0.05, ** p≤0.01, *** p≤0.001.
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Map2 expression showed a relative drop by Day 1 of differentiation in all
differentiating culture conditions which then recovered back to Day 0 levels and above by
Day 3 and 7 (Fig 2-10). The only increase that reached statistical significance was the
increase in Map2 expression in two-dimensional culture between Day 1 and 3 of
differentiation (Fig 2-11). Again, the fold changes seen over the course of differentiation in
all culture conditions were minimal relative to the Day 0 constitutive expression and none
of the differences between Map2 expression levels at each time point showed significant
differences between each planar- or hydrogel-based culture.
The gene transcript expression of Nf-l however, displayed the strongest difference
between PC12s differentiating in planar culture versus those in three-dimensional scaffolds
(Fig 2-10). By Day 1 and Day 3 of differentiation the level of expression from cells in planar
culture were in all cases higher than cells within hydrogel scaffolds. This effect was less
pronounced by Day 7 of differentiation but remained significantly higher than expression
from cells within collagen (±ECL) scaffolds. The peak fold change seen between Day 0 Nf-l
expression and the level of expression on Day 3 in planar culture did reach statistical
significance (~2.7 fold higher) (Fig 2-11). In each of the hydrogel scaffold samples, the level
of Nf-l was relatively consistent over the course of differentiation, after an initial downward
trend. Day 7 mRNA levels of Nf-l from alginate hydrogels reached a peak that was
statistically significant from the Day 1 fold-change (Fig 2-11).
Nf-h mRNA expression across all two- and three-dimensional differentiation
conditions showed a similar pattern of slight downregulation relative to Day 0 levels (Fig 210, Fig 2-11), with the exception of the Alg-Pep scaffold encapsulated neural cells that
showed a slight increase by Day 3 and Day 7. Overall no statistically significant differences
were seen in gene expression levels of Nf-h either within a growth condition differentiation
time course or between different growth conditions at each time point of differentiation.
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2.4 Discussion and Conclusions
The techniques and challenges associated with in vitro neural cell culture have evolved
dramatically since its inception (Millet and Gillette, 2012). Recent advances in biomaterial
development and additive fabrication technologies (such as bioprinting) have put the onus
on forming materials and cell growth environments that better recapitulate the
cytoarchitecture and biophysical properties of native tissue. In vitro modelling of neural
tissue forms the foundation of modern neurological research by creating a biomimetic
environment to better understand human brain development, the pathology of
neurological disease, to test and refine novel therapeutic agents, and eventually even form
regenerative tissue applications. For this to be successful the selection and development of
biological or non-biological scaffold materials that enable encapsulated cells to generate a
more representative “brain-like” environment through enhanced cell-cell contact, dynamic
cell-matrix interactions, and ultimately cell maturation and functionality are critical to this
frontier.
Although multiple individual studies of hydrogel scaffolds for neural tissue
engineering applications are present in the literature, few of them directly compare
multiple scaffold subtypes to one another or compare directly to planar 2D neural
differentiation. This section of research aimed to directly compare, at a material and cell
biological level, the effect of the biomaterial scaffold alone on encapsulated neural cell
differentiation.
Alginate and collagen type I hydrogel scaffolds have been used in a variety of
neural tissue modelling research, with varying degrees of success. Collagen hydrogels are a
widely used scaffold biomaterial from which to generate 3D neural tissue constructs. These
scaffolds are conducive to neuritogenesis (O’Connor et al., 2001; Swindle-Reilly et al.,
2012), show enhanced cell viability and activity when generated as composites with ECMderived proteins (Sood et al., 2016), and allow for the generation of synaptic connectivity
and neural cell function (O’Connor et al., 2000; Ma et al., 2004; Xu et al., 2009; Odawara,
Gotoh and Suzuki, 2013). Alginate-based hydrogel in vitro constructs however, show mixed
effects on embedded neural cell morphology and activity that is heavily dependent on
scaffold composition and crosslinking conditions (Banerjee et al., 2009; Meli et al., 2014;
Palazzolo et al., 2015), but has shown promise in bioprinting methodologies (Chung et al.,
2013; Gu et al., 2017).
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To overcome or ameliorate this steric hindrance of neuritogenesis we generated
alginate scaffolds with double-ended functionalisation peptides containing MMP2/9cleavable motifs and laminin-derived cell binding moieties, which had shown promise in
previous work with mesenchymal stem cell spreading in alginate hydrogels, and motor
neurons in polyethylene glycol scaffolds (Fonseca et al., 2011; McKinnon, Kloxin and
Anseth, 2013). Aqueous carbodiimide crosslinking chemistry was utilised to generate the
peptide-functionalised alginate (Alg-Pep) through the reaction of native carboxylic acid
groups within the alginate polymer chains and the terminal amine groups of each peptide
derived from the amine-terminus and a C-terminus lysine side-chain. Reaction efficiencies
of 40.5% and 46.8% were achieved for the crosslinking of the MMP-peptide and the
laminin-peptide respectively, resulting in MMP-peptide levels of 4.05mg/g alginate and
laminin-peptide levels of 4.68mg/g alginate. The efficiencies of these modification
reactions are comparable to those previously reported under similar reaction conditions
(Fonseca et al., 2011). This reaction chemistry generated peptide conjugates that were
covalently bonded at both terminal ends of the peptides as opposed to the wider used
pendant-style modification which grafts peptides using only a single terminus. The
combination of both cell-binding and protease-cleavable motifs linking separate
polysaccharide chains was developed in an attempt to enhance cellular interaction with a
non-mammalian hydrogel scaffold whilst also limiting the steric hindrance of the alginate
hydrogel on neuritogenesis, as seen in previous research (Banerjee et al., 2009).
The stiffness of substrates used for in vitro cell culture has a strong impact on cell
attachment, stem cell differentiation and cell morphology in both 2D and 3D (Engler et al.,
2006; Banerjee et al., 2009). To optimise neural cell differentiation, the moduli of hydrogel
scaffolds should be comparable to that of native brain tissue. To this end, the candidate
neural tissue construct biomaterials in this work were assayed under rheological
measurement to directly compare their suitability to replicate 3D brain-like soft growth
conditions. The concentrations of collagen used within these hydrogels (0.4mg/ml) mirror
previously reported positive results of collagen hydrogel formation for neural culture
(O’Connor et al., 2001). The alginate concentration used (0.5% w/v) was selected as it was
the lowest concentration of polysaccharide that could generate a stable hydrogel under
these culture conditions. This was an effort to engineer the lowest possible hydrogel
modulus in an attempt to maximise positive neural differentiation (Banerjee et al., 2009).
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All crosslinked hydrogels tested displayed storage moduli below 60Pa which is well
within the softness equivalent range of neural tissue (<1kPa). We observed the softest gels
were generated from collagen matrices (3.1Pa) and that composite scaffolds of collagen
with a Matrigel equivalent (ECL) demonstrated slightly higher moduli (4Pa). Conversely,
alginate scaffolds displayed a higher storage moduli reading of 58.1Pa, which was lower in
composite scaffolds containing ECL (43.2Pa). This drop may be due to the nature of the
ionic crosslinking between alginate polymer chains, which may be inhibited through the
presence of ECM-derived structural proteins not allowing for adequate proximity of
crosslinking regions. Alg-Pep scaffolds displayed lower moduli measurements than the base
and ECL-doped hydrogels (15.4Pa) owing to the fact that the carboxyl-groups utilised within
ionic crosslinking become the attachment points for the peptide reactions. The doubleended nature of the peptide binding itself may also interfere on a steric level with how the
alginate chains crosslink with each other and therefore lower the stiffness of the formed
hydrogel during sol-gel transition. The level of peptide-crosslinking chemistry may
therefore not only be used to functionalise scaffolds with biomimetic moieties, but also as
a mechanism by which to tailor hydrogel moduli.
Another key criterion for the applicability of biomaterials for use in neural tissue
engineering applications is the ability to maintain cell viability both during the crosslinking
process and over the course of neural differentiation. The five hydrogel compositions
within this study showed comparable levels of PC12 neural cell viability, both after the
crosslinking process and after 7 days of differentiation. This indicates that neither
crosslinking process was detrimental to cell survival and that the metabolic activity of the
differentiating cells was preserved over the time course of differentiation. Only at Day 1
and 3 post-differentiation did a slight trend of lower viability in the collagen and Alg-Pep
based scaffolds in comparison to the alginate (±ECL) hydrogels emerge. The fact that these
differences are quite minimal, and that in all samples tested cell viability increases during
the time course of differentiation, leads to the conclusion that strictly from a basis of cell
survival within these constructs: all tested hydrogels show comparable cell biocompatibility
profiles during neural differentiation.
Large differences were seen between the neural tissue scaffolds however, when
assays of neuritogenesis and neural cell morphology were undertaken. PC12 cells show
rounded cell morphologies under proliferative conditions, but quickly undergo
neuritogenesis under neurotrophic treatment and display extensive morphological changes
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over 7 days of differentiation [(Fig 2-4) and (Das, Freudenrich and Mundy, 2004)]. PC12s
when differentiated in collagen ± ECL hydrogels also underwent neuritogenesis over a
similar time frame and with neurites extending in all directions within the scaffold. No
discernible positive effect on neuritogenesis was seen in collagen scaffolds containing the
ECL protein mix. These morphological changes were however not seen in the alginate or
ECL composite alginate scaffolds; which contained aggregates of PC12s with a rounded cell
morphology. This mirrors the rounded morphology of NSCs embedded in alginate scaffolds
of equivalent and higher storage moduli (Banerjee et al., 2009), and the lack of dorsal root
ganglia neuritogenesis also within alginate hydrogels (Novikova et al., 2006). The addition
of ECL as a component of the alginate hydrogel did not elicit any positive neuronal
morphology changes of the PC12s in this study, although the addition of fibronectin into
alginate scaffolds in previous studies has been shown to ameliorate the inhibition of
neuritogenesis to a degree (Novikova et al., 2006).
Strong positive neurite outgrowth of primary rat cortical neurons within
unmodified but “ultrasoft” alginate hydrogels of 0.1% - 0.4% (w/v), and with substoichiometric concentrations of crosslinking calcium ions, has been reported (Palazzolo et
al., 2015), although we were unable to generate hydrogel structures from the alginate
sources used in this study at the low concentrations the authors reported (data not shown).
Even at comparable storage moduli (<100Pa) we do not observe comparable levels of
neurite outgrowth, suggesting that modulus alone is an incomplete marker of whether
neurite outgrowth will take place. In this instance it may be that sub-stoichiometric
crosslinking of alginate scaffolds, rather than low dry-mass biomaterial concentrations,
elicit positive neuritogenesis through limited steric inhibition of cell movement through
incompletion of the gelation process. This system of incomplete crosslinking however,
would be difficult to control and would be impossible to monitor and maintain partial solgel transition during extended neural cell culture.
It is possible that different neural cell types respond differently to the same
hydrogel environment and that PC12s and primary neurons would show different
morphological trends due to intrinsic cell-line and native-neuron differences, however
preliminary data showed that embryonic primary rat cortical neurons were also unable to
undergo neuritogenesis within alginate scaffolds, but rapidly do so in collagen hydrogels
(Appendix 2.5.2), matching the effect seen on embedded PC12s. This reinforces the
concept of utilising neural cell lines as a proxy for true neuronal responses.
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The differences in conduciveness to neuritogenesis between alginate and collagenbased scaffolds may be linked to the difference in storage moduli between the biomaterials
(where collagen showed a much softer profile), but the recorded moduli for alginate
hydrogels recorded in this study is still well within the degree of softness expected of native
tissue and of equivalent successful neural tissue modelling studies (McKinnon, Kloxin and
Anseth, 2013; Palazzolo et al., 2015). Therefore, the apparent inhibition or enhancement of
neuritogenesis may hinge on biophysical and biomimetic factors beyond simple modulus
testing. This could include crosslinking fibre formation and structural elements such as
porosity and polymer chain alignment and assembly, which may differ greatly between
alginate and collagen hydrogels.
This lack of observable neuritogenesis seen within alginate and ECL composite
alginate hydrogels is also reflected in the MMP- and laminin-peptide functionalised alginate
scaffolds. Previous functionalisation of alginate scaffolds with laminin-derived binding
epitopes allowed for a more in vivo-like glial and neuronal morphology in equivalent
alginate (w/v) scaffolds (Frampton et al., 2011), although in constructs of a much smaller
volume and with cell densities much higher than those used in this study. It is plausible that
higher cell densities may impact the gelation process and minimise the effective
crosslinking of alginate chains due to the steric hindrance of the cells themselves, in a
fashion similar to sub-stoichiometric crosslinking methodologies. Similar double-ended
MMP-sensitive peptide functionalisation of both alginate and PEG scaffolds did show
promise for embedded mesenchymal stem cell spreading and motor neuron axonogenesis
(Fonseca et al., 2011; McKinnon, Kloxin and Anseth, 2013). The different outcomes
following peptide functionalisation of inert alginate scaffolds shown in this study may be
due to multiple factors. The degree of functionalisation itself may not be at a level high
enough to elicit a dense enough network of cleavable or cell-adhesive moieties for
neuritogenesis and cell spreading to take place. Although reaction efficiencies were
equivalent to those previously reported, the type and source of alginate used in each study
(such as the content and ratio of β-D-mannuronic acid and α-L-guluronic acid monomers)
have profound effects on viscosity and gelation properties that may enhance or inhibit the
effects of peptide modification. Furthermore, the MMP-cleavable motif used in this study
was designed to be sensitive to MMP-2 and MMP-9 secreted proteases, although a whole
raft of protease-sensitive sequences can be generated, therefore it is possible that multiple
sequences may enhance neuritogenesis of encapsulated differentiating neural cells
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depending on their source. All of these elements could be modified in future work to try
and tailor the use of alginate scaffolds for neural-tissue engineering.
The gene and protein expression profiles of PC12s within each scaffold subtype also
showed stark differences over the course of neural differentiation and also when compared
to standard 2D planar culture. The protein expression levels of both β-III-Tubulin and
GAP43 increase during PC12 differentiation in 2D planar culture in accordance with
previous studies (Ohuchi et al., 2002; Das, Freudenrich and Mundy, 2004). This pattern of
upregulation over 7 days of differentiation was seen across all 3D PC12 hydrogel cultures,
even within the alginate (±ECL) and peptide-functionalised alginate cultures which showed
no evidence of neuritogenesis. Intriguingly, this result suggests that even in matrices that
restrict neural morphological development, the embedded neural cells still positively
respond to signalling factors triggering differentiation-related protein expression. Equally
as fascinating is the finding that at early time points (Day 1 and 3) β-III-Tubulin protein
levels are significantly higher in neural cells differentiating in 3D alginate (±ECL) hydrogels
than those seen at the same time points in 2D culture. This upregulation at each time point
in 3D alginate scaffolds remains significantly higher than 3D collagen (±ECL) encapsulated
neural cells until Day 7, and which themselves tend to match with 2D differentiation levels
and the peptide-functionalised alginate hydrogels. This increase in canonical neuronal
proteins from cells in 3D alginate scaffolds relative to 3D collagen scaffolds is also true of
GAP43 protein expression. This finding may seem counterintuitive as higher levels of neural
differentiation markers may be expected from culture conditions that allow for
neuritogenesis and mature neural morphology formation. In this case however, it does
appear that these particular neuronal markers although upregulated during the course of
induced differentiation are unreliable markers of neuronal morphology development. The
gene expression profiles of β-III-tubulin and Gap43 follow a similar pattern to protein
expression and are upregulated during differentiation. However, the relative increase of
each gene is slight, and no upregulation in any scaffold reaches statistical significance, and
the differences seen between gene expression at each time point is not statistically
different from PC12s in other hydrogel scaffold types, unlike those seen for protein
expression levels.
The dendritic marker MAP2 and its phosphorylated forms interact with the
microtubule network within neural cells and may have a role in processes regulating
cellular morphology (Sánchez, Díaz-Nido and Avila, 2000). In 2D planar differentiation,
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MAP2 (C/D isoform) and the serine-136 phosphorylated form (P-MAP2) show
downregulation over the course of PC12 differentiation. Robust differences are seen in
MAP2 and P-MAP2 levels between PC12s differentiating in alginate and collagen scaffolds,
whereby both markers are absent from PC12s in 3D alginate (±ECL) constructs but show a
slower downregulation pattern mimicking the 2D differentiation samples in collagen (±ECL)
constructs. Unlike the neuronal markers β-III-Tubulin and GAP43 whereby upregulation is
discrete from morphological development, MAP2 and P-MAP2 show large differences
between the same cell type differentiating in distinct biomaterial scaffolds. Even more
surprising is the finding that the MAP2 and P-MAP2 protein expression pattern in the
peptide-modified alginate scaffolds follows a similar pattern to 3D collagen and 2D planar
differentiation rather than the 3D base alginate scaffolds. When looking at Map2 gene
expression however, this pattern of downregulation is not seen. Instead a high constitutive
expression with an initial trend of downregulation and then upregulation over 7 days of
differentiation is comparable across PC12s differentiated in all scaffold subtypes. This is an
interesting disconnect between the final protein marker product and the underlying gene
expression profile which suggests strong post-transcriptional regulation of the Map2 gene
depending on the cell-biomaterial interactions encountered during differentiation.
Distinct differences are also seen in the expression of the neurofilament proteins
NF-L and NF-H which have been shown previously to be upregulated slightly during PC12
differentiation (Ohuchi et al., 2002). In 2D planar PC12 differentiation in this study, NF-L
levels decrease over time, whereas NF-H protein levels increase. This difference in
expression profiles may be due to a recapitulation of developmental timings of each
neurofilament with early expression of NF-L followed by a later expression pattern of NF-H
(Liu et al., 2004). However, within alginate hydrogels (±ECL), NF-L levels increase over time,
whereas NF-H was not detected, suggesting a link between the lack of biomaterial
interaction and the morphological changes within the encapsulated PC12s. The reverse of
this pattern is seen in collagen hydrogels (±ECL) which do not show detectable levels of NFL but do show positive NF-H banding, but with a different pattern to that seen from 2D
planar differentiation. Interestingly, PC12s differentiated within peptide-modified alginate
scaffolds show NF banding patterns indicative of both collagen and alginate hydrogel
samples; with NF-L expression measurable at all time points and an upregulation of NF-H
that follows the same pattern as 2D differentiation. Some NF-L probes displayed double
banding within samples from the 3D alginate (±ECL) and peptide-alginate samples not seen
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in 2D planar culture, which may demonstrate an effect of post-translational modification
such as glycosylation and/or phosphorylation (Liu et al., 2004). It has been seen in previous
studies that Nf-l gene expression increases over the course of PC12 differentiation (Won et
al., 2015), which is also seen in this study in 2D planar differentiation, but to a much more
static degree in PC12s within all 3D hydrogel scaffolds. This static expression profile is again
seen with Nf-h gene levels; that display high constitutive expression that remains relatively
stable over the time course of differentiation. As was the case with MAP2 gene and protein
expression, these disparate patterns do not reflect the final protein patterns seen
experimentally. Again, it can be concluded that strict post-transcriptional regulation of
these genes must be taking place and that constant gene expression levels of these
markers may be a factor of the PC12s themselves, and must be factored into any analysis
involving other neural cell types.
The differing protein expression patterns of MAP2, P-MAP2, NF-L and NF-H
between the hydrogel compositions and those derived from 2D differentiation highlight the
complex interplay of these neural markers as PC12s undergo differentiation in
environments that display different biophysical properties, that may or may not support
neuritogenesis, and those that contain native-ECM binding motifs or not. From these data
it appears that these protein markers are a more effective measure of cell-matrix
interactions and possible neurite elongation than the canonical neuronal markers β-IIITubulin and GAP43. It is worthy of note however, that the constitutive expression levels of
many neuronal genes and proteins within PC12s in basal growth media results in a more
subtle upregulation during differentiation as was discussed above, and has discounted
certain markers for use in previous differentiation studies of PC12s (Das, Freudenrich and
Mundy, 2004). It has also been noted that intermediate filament expression patterns (such
as neurofilaments) within PC12s do diverge from patterns seen in native neural cultures
(Franke, Grund and Achtstatter, 1986). This surprising gene expression disconnect from
translated protein products may also be related to the reportedly high level of posttranscriptional regulation of differentiation-associated genes in PC12s (Lindenbaum et al.,
1988; Perrone-Bizzozero, Cansino and Kohn, 1993).
In conclusion, the striking differences between protein marker expression in PC12s
within 3D hydrogels and 2D culture is a firm demonstration of cell-matrix interactions
dictating cellular responses at the molecular level, even under identical differentiation
inducing conditions. Even with comparable cell viability retention and scaffold stiffness
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analogous to that of native brain tissue, differentiation within alginate-based hydrogels
restricted neurite outgrowth and in vivo-like morphology, but elicited strong canonical
neuronal marker expression, but differential patterns of MAP2/P-MAP2 and neurofilament
protein expression than was seen in 2D planar differentiation. Conversely, collagen-based
3D hydrogel scaffolds had almost the opposite effect on the embedded neural cells; by
allowing for extensive neuritogenesis together with gene and protein expression patterns
more equivalent to 2D planar culture. Strikingly, peptide-modified alginate hydrogels
(containing MMP-sensitive and laminin-binding motifs) although not conducive to
neuritogenesis, showed protein expression patterns reflective of both alginate-embedded
and collagen-embedded PC12s. This demonstrates that not only are encapsulated neural
cells responding to the biophysical properties of the hydrogels themselves, but must be
interacting at a biochemical level with the moieties presented within the hydrogels to
regulate and modulate molecular pathways of neural cell differentiation.

2.4.1 Summary of Chapter Findings


Using aqueous carbodiimide chemistry; double-ended MMP-cleavable and lamininbinding peptide motifs can be covalently bonded to alginate polymers with high
efficiency.



Collagen type I, alginate and peptide-modified alginate hydrogels all allow for high
retention of cell viability of encapsulated neural cells during scaffold gelation, as well as
over the time course of neural differentiation.



Rheological analysis of hydrogels reveals all candidate scaffolds have storage moduli
below 100Pa. Collagen hydrogels show the lowest degree of stiffness, with alginate
hydrogels the highest. Peptide-modified alginate hydrogels show intermediate stiffness
measurements between collagen and basal alginate scaffolds.



Collagen type I hydrogels (both with and without ECM protein components) allow for
neurite extension of encapsulated PC12 neural cells over the same time course as 2D
planar differentiation.



Low concentration alginate hydrogels are non-conducive to neuritogenesis of
encapsulated differentiating PC12 neural-like cells. This effect is not ameliorated by the
addition of extracellular matrix proteins.
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Peptide-modified alginate hydrogels also do not allow for neuritogenesis of
encapsulated neural cells, but do show a tendency for visible “halo-like” structures
around cellular aggregates, suggesting cell-scaffold molecular interactions.



The canonical neuronal protein markers β-III-Tubulin and GAP43 increase in expression
over the time course of neural differentiation in 2D and 3D culture. These increases do
not reflect the neuritogenic potential of the hydrogel scaffolds and are highly
expressed in alginate and alginate-peptide scaffolds which restrict neurite formation.



Other neuronal protein markers MAP2, P-MAP2, NF-H, and NF-L do show stark
differences in expression profiles during neural differentiation in the various
biomaterial scaffolds. These markers therefore represent more reliable measures of
neuritogenic potential of candidate biomaterials.



Gene expression levels of the above markers in PC12s display a high constitutive
expression level that show low levels of fluctuation during differentiation. These low
relative changes in gene expression do not directly reflect the large differences seen
with protein expression analysis. This is suggestive of a harsh post-transcriptional
regulation of these genes at least within the PC12-based model.
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2.5 Appendix
2.5.1 Peptide Functionalisation Mass Spectrometry Data
Following reversed-phase HPLC chromatography, peptide-containing aliquots were purity
tested through mass spectrometry analysis. Double-charged peptide component peaks
were used to determine the purest aliquots for down-stream alginate crosslinking
chemistry. Some example spectra are shown below.

Appendix Fig 2-12: Mass spectrometry readings of aliquots of MMP- and lamininpeptide following HPLC purification. The strong peaks of the double charged
peptides allowed for selection and lyophilization of pure full-length peptides.

2.5.2 Primary Rat Cortical Neural Cells within Alginate and Collagen
Scaffolds
Although PC12s, a rat-derived neural-like cell line, were used as a proxy for primary or stem
cell derived neuron behaviour in 3D environments, it was necessary that gross
morphological changes witnessed from the PC12 3D hydrogel tissue constructs should
reflect those of primary neural cultures. Embryonic (E18) rat cortical cells (kindly supplied
by Dr. Justin Bourke, St. Vincent’s Hospital Melbourne) were embedded in equivalent
hydrogel matrices and differentiated over 7 days to ensure the inhibition or enhancement
of neuritogenesis seen with PC12s in each scaffold type was recapitulated. E18
Differentiation media was composed of Neurobasal (Gibco), B27 (Thermo Fisher Scientific),
N2 (Thermo Fisher Scientific), GlutaMAX (Thermo Fisher Scientific), 100U/ml Penicillin and
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100μg/ml Streptomycin (Gibco). Some demonstrative images are shown below (Appendix
Fig 2-13).

Appendix Fig 2-13: Bright field (top) and immunofluorescent (bottom) images of
embryonic E18 rat cortical neurons differentiated within alginate and collagen 3D
hydrogel scaffolds. β-III-Tubulin immunostaining is shown in green. As with PC12s no
neuritogenesis was observed in alginate scaffolds, whereas extensive neurite branching
and extension was seen from the same cells in collagen scaffolds (black arrow heads).
Scale bars represent 50μm.
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Chapter 3: Subtype Specific Neural
Differentiation of Human Induced
Pluripotent Stem Cells

3.1 Introduction
The advent of induced pluripotent stem cell (iPSC) technology has incredible potential to
drive the next generation of human neurological research. Human iPSCs (hiPSCs)
differentiated into neural lineages in vitro do so following the same developmental timings
and maturation profiles as is seen in utero, and even more remarkably have the capacity to
self-organise into multicellular substructures that are representative of early brain
cytoarchitecture (Petros, Tyson and Anderson, 2011; Anderson and Vanderhaeghen, 2014;
Kelava and Lancaster, 2016). This retention of in vivo-like properties of differentiation in
the dish, combined with the fact that they can be reliably generated on a patient-specific
basis, makes hiPSCs an attractive foundation for in vitro modelling of genetically linked
neurodevelopmental and neurodegenerative pathologies (Park et al., 2008; Mattis and
Svendsen, 2011; Okano and Yamanaka, 2014). By differentiating human pluripotent stem
cells into particular neural subtypes in vitro that carry mutations implicated in disease
pathologies, many researchers have already begun to recapitulate and better understand
such conditions as Parkinson’s Disease (Soldner et al., 2009; Kriks et al., 2011; Miller et al.,
2013; Schwab and Ebert, 2015), Alzheimer’s Disease (Israel et al., 2012; Choi et al., 2014; D.
Zhang et al., 2014; Duan et al., 2014; Kim et al., 2015; Nieweg et al., 2015; Mungenast,
Siegert and Tsai, 2016), Huntington’s Disease (Juopperi et al., 2012), Amyotrophic Lateral
Sclerosis (Motor Neurone Disease) (Di Giorgio et al., 2008), Spinal Muscular Atrophy (Ebert
et al., 2009; Corti et al., 2012), Autism Spectrum Disorders (Mariani et al., 2015; Marchetto
et al., 2017), and syndromic genetic Epilepsies such as Dravet Syndrome and Rett
Syndrome (Marchetto et al., 2010; Ananiev et al., 2011; Cheung et al., 2011; Kim, Hysolli
and Park, 2011; Farra et al., 2012; Yu Liu et al., 2013; Dajani et al., 2013; Higurashi et al.,
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2013; Jiao et al., 2013; Chen et al., 2014; Williams et al., 2014; Parent and Anderson, 2015;
Du and Parent, 2015; Z.-N. Zhang et al., 2016; Maeda et al., 2016).
The strength of both in vitro neurological developmental- and disease-modelling is
underpinned through the accurate generation of specific neural subtypes that are
differentiated and matured to a level comparable to in vivo neural networks. Forebrain
neural development in utero is derived from the anterior-dorsal region of the neural tube
(the embryological precursor of the central nervous system). Interestingly, neural cells from
this brain region represent the outcome of the default differentiation lineage of
neuroectodermally induced cells from hiPSCs (Zeng et al., 2010; J.-E. Kim et al., 2011; Shi et
al., 2012), rather than stochastic differentiation of multiple neuronal subtypes from
multiple neural tube regions.
However, as well as this predominantly excitatory pool of cells that form forebrain
structures (such as the cortex) from this lineage pathway: approximately 20% of neocortical
cell numbers are comprised of GABAergic inhibitory neural cell types (Arber and Li, 2013).
These neural cell subtypes are generated from anterior-ventral regions of the neural tube
and migrate tangentially into cortical regions from structures termed ganglionic eminences
(Danjo et al., 2011; Arber and Li, 2013). The temporo-spatial patterning of the neural tube
in utero is derived from gradients of morphogens that define dorsal-ventral and rostralcaudal axes (Briscoe and Ericson, 2001; Le Dréau and Martí, 2012). One such morphogen is
Sonic Hedgehog (SHH) which is a ventralising ligand secreted from the neural tube
floorplate and notochord (Jessell, 2000). By replicating this exposure to SHH, or smallmolecule agonists of the SHH-signalling pathway, many in vitro pluripotent stem cellderived neural precursor cells (NPCs) can be patterned to a ventral and therefore
GABAergic interneuron cell identity (Maroof et al., 2010; Danjo et al., 2011; Goulburn et al.,
2012; Ma et al., 2012; Arber and Li, 2013; Yan Liu et al., 2013; DeRosa et al., 2015).
Therefore, to fully model human forebrain cortical development in a dish, the
cellular components of the in vitro model must contain both dorsally-derived excitatory
cells and ventrally-derived inhibitory interneurons in the appropriate ratios and combined
in a developmentally relevant time frame. This will be especially important within studies
of some genetic epilepsies, of which many carry mutations that specifically affect
GABAergic neuronal migration and function (Noebels, 2015). Although multiple studies are
present in the literature that look at single neural cell subtype differentiation and end-point
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analysis, very few engage in parallel neural induction strategies that directly compare the
molecular markers of differentiation, maturation and network formation.
The purpose of this chapter will be to focus on the derivation of forebrain
excitatory (dorsal) neural cell types in direct timeline comparison to deriving forebrain
inhibitory (ventral) GABAergic interneurons. This will shed light on the molecular processes
of forebrain neural cell development and maturation, and the intrinsic differences of the
process from neural cells from distinct neural tube regions triggered through morphogen
patterning. As well as biomolecular markers of differentiation such as gene and protein
expression, the acquisition of neuronal cell activity and function will also be studied.
All of these elements combined will help inform future models of complete
forebrain development in vitro and will be an integral foundation stone on which to derive
comparable developmental and disease-state neural tissue models. It is the processes and
analyses formed within this chapter that will be used to inform future three-dimensional
modelling techniques.
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3.2 Materials and Methods
3.2.1 iPSC Culture
All work in this chapter utilised the commercial human iPSC lines; ATCC-BXS0116 Human
Induced Pluripotent Stem (IPS) Cells (ATCC® ACS-1030™) derived from CD34+ bone marrow
cells and ATCC-DYS0100 Human Induced Pluripotent Stem (IPS) Cells (ATCC® ACS-1019™)
derived from foreskin fibroblasts. iPSCs were grown in feeder-free culture conditions on
Vitronectin XF (Stem Cell Technologies) coated 6-well tissue culture plates in TeSR-E8
media (Stem Cell Technologies). iPSC colonies were passaged every 6-7 days with Gentle
Cell Dissociation Reagent (GCDR) (Stem Cell Technologies) and were re-plated with TeSR-E8
media containing the RHO/ROCK pathway inhibitor Y-27632 (10μM, Stem Cell
Technologies). Media was changed daily, except for the first day after a passage. Areas of
random differentiation within colonies were removed manually. All iPSC and neural
differentiation experiments used iPSCs below passage number 20.

3.2.2 Neural Differentiation
Dorsal neural induction of iPSCs was triggered using the monolayer dual SMAD-inhibition
protocol using commercially available STEMdiff Neural Induction Media (NIM) (Stem Cell
Technologies). Briefly, iPSCs were dissociated into single cells using GCDR (Stem Cell
Technologies) and plated at densities of 1 x 106 cells/well of a 6-well tissue culture plate
coated with poly-L-lysine (0.01%, Sigma) & laminin (20μg/ml, Sigma) (PLL) in 2ml NIM per
well. Media was changed daily for the first 7 days of induction, also containing RHO/ROCK
pathway inhibitor Y-27632 (10μM, Stem Cell Technologies).
After 7 days of induction, media was changed to STEMdiff Neural Proliferation
Media (NPM) (Stem Cell Technologies) for another 7 days to trigger neural precursor cell
(NPC) maturation. NPCs were passaged at Day 10 to allow for continued expansion and
differentiation under final plating conditions onto PLL coated tissue culture plates. At Day
14 post-induction, media was changed to a final neural maturation media (NMM) which
consisted of a 1:1 mix of “N2 media” and “B27 Media”. N2 media consisting of DMEM/F12
(Lonza), N-2 Supplement (1x, Thermo Fisher Scientific), GlutaMAX (1x, Gibco), Nonessential amino acid mixture (1x, Lonza), 100U/ml Penicillin and 100μg/ml Streptomycin
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(Gibco). B-27 media consisting of Neurobasal (Gibco), B27 Supplement (1x, Thermo Fisher
Scientific), and GlutaMAX (1x, Thermo Fisher Scientific). The combined maturation media
was then supplemented with BDNF (20ng/ml, PeproTech), GDNF (20ng/ml, PeproTech),
and DAPT (2μM, Stem Cell Technologies) to enhance neuronal differentiation and cell cycle
synchronisation of differentiating NPCs (Crawford and Roelink, 2007; Borghese et al.,
2010). Maturation media was changed every 2-3 days over the course of differentiation.
Ventral neural induction of hiPSCs followed the same protocol and media formulations as
above but with the addition of Purmorphamine (1.5μM, Stem Cell Technologies) from Day
2 to 14 post-induction.

3.2.3 Immunofluorescence Microscopy
Samples for immunocytochemistry were fixed for 15 minutes at room temperature in 10%
neutral-buffered formalin solution (Sigma) and permeabilised for 15 minutes at room
temperature in 0.1% Triton-X-100 (Sigma) in phosphate buffered saline (PBS) (137mM
NaCl, 10mM Phosphate, 2.7mM KCl, pH 7.4). Samples were blocked for 1 hour in 5% goat
or donkey serum (Millipore) in PBS before incubation with primary antibodies (also in block
solution) overnight at 4⁰C; anti-Oct4 (Stem Cell Technologies 60093, 1:1000); anti-Pax6
(Stem Cell Technologies 60094, 1:1000); anti-Nanog (Cell Signaling Technology 4903,
1:1000); anti-Sox2 (Stem Cell Technologies 60055, 1;1000); anti-Tra-1-60 (Stem Cell
Technologies 60064, 1:1000); anti-TUJ1 (Covance MMS-435P, 1:2000); anti-Nestin (Stem
Cell Technologies 60091, 1:1000); anti-MAP2 (Cell Signaling Technology 4542, 1:1000); antiGAP43 (Millipore AB5220, 1:1000); anti-Synapsin I (Abcam ab64581, 1:1000); anti-Reelin
(Abcam ab138370, 1:1000); anti-TBR1 (Abcam ab31940, 1:1000); anti-CTIP2 (Abcam
ab18465, 1:1000); anti-BRN2 (DSHB PCRP-POU3F2-1A3, 1:500); anti-vGLUT1 (Sigma
AMAb91041, 1:1000); anti-vGLUT2 (Abcam ab101760, 1:1000); anti-GAD65+67 (Abcam
ab11070, 1:1000); anti-GABAAR1 (Synaptic Systems 224204, 1:1000); anti-GABABR1 (Abcam
ab55051, 1:1000); anti-S100β (Sigma S2532, 1:1000); anti-GFAP (Stem Cell Technologies
01415, 1:2000). Samples were washed three times in PBS before addition of secondary
antibodies in block solution for 1 hour at room temperature: goat-anti-mouse IgG AF488
(Invitrogen A11029, 1:2000); goat-anti-mouse IgG AF594 (Life Technologies A11032,
1:2000); donkey-anti-rabbit IgG AF488 (Invitrogen A21206, 1:2000); donkey-anti-rabbit IgG
AF594 (Invitrogen A21207, 1:2000); donkey-anti-rat IgG AF594 (Invitrogen A12109, 1:2000);
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donkey-anti-goat IgG AF488 (Abcam ab150129, 1:2000); goat-anti-guinea pig IgG AF488
(Abcam ab150185, 1:2000). Samples were washed three more times in PBS before addition
of DAPI (Sigma) for 10minutes, for cell nuclei visualisation. Fluorescent images were
acquired on an Olympus IX70 wide field microscope with Spot RT Slider digital camera and
Spot Advanced software, version 4.8 (Diagnostic Instruments).

3.2.4 Flow Cytometry
For iPSC-based flow cytometry analysis, colonies were dissociated to single cells using
GCDR (37⁰C, 10 minutes) and trituration, prior to centrifugation (500xg, 5 minutes). Cells
were resuspended in 10% neutral-buffered formalin solution (Sigma) for fixation for 15
minutes under mild-shaking conditions. iPSC-derived NPC cultures were dissociated with
Accutase (Stem Cell Technologies) (37⁰C, 10 minutes) and gentle trituration. The fixation
procedure was the same as for dissociated iPSCs. Cell suspensions were passed through a
40μm filter (BD Falcon) to ensure the removal of large cell aggregates. All washes were
preceded by a centrifugation step to pellet cells from suspension. Cells were permeabilised
through 0.1% Triton-X-100 in PBS (137mM NaCl, 10mM Phosphate, 2.7mM KCl, pH 7.4) for
15 minutes at room temperature under gentle mixing. Cell suspensions were blocked in 1%
Bovine Serum Albumin (BSA) (Sigma) in PBS for 1 hour at room temperature prior to the
addition of primary antibodies or fluorescently labelled primary antibodies in block solution
for 1 hour at room temperature: anti-Oct4 (Stem Cell Technologies 60093, 1:1000); antiNanog (Cell Signaling Technology 4903, 1:1000); anti-Pax6 (Stem Cell Technologies 60094,
1:1000); anti-Sox2-PerCp-Cy5.5 (BD Stemflow 561562 kit); anti-SSEA4-AF647 (BD Stemflow
562626 kit); anti-Tra-1-60-PE (BD Stemflow 562626 kit); anti-Nestin-AF647 (BD Stemflow
561562 kit); and anti-DCX-PE (BD Stemflow 561562 kit). Samples were centrifuged and
washed three times with block solution. For non-fluorescently labelled primary antibody
probes, a second incubation with secondary antibodies was done for 1 hour at room
temperature: goat-anti-mouse IgG AF488 (Invitrogen A11029, 1:2000); donkey-anti-rabbit
IgG AF488 (Invitrogen A21206, 1:2000); goat-anti-mouse IgG AF647 (Invitrogen A21236,
1:2000); goat-anti-rabbit IgG AF647 (Invitrogen A21245, 1:2000). Data acquisition and
analysis was performed on the CytoFLEX Flow Cytometer with CytExpert software, version
2.0 (Beckman Coulter)
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3.2.5 Western Blot Assay
For protein concentration and Western blot assays, cells were harvested with Accutase
(Stem Cell Technologies) for 10 minutes at 37⁰C and gentle trituration. Cells were pelleted
under centrifugation at 500xg for 5 minutes and the supernatant removed. Pellets were
snap frozen at -80⁰C and stored until protein extraction.
Cell pellets were resuspended in 100-200μl of M-PER Mammalian Protein
Extraction Reagent (Thermo Fisher Scientific) and mixed gently at room temperature for 10
minutes. After centrifugation at 10,000xg for 15 minutes the supernatants were
transferred to new 1.7ml microfuge tubes and stored at -80⁰C until needed for
downstream assays.
A colourmetric Bradford assay was used for total protein quantification, calibrated
against a Bovine Serum Albumin (BSA) (Sigma) standard curve. 1μl of each protein sample
was utilised for protein quantification together with 200μl of 1:5 diluted Bradford Reagent
(Bio-Rad). Absorbance readings at 590nm were measured on a FLUOstar Galaxy plate
reader (BMG).
For SDS-PAGE: protein samples were denatured at 70⁰C for 10mins in the presence
of NuPAGE LDS Sample Buffer (Thermo Fisher Scientific) and NuPAGE Sample Reducing
Agent (Thermo Fisher Scientific). Protein samples were separated on BOLT 4-12% Bis-Tris
Gels (Thermo Fisher Scientific) at 150V for 45 minutes. Molecular weight estimation was
achieved with parallel loading of Precision Plus Protein Kaleidoscope Prestained Protein
Standards (Bio-Rad). Protein lanes were transferred on to nitrocellulose membranes (GE
Healthcare Life Sciences) using a Semi-Dry Transfer Cassette (Bio-Rad) at 20V for 70
minutes in Bjerrum Schafer-Nielsen buffer (48mM Tris, 39mM glycine, 1.3mM SDS, 20%
Methanol, pH 9). Successful protein transfer was confirmed with Ponceau S stain (0.1%
w/v) in acetic acid, and de-stained through washing in Tris buffered saline (TBS) with 0.05%
Tween-20 (TBST) (50mM Tris, 150mM NaCl, pH 7.6). Membranes were blocked for 1 hour
at room temperature in 5% (w/v) low fat milk powder in TBST. Membranes were incubated
with primary antibodies overnight in the block solution at 4⁰C on a plate rocker: anti-Nanog
(Cell Signaling Technology 4903, 1:2000); anti-Nestin (Stem Cell Technologies 60091,
1:2000); anti-TUJ1 (Covance MMS-435P, 1:2000); anti-neurofilament-H (Cell Signaling
Technology #2836, 1:2000), anti-neurofilament-L (Cell Signaling Technology #2837, 1:2000);
anti-Tau (Neuromics CH23018, 1:1000); anti-FOXG1 (Abcam ab18259, 1:2000); anti-Reelin
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(Abcam ab138370, 1:1000); anti-BRN2 (DSHB, 1:750); anti-PSD95 (Abcam ab2723, 1:2000);
anti-Synaptophysin (Abcam ab14692, 1:2000); anti-vGLUT1 (Sigma AMAb91041, 1:1000);
anti-vGLUT2 (Abcam ab101760, 1:1000); anti-GAD65+67 (Abcam ab11070, 1:1000); antiGABAAR1 (Synaptic Systems 224204, 1:1000); anti-GABABR1 (Abcam ab55051, 1:1000); antiNMDAR1 (Millipore AB9864R, 1:1000); anti-AMPAR1 (Abcam ab31232, 1:1000); anti-S100β
(Sigma S2532, 1:2000); anti-GalC (Millipore MAB342, 1:1000) & anti-GAPDH (Cell Signaling
Technology #5174, 1:5000). Membranes were washed three times in TBST prior to addition
of secondary antibodies. Membranes were incubated with secondary antibodies in block
solution for 1 hour at room temperature on a plate rocker: Goat-anti-Mouse-HRP
(Millipore, 1:10,000); Goat-anti-Rabbit-HRP (Millipore, 1:10,000); Donkey-anti-Chicken-HRP
(Millipore, 1:10,000); Goat-anti-Guinea Pig-HRP (Invitrogen, 1:10,000) Membranes were
washed a further three times in TBST and once in TBS prior to chemiluminescent detection.
Imaging of protein bands on membranes was achieved on a ChemiDoc MP system (Bio-Rad)
after incubation with Western Lightning® Ultra chemiluminescence substrate (Perkin
Elmer).

3.2.6 Gene Expression
Relative gene expression analysis was performed using quantitative polymerase chain
reaction (qPCR) methodology. Cells were harvested with Accutase (Stem Cell Technologies)
for 10 minutes at 37⁰C and gentle trituration. Cells were pelleted under centrifugation at
500xg for 5 minutes and the supernatant removed. Pellets were snap frozen at -80⁰C and
stored until RNA extraction.
RNA was purified from frozen cell pellet samples using the RNeasy Plus Mini Kit
(Qiagen) as per the manufacturer’s instructions into a total elution volume of 50μl nuclease
free water. RNA concentration was determined using an Ultraspec 2200 Pro
Spectrophotometer (GE Healthcare Life Sciences) and RNA integrity was confirmed by
running samples on a 1% Agarose (w/v)-EtBR Tris-acetate (TAE) buffered gel under
electrophoretic conditions for 40 minutes at 80V followed by imaging on a ChemiDoc MP
(Bio-Rad) to confirm sharp ribosomal RNA banding.
cDNA was generated from 1μg of each RNA using the Omniscript Reverse
Transcription Kit (Qiagen) with 1μM oligo dTs (Thermo Fisher Scientific) and 1U/ml RNase
Inhibitor (Qiagen). Reverse transcription reactions took place at 37⁰C for 80 minutes in a
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20μl reaction volume. On completion of the reaction, samples were further diluted with
20μl of nuclease free water. cDNA samples were stored at -20⁰C until used in qPCR
reactions.
qPCR reactions were performed with SYBR Green PCR Master Mix (Qiagen) in 10μl
reaction volumes with 1μM of each primer set. All primer pairs were designed using
Primer-BLAST (NCBI) (Table 3-1). All amplicons were designed de novo to be between 50250bp in length and have equivalent primer annealing temperatures.

Table 3-1: Primer pair sequences used for qPCR analysis of human iPSC-derived
neural cultures.

Reactions were run on a RealPlex Mastercycler (Eppendorf) with the following
parameters: 95⁰C for 2 minutes, then 40 cycles of 95⁰C for 5s and 60⁰C for 10s, followed by
a melt curve recording. Amplicon specificity was determined via melt curve peak analysis.
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All relative expression data was normalised to HPRT1 housekeeping gene expression. Data
were analysed by the ΔΔCt method in Microsoft Excel and statistical analyses performed in
GraphPad Prism using multiple unpaired T-test analyses. Data is shown ± standard error of
the mean with significance denoted when the p-value ≤0.05. Four biological repeats were
completed for each differentiation type (dorsal/ventral) for each time point. Robust
regression analysis of fold change expression data was performed in Stata statistical
software (version 15.1). Regression coefficients were maintained between ordinary least
squares (OLS) regression and those of the robust regression analysis. Raw output tables are
displayed in Section 4.5.1.

3.2.7 Electrophysiological Analyses
For patch clamp-based electrophysiological recordings, NPCs were seeded on 13mm glass
cover slips coated with poly-L-lysine (0.01%, Sigma) & laminin (20μg/ml, Sigma) and
maintained in 12-well tissue culture plates. Cell-seeded coverslips were differentiated using
the same protocol as for other molecular analyses (Section 3.2.2) before patch-clamp
recordings. For electrophysiological recordings, coverslips were transferred to a recording
chamber fitted to an AxioExaminer D1 microscope (Carl Zeiss) and cells were superfused at
1–2 ml/min with a recording solution composed of 137mM NaCl, 5mM KCl, 10mM HEPES,
1mM MgCl2, 2mM CaCl2, 10mM glucose (pH 7.35; 300–305 mOsmol/kg). Neurons were
visually identified by a round-to-oval soma (diameter of ~ 10 μm) and patent bipolar
processes. Whole-cell patch clamp recordings were made at room temperature using
borosilicate microelectrodes (2–6 MΩ; 1.0 mm O.D.; 0.58 mm I.D., Sutter) filled with an
internal solution containing 115mM K-gluconate, 10mM HEPES, 7mM KCl, 0.05mM EGTA,
2mM Na2ATP, 2mM MgATP, 0.5mM Na2GTP (pH 7.3; 290–295 mOsmol/kg). All chemicals
were purchased from Sigma unless otherwise indicated. Signals were recorded with a
MultiClamp 700B amplifier (Molecular Devices), data acquisition system (Digidata 1440A,
Molecular Devices), and AxoGraph X analysis software (AxoGraph Scientific). The above
protocol was adapted from neurosensory cell patch clamp methodologies (Needham et al.,
2014). The data presented in Section 3.3.5 is representative of ventral-patterned neuronal
cultures (n=9) and dorsal-patterned neurons (n=1) at Day 95 of differentiation. Preliminary
data acquisition was attempted at Day 60 but limited success in patching of the cells
required an extended maturation time before re-testing at Day 95 of differentiation.

104

3.3 Results
3.3.1 Pluripotency Validation and Quantification
To ensure robust and stable expansion and proliferation of hiPSCs prior to neural
differentiation, protein markers of pluripotency such as OCT4, SOX2, NANOG and TRA-1-60
were assayed via fluorescent immunocytochemistry (Fig 3-1). Each hiPSC colony showed
strong nuclear-localised staining for the pluripotency-associated transcription factors OCT4,
SOX2 and NANOG. The cell-surface pluripotency marker TRA-1-60 was also present
throughout cells within each hiPSC colony.

Fig 3-1: Fluorescent immunocytochemistry of pluripotency-associated protein
markers in hiPSC colonies. Pluripotency-associated transcription factors OCT4,
NANOG and SOX2 show strong nuclear staining, as well as the cell-surface TRA-160 marker. Cell nuclei are stained with DAPI. Scale bars represent 200μm. BF;
bright field.

To better quantify the quality of hiPSC colonies and to determine the number of
differentiated cells within a stable culture that may have lost markers of pluripotency,
hiPSCs underwent flow cytometric analysis. The same markers were chosen as for the
immunocytochemical analysis above, together with another cell-surface pluripotency
marker, SSEA4. Dual staining of both OCT4 and NANOG showed an OCT4-positive cell
population of 96.41% and a NANOG-positive hiPSC population of 95.47% within a typical
culture. Co-localisation of both OCT4 and NANOG was present in 95.08% of cells (Fig 3-2 A).
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This high proportion of pluripotent marker-positive cells was also observed when
assaying for TRA-1-60 (95.25%), SOX2 (94.99%) and SSEA4 (99.40%) (Fig 3-2 B). Colocalisation of these markers within the hiPSCs showed high correlation with each other:
TRA-1-60 & SOX2 (92.98%), TRA-1-60 & SSEA4 (95.73%), and SOX2 & SSEA4 (95.18%).

Fig 3-2: Flow cytometric analysis of undifferentiated hiPSC colonies for pluripotencyassociated protein markers. (A) NANOG and OCT4 dual staining. (B) Triple-staining of
TRA-1-60, SOX2 and SSEA4. hiPSC samples (red), negative controls (green).

3.3.2 Generation of Neural Precursors from hiPSCs
The first stage in neural differentiation of hiPSCs is the restriction of potency to that of a
neuroectodermal or neuroepithelial lineage. In this study, initial germ layer restriction was
achieved through dual-SMAD inhibition using a commercially available neural induction
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media (STEMdiff, Stem Cell Technologies) (NIM). Gene expression analysis of hiPSCs
dissociated as single cells and grown in monolayer in NIM for 7 days showed strong downregulation of the pluripotency-associated gene OCT4 (~250-fold less seen at Day 7 than Day
0), and robust upregulation of the neural precursor cell (NPC) marker PAX6 over 7 days of
neural induction (Fig 3-3 A), with an approximate 128-fold increase from Day 3 to Day 7 of
differentiation. All fold change differences in gene expression reached statistical
significance, with PAX6 non-detectable in undifferentiated Day 0 hiPSCs.

Fig 3-3: Gene and protein expression of pluripotency and neural precursor cell markers
over 7 days of neural induction. (A) qPCR analysis of the pluripotency marker OCT4
downregulation during differentiation, and the upregulation of the early neural
precursor marker PAX6. Data is shown as mean values ± standard error of the mean.
Statistical significance denoted by * p≤0.05, ** p≤0.01. ND; Not detected. (B)
Upregulation of PAX6 protein expression over the same time course of neural
induction. Cell nuclei are shown with DAPI staining. BF; bright field images. Scale bars
represent 100μm.
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Upregulation of this NPC marker transcript was also reflected at the protein level,
with PAX6 protein being robustly upregulated in differentiating hiPSCs over 7 days of neural
induction, as shown through fluorescent immunocytochemistry (Fig 3-3 B).
This upregulation of the early NPC marker PAX6 at both the gene and protein
expression level is indicative of early forebrain neural differentiation events, together with
the downregulation of OCT4 gene expression showing the loss of pluripotent cell identity.
To better quantify the efficiency of neural induction and to track the degree of
forebrain precursor marker expression and concurrent loss of pluripotency markers,
differentiating cells underwent quantitative flow cytometry. Over 10 days of neural
differentiation, the percentage of cells expressing OCT4 dropped from 97.26% in
undifferentiated (Day 0) hiPSCs to 2.52% after 10 days of neural induction (Fig 3-4 A). The
loss of pluripotency-associated markers occurred very early on in the differentiation with
OCT4-positive cells accounting for 52.40% of the cell population after 1 day of
differentiation, and 45.63% of cells by Day 3. After 7 days of neural induction only 3.31% of
assayed cells showed OCT4 marker expression.
At later stages within the neural induction time frame, PAX6-positive cells
accounted for 74.57% of the population by Day 7 and 82.46% by Day 10 (Fig 3-4 B). This
high degree of neural induction efficiency is mirrored when looking at another NPC marker:
the intermediate filament protein NESTIN. After 7 days of neural induction NESTIN-positive
cells were present at a level of 88.90%, which remained stable at 88.32% by Day 10.
However, the NPC/early neuronal protein marker DOUBLECORTIN (DCX) showed no
expression in NPC cultures by Day 7 or 10, demonstrating that more extensive
differentiation timelines are necessary to derive more mature NPC and neuronal markers.
To further refine the induction protocol, a second proliferative media (also
commercially available) termed neural proliferation media (NPM) was studied in parallel to
NIM induction alone to assay any positive or negative effects on NPC induction and marker
expression. After 14 days of NIM-alone differentiation of hiPSCs, a high prevalence of PAX6positive cells was maintained in the population, but the level of NESTIN-positive cells was
more restricted in the NPC cultures and was predominantly localised to aggregated cell
clusters in the monolayer induction culture (Fig 3-5). However, a stepwise neural
differentiation of 7 days of NIM treatment followed by 7 days of NPM triggered NPC
cultures with both a prevalent degree of PAX6-positive cells and also a much stronger and
108

Fig 3-4: Flow cytometric analysis of pluripotency markers, neural precursor markers and
early born neuronal markers in hiPSC cultures undergoing neural induction. (A) Levels of
OCT4-positive cells during 10 days of neural differentiation. (B) PAX6 and NESTIN
positive cells represent successful neural precursor induction by Day 7-10 of
differentiation. Negative DOUBLECORTIN staining indicates no early-neuronal cells are
present in the precursor pool. iPSCs/NPCs (red), negative controls (green).
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widespread NESTIN signal throughout the culture. Interestingly, the size of cell nuclei also
appeared to show differences under these differing culture conditions. NIM-alone treated
NPCs retained smaller and more densely packed cell nuclei, whereas the NIM-NPM treated
neural cultures showed bias to larger nuclei (Fig 3-5). This demonstrates that distinct
differences within the differentiation pathway are occurring between these two methods
resulting in higher degrees of NESTIN induction in cultures exposed to NPM following dual
SMAD-inhibition methods of neural induction.

Fig 3-5: Neural precursor marker expression in hiPSCs undergoing neural differentiation
over 14 days with either neural induction media (NIM) alone, or in 7 days of NIM and 7
days of neural proliferation media (NPM). Cell nuclei are visualised with DAPI stain.
Scale bars represent 100μm.

To fully differentiate the NPC cultures into mature neural cells displaying typical
neuronal morphology and marker expression, media composition was changed to a neural
maturation media (NMM) containing N2 and B27 primary neural culture supplements as
well as brain-derived neurotrophic factor (BDNF), glial cell-derived neurotrophic factor
(GDNF) and the gamma-secretase inhibitor N-[N-(3,5-difluorophen- acetyl)-l-alanyl]-Sphenylglycine t-butyl ester (DAPT) (See Methods Section 3.2.2). This procedure of neural
induction of hiPSCs and consequent maturation resulted in neural cell cultures displaying
extensive neuritogenesis and branching, together with mature neuronal marker expression
of β-III-TUBULIN after 28 days of differentiation (Fig 3-6 B). This methodology therefore was
adopted for all future hiPSC neural differentiation experimental setups, with the procedure
outlined in Fig 3-6 A. To retain adequate levels of cell viability during differentiation, the
RHO/ROCK pathway inhibitor Y-27632 was added as a component of the NIM media.

110

It is interesting to note that even after 4 weeks of neural differentiation, the NPC
marker PAX6 was still retained in a subset of cells, indicating the early-neuronal nature of
the derived cells and the retention of NPC cell identity throughout differentiation. All of
which reflects the extended timeline of differentiation and maturation seen in utero.

Fig 3-6: Schematic representation of neural differentiation protocol of hiPSCs and
example images of derived neural cultures. (A) Timeline of the hiPSC-neural
differentiation pathway involving stepwise treatment with neural induction media
(NIM), neural proliferation media (NPM) and maturation media. The maturation media
also contained the neurotrophic factors; brain-derived neurotrophic factor (BDNF), glial
cell-derived neurotrophic factor (GDNF), and the Notch signalling inhibitor N-[N-(3,5difluorophen- acetyl)-l-alanyl]-S-phenylglycine t-butyl ester (DAPT). (B) Fluorescent
immunocytochemistry of hiPSC-derived neural cultures after 4 weeks of differentiation
showing the mature neuronal marker β-III-TUBULIN and NPC marker PAX6. Cell nuclei
are shown through a DAPI stain. Scale bars represent 100μm.

111

3.3.3 Dorsal Forebrain Differentiation and Maturation
Following the neural induction principles outlined above (Section 3.3.2), hiPSCs were
differentiated towards a neural lineage for 60 days. No other patterning morphogens were
added into any stage of the differentiation protocol in order to derive the default dorsal
forebrain excitatory neuronal identity as is seen in other differentiation studies (Gaspard et
al., 2008; Zeng et al., 2010; Shi et al., 2012; Shi, Kirwan and Livesey, 2012). Following this
extended maturation period, extensive neurite outgrowths developed in the iPSC-derived
neural cultures together with positive immunostaining of both neuronal and astroglial
markers (Fig 3-7).
A subpopulation of cells within the hiPSC-derived neural culture maintained NPC
marker expression (PAX6 and NESTIN) even after 60 days of differentiation and maturation,
showing retention of neural precursor characteristics. Widespread neural morphology in
tandem with strong positive staining of the neuronal markers β-III-TUBULIN, MAP2 and
GAP43 were seen throughout the iPSC-derived cultures at this time point: indicative of
successful and highly efficient neural induction and maturation. Interestingly, the astroglial
markers Glial Fibrillary Acidic Protein (GFAP) and S100β were also present in cells within
the neural culture that did not show colocalisation with the β-III-TUBULIN neuronal marker,
but robust colocalisation with each other (Fig 3-7). These cell types also had an immature
cell morphology suggesting an early degree of astroglial differentiation, which does agree
with in utero forebrain neurogenesis where glial cell differentiation follows chronologically
that of neuronal differentiation (Hansen, Rubenstein and Kriegstein, 2011).
This dorsal-forebrain default neural differentiation pathway gives rise to corticalassociated structures in vivo and in vitro. To track the development of cortical generation
and lamination events in vitro we observed markers known to localise to particular earlyborn (deep layer) and late-born (upper layer) cortical neurons (Fig 3-8). Reelin is an
extracellular glycoprotein secreted from Cajal-Retzius cells, which form the outermost layer
(Layer I) of the developing cortex (Frotscher et al., 2009). REELIN immunostaining of iPSCderived dorsal neural cultures showed diffuse but positive staining suggestive of a small
proportion of neural cells of the early outer cortical plate (Fig 3-8). The transcription factor
TBR1 is highly expressed within cells of the cortical preplate and within layer VI early-born
(deep layer) neurons. It was also strongly expressed within a subpopulation of cells within
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Fig 3-7: Fluorescent immunocytochemistry of hiPSC-derived neural cultures after 60 days
of differentiation. A subpopulation of cells retain the NPC markers PAX6 and NESTIN,
while many display the canonical neuronal markers β-III-TUBULIN, MAP2, and GAP43.
Astroglial markers (GFAP and S100β) are also seen colocalised in a subpopulation of cells.
Nuclei shown through DAPI staining. Scale bars represent 100μm.

these in vitro neural cultures, suggestive of not only cortical plate identity but also more
mature deep layer cortical generation events. This is mirrored by the protein expression of
CTIP2, a zinc finger transcription factor, that localises to neural cells in layer V of the
developing cortex. A subpopulation of CTIP2-positive cells in these in vitro neural cultures is
suggestive of development beyond cortical preplate generation. Late-born neurons or
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upper cortical layer neurons (layers II-IV) show different protein marker expression and a
well-known marker of these cell types and layer identity is BRN2. BRN2 expression within
the in vitro iPSC-derived neural cultures at this time point was less prevalent than was seen
for TBR1 and CTIP2 (Fig 3-8). As BRN2-positive neurons and upper layer cortical identity
follows a more protracted timeline of development than deep layer neurons, this further
shows that these neural cultures are representative of developmental timings and
cytoarchitecture formation events seen in utero.

Fig 3-8: Fluorescent immunocytochemistry of cortical-associated layer markers of
hiPSC-derived neural cultures. REELIN staining indicative of outer-layer (layer I) cortical
identity. TBR1 associated with early-born (layer VI) and preplate cortical regions. CTIP2positive staining representative of layer V cortical regions. BRN2 as a marker of lateborn upper layer (II-IV) cortical neurons. Cell nuclei imaged with DAPI stain. Scale bars
represent 100μm.

As well as localisation markers by which to describe the comparable in vivolocation of the differentiating neural cultures, we also aimed to describe the neuronal
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subtype specificity of the derived neural cells. Dorsal forebrain differentiation reportedly
derives excitatory glutamatergic pools of neuronal cells. To this end we stained for the
presence of the presynaptic glutamate re-uptake transporter vGLUT2 and the glutamate
decarboxylase enzymes GAD65+GAD67, present within glutamatergic neurons and
GABAergic inhibitory neuronal subtypes respectively (Fig 3-9). From these data it is clear
that the vast majority of derived neural types using this differentiation protocol expressed
markers of excitatory glutamatergic neurons, and not of inhibitory GABAergic cell types.
This fits with the known patterning effects and down-stream neural-tube derived signalling
events that predispose NPCs to differing lineage subtypes as outlined in Section 3.1.

Fig 3-9: Fluorescent immunocytochemistry of excitatory and inhibitory neuronal
markers of hiPSC-derived neural cultures. The excitatory glutamatergic marker VGLUT2
shows high level expression throughout the culture, whereas the GABAergic markers
GAD65+67 show no expression in the derived neuronal cells. Nuclei are shown through
DAPI staining. Scale bars represent 100μm.

To better track protein markers of neural differentiation and maturation over time,
Western blot analysis of a panel of neural markers was undertaken to investigate the
timing and maturation events of the hiPSC-derived neural cultures (Fig 3-10). The
pluripotency-associated marker NANOG was highly expressed in undifferentiated hiPSC
cultures but was completely absent during extended neural induction from 14 days to 60
days post induction, showing the expected loss of stem cell pluripotency after initiation of
differentiation. The NPC marker NESTIN showed no expression within undifferentiated
hiPSC cultures, but instead peaked at Day 14 post-neural induction following the expected
timeline of NPC generation, and was also present but to a lesser degree after neural
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maturation following 60 days of differentiation. β-III-TUBULIN expression was seen at Day
14 post-neural induction and continued to increase in intensity over the full time-course of
differentiation, demonstrating the development and enrichment of neuronal cells within
the culture. This early expression profile shows that canonical neuronal lineage markers are
expressed early in the differentiation process, but other markers of neuronal
differentiation, such as the axonal marker TAU and the neurofilament-light and -heavy
chains (NF-L and NF-H), required more extended periods of maturation before detectable
levels are seen in hiPSC-derived neural cultures in vitro (Fig 3-10).

Fig 3-10: Western blot analysis for an array of neural markers present within
undifferentiated hiPSCs, hiPSC-NPC cultures after 14 days of differentiation, and
hiPSC-derived dorsal neural cultures after 60 days of differentiation.

The early forebrain and telencephalic marker FOXG1, as well as the early- and lateborn cortical neuronal markers REELIN and BRN2 all showed protein expression by Day 60
of neural differentiation. The presence of these temporo-spatial localisation markers
reinforces the finding that neural cultures differentiated in this way are biased to lineages
derived from dorsal-anterior neural tube regions.
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For neural networks to form in vitro, as they do developmentally, it is important
that they express and assemble molecular machinery that form functional synaptic
connections. By observing the presence of proteins involved in pre- and post-synaptic
pathways it is possible to infer that neural cells in culture have the capacity to form such
connections with surrounding cells. To this end the pre-synaptic marker SYNAPTOPHYSIN
(SYN) and post-synaptic density marker 95 (PSD95) protein expression were both
investigated. By Day 60 of neural differentiation, both SYN and PSD95 displayed detectable
levels of protein expression, showing that the differentiating neurons were expressing
genes relevant to pre- and post-synaptic structure formation (Fig 3-10).
For neuronal subtype identification; the glutamatergic pre-synaptic markers
vesicular glutamate transporters vGLUT1 and vGLUT2 showed robust expression after 60
days of neural differentiation, with a lower expression of vGLUT2 after 14 days of
differentiation. The GABAergic neuronal markers GAD65+67 were not detected in these
neural cultures (Fig 3-10). Taken together, this suggests a prominent bias towards
differentiation to excitatory neuronal subtypes.
Together with general synaptic machinery, the array and type of neurotransmitter
receptors present within neural cultures are indicative of the maturity of the cells as well as
displaying which neurotransmitters functional neural networks would respond to. The
ionotropic glutamate receptors N-Methyl-D-Aspartate Receptor 1 subunit (NMDAR1, also
designated as GluN1), and α-Amino-3-hydroxy-5-Methyl-4-isoxazole Propionic Acid
Receptor 1 subunit (AMPAR1) both displayed protein expression by Day 60 of
differentiation (Fig 3-10). The presence of both of these functional receptors would enable
neuronal sensitivity and response to glutamate-based neurotransmission. The ionotropic
GABA-A receptor (GABAAR1 subunit) and the G-protein coupled GABA receptor subunit
GABABR1 were also highly expressed within the hiPSC-derived dorsal neural cultures at
later time points (Fig 3-10). The presence of all four neurotransmitter receptors at the
protein level after 60 days of differentiation suggests that mature neuronal cells may be
sensitive to both excitatory and inhibitory neurotransmitter signalling.
The astroglial marker S100β, was also expressed by Day 60 of differentiation, which
illustrates that astrocytic lineages were also a component of neural cultures at this level of
maturation. However, galactosylceramidase (GALC) a marker of mature oligodendrocytes,
and lineage restricted oligodendrocyte precursors, did not display any positive signal
through Western blot analysis (Fig 3-10). This either suggests a longer maturation time may
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be necessary by which to generate oligodendroglial lineages, or that this pathway of
lineage differentiation is intrinsically low in dorsal forebrain neural induction.

3.3.4 Molecular Comparisons of Dorsal and Ventral Forebrain Neural
Lineage Differentiation
In parallel with hiPSCs differentiated towards default forebrain “dorsal” lineages, we also
wanted to investigate differentiation of NPCs to “ventral” neural tube lineages through
morphogen patterning via the SHH pathway agonist Purmorphamine (Pur). For direct
timeline comparisons to be made, the scheme of neural induction, proliferation and
maturation was kept the same as outlined in Section 3.3.3, but with the addition of Pur
from Day 2 to Day 14 of differentiation (Fig 3-11).

Fig 3-11: Schematic representation of the protocols for parallel differentiation of dorsal
(excitatory) forebrain lineages and ventral (inhibitory) forebrain lineages from hiPSCs.
Both differentiation pathways include stepwise treatment with neural induction media
(NIM), neural proliferation media (NPM) and maturation media. The maturation media
also contained the neurotrophic factors; brain-derived neurotrophic factor (BDNF), glial
cell-derived neurotrophic factor (GDNF), and the Notch signalling inhibitor N-[N-(3,5difluorophen- acetyl)-l-alanyl]-S-phenylglycine t-butyl ester (DAPT). In addition, the
ventral differentiation pathway contained purmorphamine (Pur) a small molecule
agonist of the sonic hedgehog signalling pathway.
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After 60 days of differentiation following these protocols, protein marker
expression was assayed through fluorescent immunocytochemistry. The early-cortical layer
VI and preplate marker TBR1 showed extensive expression in dorsal neural cultures (as was
seen in Section 3.3.3) but was lacking from neural cultures that underwent ventralising
pathway signalling (Fig 3-12), despite having comparable levels of β-III-TUBULIN-positive
neuronal cells.

Fig 3-12: Fluorescent immunocytochemistry of early and late cortical plate markers in
neural cultures differentiated from hiPSCs into dorsal and ventral forebrain lineages. All
samples are stained with β-III-TUBULIN to highlight mature neuronal cell types and also
markers of deep-layer and upper-layer cortical markers TBR1, CTIP2 and BRN2. Cell
nuclei are imaged through DAPI staining. Scale bars represent 100μm.
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As well as positive staining within nuclei of dispersed neural cells, TBR1 expression
was also strongly localised to the outer layer of neural ganglia-like structures that formed
within the differentiating cultures (Fig 3-12, white arrow heads). This pattern of staining is
indicative of organoid-like cortical self-organisation within these cellular aggregates.

Fig 3-13: Fluorescent immunocytochemistry of excitatory and inhibitory neuronal
markers in neural cultures differentiated from hiPSCs into dorsal and ventral forebrain
lineages. All samples are stained with β-III-TUBULIN to highlight mature neuronal cell
types with glutamatergic markers vGLUT1/2 and GABAergic markers GAD65+67. Cell
nuclei are imaged through DAPI staining. Scale bars represent 100μm.
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A similar pattern was also observed in dorsal cultures that displayed CTIP2-positive
expression, with strong staining in the outer layer of cellular aggregates within the cultures
(Fig 3-12). Unlike TBR1 however, CTIP2 staining was prevalent throughout the ventralised
neural culture which suggests a role for CTIP2 within ventral neural tube neural lineage
generation. The upper-layer cortical marker BRN2 showed dense staining in dorsal neural
cultures which were predominantly localised and prevalent in ganglion-like aggregates. It
was however, also seen to a lesser degree within ventral-patterned neural lineages.
Striking differences between markers of neuronal subtype specificity were also
apparent between dorsal and ventral patterned cultures (Fig 3-13). The glutamatergic
neuronal markers vGLUT1 and vGLUT2 both displayed higher degrees of staining within
dorsal rather than ventral cultures. Conversely, the GABAergic markers GAD65+67 showed
higher levels of expression from ventrally-patterned cell lineages.
To better understand the potential neurotransmitter responsiveness of each neural
lineage subtype, we investigated the presence of the ionotropic glutamate receptor subunit
AMPAR1, and the ionotropic and metabotropic GABA receptor subunits GABAAR1 and
GABABR1 respectively (Fig 3-14). Intriguingly, even though AMPAR1 protein expression was
seen in both dorsal and ventral patterned cultures and did show colocalisation with cells
expressing the neuronal marker β-III-TUBULIN, a strong presence of this glutamate
receptor was also visualised in surrounding cell types, with weaker or absent mature
neuronal staining. Conversely, the staining pattern for GABAAR1 showed near perfect
overlap with post-mitotic neuronal cells in both dorsal and ventral neural cell pools, with
no apparent staining in other cells of glial or immature lineage. The G-protein coupled
receptor subunit GABABR1, in contrast, only showed prevalent staining in non-neuronal cell
types. Suggesting a developmental effect of this metabotropic receptor at this stage of
differentiation in immature or glial cell lineages from hiPSC-derived neural cultures (Fig 314).
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Fig 3-14: Fluorescent immunocytochemistry of neurotransmitter receptor subunit
markers in neural cultures differentiated from hiPSCs into dorsal and ventral forebrain
lineages. All samples are stained with β-III-TUBULIN to highlight mature neuronal cell
types. Other staining displays the ionotropic glutamate receptor subunit AMPAR1, and
the GABA-receptor subunits GABAAR1 and GABABR1. Cell nuclei are imaged through
DAPI staining. Scale bars represent 100μm.

122

To more accurately compare neural marker expression levels between the dorsallyand ventrally-patterned neural cultures, we undertook Western blot analysis of a wide
panel of proteins related to; post-mitotic neuron identity & axonogenesis, neuronal
neurotransmitter subtype, developmentally related forebrain localisation, pre- and postsynaptic machinery, and neurotransmitter receptor subunits (Fig 3-15).
Neither neural culture derived through the dorsal or ventral differentiation
protocol displayed any expression of the pluripotency marker NANOG, while it was highly
expressed in undifferentiated hiPSCs. The neuronal structural protein β-III-TUBULIN and
axonal marker TAU showed comparable levels of protein expression in both dorsal and
ventral cultures after 60 days of maturation, with a slight elevation seen within the
ventrally-patterned cultures. However, neurofilament-light chain (NF-L) was seen at a much
lower level in ventral cultures than the default excitatory dorsal cell populations. None of
the above markers were observed in undifferentiated hiPSC cultures (Fig 3-15).
Stark and robust differences were seen at the protein expression level for
identifiers of excitatory neurons and inhibitory interneurons between dorsal and ventral
cultures. The glutamatergic neuronal marker vGLUT1 was only detected within dorsallypatterned neural cultures, whereas the GABAergic neuronal markers GAD65+67 were
conversely only detected in ventrally-patterned differentiation cultures (Fig 3-15).
The early forebrain marker FOXG1 was strongly expressed in both dorsal and
ventral cultures, indicating both retained anterior neural tube marker characteristics.
However, divergence was observed when looking at the early-cortical marker REELIN and
late-cortical marker BRN2, which were both expressed within dorsally-patterned neural
cells but were either absent (in the case of REELIN) or reduced (in the case of BRN2) in
ventrally-patterned cultures. These results highlight the dorsal-ventral cellular identity and
brain regionalisation instigated respectively by these neural induction protocols.
The pre- and post-synaptic markers SYNAPTOPHYSIN and PSD95 mirror the
expression of the neuronal and axonal markers, and were detected in both dorsal and
ventral cultures, again with a slightly biased elevation in ventrally-patterned neural cells.
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The GABAergic neurotransmitter receptor subunits GABAAR1 and GABABR1, in
contrast, were much more highly expressed in neural cultures undergoing ventral
differentiation than dorsal patterned cultures, although they did still retain detectable
levels of each receptor subunit (Fig 3-15). The glutamate receptor subunit NMDAR1
showed much more comparable levels of expression between the two methods of neural
induction, albeit again with a slight elevation within ventral-patterned neural cells.

Fig 3-15: Western blot analysis for an array of neural markers present within
undifferentiated hiPSCs, and dorsal- & ventral-patterned hiPSC-neural cultures
after 60 days of differentiation.

To develop a greater resolution of gene regulation timings and strengths between
dorsal- and ventral-patterned neural cultures; quantitative polymerase chain reaction
(qPCR) analysis was used to investigate the level of gene expression in each patterned
culture over the time-course of differentiation (Fig 3-16 to Fig 3-21).
The relative expression of the NPC marker NESTIN peaked by Day 20 in dorsalpatterned cultures, and Day 30 in ventral cultures, before reduction to lower expression
levels over the remaining time course of differentiation. At all the time points assayed, the
pattern of early NESTIN upregulation and then downregulation was followed in both dorsal
and ventral cultures with no significant differences in expression level. There was a slight
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trend for ventral cultures to display higher levels of expression at the later time points
assayed but this difference never reached statistical significance (Fig 3-16). The dorsal-NPC
marker PAX6 followed a similar peak of expression in the early stages of neural
differentiation (Day 20) before subsiding to a lower but stable level of expression. This
pattern was restricted to dorsal-patterned cultures which show increased and statistically
significant higher expression levels compared to PAX6 expression within ventral-patterned
cultures on Day 20, 30 and 40 of differentiation. The reverse is true of the ventral-NPC
marker NKX2.1, which is barely detectable in dorsal-patterned cultures, but shows robust
and substantially higher relative expression in ventral-patterned neural cells at all time
points assayed (all of which reached statistical significance). For all three of these NPC
markers; a peak of expression around Day 20 of differentiation suggests the maximal
generation of neural precursors after approximately three weeks of differentiation with a
gradual decrease over the following 40 days of differentiation and maturation.

Fig 3-16: Quantitative PCR analysis for NPC markers expressed within dorsal- and
ventral-patterned hiPSC-derived neural cultures over 60 days of differentiation. Data is
shown as mean values ± standard error of the mean of four independent experiments.
Statistical significance denoted by * p≤0.05, ** p≤0.01, *** p≤0.001 based on unpaired
two-tailed t-tests.
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Similar analyses were performed to observe changes in the canonical neuronal
marker β-III-TUBULIN and axonal marker TAU, as well as the pre- and post-synaptic
associated markers SYNAPTOPHYSIN and PSD95 (Fig 3-17). β-III-TUBULIN expression
showed a strong early expression by Day 20 in dorsal cultures, which lowered by
approximately half for the remainder of the differentiation period. In contrast, ventral
cultures displayed a more delayed peak of β-III-TUBULIN expression (Day 30) which
dropped over the next 30 days of differentiation. However, expression levels in ventral
cultures were significantly higher than those seen in dorsally-patterned cultures from Day
30 to 50 (~2.1-fold higher at Day 30). In addition, the axonal marker TAU, showed a pattern
of continuous slight upregulation over the 60-day time-course of differentiation in both
dorsal and ventral cultures, with a trend of higher levels of expression in ventral cultures at
Day 50 and 60, however this difference did not reach statistical significance (Fig 3-17).

Fig 3-17: Quantitative PCR analysis for neuronal and synaptic markers expressed within
dorsal- and ventral-patterned hiPSC-derived neural cultures over 60 days of
differentiation. Data is shown as mean values ± standard error of the mean of four
independent experiments. Statistical significance denoted by * p≤0.05, ** p≤0.01 based
on unpaired two-tailed t-tests.
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The pre-synaptic marker SYNAPTOPHYSIN showed a distinct point of upregulation
after 20 days of dorsal-patterned differentiation. This level of expression was maintained
within dorsally-patterned cultures for the remainder of the assayed differentiation timeline
with a slight drop by Day 60. Relative to dorsal cultures, ventral cultures showed a delayed
peak of expression (at Day 30 - mirroring the temporal peak of β-III-TUBULIN expression)
and maintained a similar level of expression until Day 60. A trend for higher expression
levels of SYNAPTOPHYSIN within these later time points in ventral cultures was seen,
although statistically significant increased expression was only recorded at Day 50 between
the two differentiation strategies. A similar timing peak of PSD95 expression was also seen
after 20 days of neural induction and maturation that was stable over the time course of
dorsal differentiation but appeared to peak at Day 30 in ventral cultures (which
represented a significant increase relative to the dorsal expression level), before lowering
to dorsal-patterned equivalent expression levels (Fig 3-17).
To monitor excitatory and inhibitory neuronal maturation in either the dorsal or
ventral neural patterning schemes, we also tracked gene expression levels of glutamatergic
and GABAergic pre-synaptic neuronal markers (Fig 3-18). Dorsal-patterned differentiation
of hiPSCs resulted in increased expression of the glutamatergic neuronal makers vGLUT1
and vGLUT2 after 20 days of differentiation that remained steadily expressed until Day 60.
However, the GABAergic markers GAD67 and GABA Transporter 1 (GAT1) displayed very
low level basal expression without robust upregulation over the timeline of differentiation.
In contrast to this, ventrally-patterned neural cultures showed steady upregulation of both
GAD67 (from Day 14) and GAT1 (from Day 30) during differentiation, which by later
timepoints showed statistically significant increases compared to the levels seen in dorsal
cultures. In tandem with this, glutamatergic markers in ventral cultures were repressed
under these patterning conditions, whereby vGLUT1 expression was far below that seen in
dorsal neural culture (Day 20-50) (Fig 3-18). This repression of glutamatergic neuronal
identity was less pronounced when looking at vGLUT2 expression, which although
displayed a trend of lower expression in ventrally-patterned cultures than dorsal, these
lower expression levels did not reach statistical significance. For both sets of these
glutamatergic and GABAergic markers, it is apparent that there is much more robust
upregulation of the non-default ventral lineage markers in the ventral-targeted
differentiation than there is repression of the default glutamatergic pathway markers.
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Fig 3-18: Quantitative PCR analysis for excitatory and inhibitory neuronal markers
expressed within dorsal- and ventral-patterned hiPSC-derived neural cultures over 60
days of differentiation. Data is shown as mean values ± standard error of the mean of
four independent experiments. Statistical significance denoted by * p≤0.05, ** p≤0.01,
*** p≤0.001 based on unpaired two-tailed t-tests.

After understanding the extent of neuronal subtype divergence triggered by the
patterning protocols during differentiation, we examined how markers of forebrain cortical
localisation differed between the differentiation pathways. Observing the expression of the
early- to late-cortical formation markers REELIN, TBR1, CTIP2 and Special AT-rich sequence
Binding protein 2 (SATB2) we were able to track the timing of markers relevant to deeplayer and upper-layer cortical neuronal generation in vitro (Fig 3-19).
Across all the cortical markers assayed, robust gene expression was seen only in
dorsal-patterned cultures, with comparably lower levels seen in ventrally-induced cell
populations. This is again not only suggestive of a neuronal subtype divergence triggered by
each patterning methodology, but also one of brain region specification. However, it should
be noted that the level of expression for the cortical localisation markers displayed high
variation between biological repeats – resulting in a large spread of expression data. As
each marker is suggestive of only a subset of excitatory neural types it is possible that a
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stochastic generation of each subtype may strongly alter bulk mRNA expression from mixed
cultures between biological repeats. Even so, strong upregulation of excitatory cortical
markers was only recorded within dorsally-patterned cultures, albeit with high variance. A
strong upregulation of the layer I marker REELIN by Day 20 and 30 post-differentiation
dropped to a stable plateau for the remainder of the maturation timeline, and similar
patterns are seen for both the cortical pre-plate and layer V/VI markers TBR1 and CTIP2
expression (Fig 3-19).
The upper-layer late-born cortical marker SATB2 also showed slight upregulation
over the course of differentiation, however the relative expression only reached just over a
two-fold increase at its peak, suggestive of a baseline expression that still shows heavy bias
in dorsally-patterned lineages, but which does not show a dramatic increase within the
timeframe of this assay.

Fig 3-19: Quantitative PCR analysis for early and late cortical markers expressed within
dorsal- and ventral-patterned hiPSC-derived neural cultures over 60 days of
differentiation. Data is shown as mean values ± standard error of the mean of four
independent experiments. Statistical significance denoted by * p≤0.05, ** p≤0.01, ***
p≤0.001 based on unpaired two-tailed t-tests.
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In order to further visualise the extent of the efficacy of neuronal subtype
patterning we undertook robust regression analysis to compare each subtype-specific
marker expression profile over the full time course of differentiation. Rather than simple
point-to-point statistical comparisons this methodology seeks to compare the difference in
the overall strength and pattern of expression between dorsal- and ventral-patterned
neural cultures for each gene. The markers analysed were those related to dorsal neuronal
identity (vGLUT1 and vGLUT2), ventral neuronal identity (GAD67 and GAT1), and cortical
(dorsal) localisation (REELIN, TBR1, CTIP2 and SATB2) (Table 3-2).
From this analysis it can be seen that a strong, statistically significant divergence is
seen from both dorsal/excitatory neuronal markers when comparing dorsally-patterned
and ventrally-patterned neural cultures across the 60 days of differentiation. Both vGLUT1
and vGLUT2 show strong significant differences in expression between the dorsal and
ventral cultures when analysed using regression methodologies. This is equally mirrored
with the expression pattern of the ventral neuronal markers GAD67 and GAT1, which only
maintain robust expression patterns within ventrally-patterned neural cultures (Table 3-2
and Fig 3-18)

Table 3-2: Regression analysis table of dorsal and ventral neuronal identity gene
markers for the time course of differentiation for dorsally versus ventrally patterned
neural cultures. Statistical significance denoted by * p≤0.05, ** p≤0.01, *** p≤0.001.

The forebrain cortical localisation markers are also shown by this analysis to be
statistically biased to expression predominantly within dorsally-patterned neural cultures
for all of the early to late cortical marker genes (REELIN, TBR1, CTIP2, and the modestly
expressed SATB2) (Table 3-2). Taken altogether this analysis confirms the divergence in
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neuronal subtype differentiation that is occurring during the dorsal and ventral patterning
techniques used in this chapter.
As another indicator of neuronal maturity and synaptic-associated development,
we chose to observe the gene expression patterns of both the glutamatergic receptor
subunits NMDAR1 and AMPAR1, as well as the ionotropic and metabotropic GABA receptor
subunits GABAAR1 and GABABR1 (Fig 3-20).

Fig 3-20: Quantitative PCR analysis for glutamatergic (AMPAR1 and NMDAR1) and
GABAergic (GABAAR1 and GABABR1) neurotransmitter receptor subunits expressed
within dorsal- and ventral-patterned hiPSC-derived neural cultures over 60 days of
differentiation. Data is shown as mean values ± standard error of the mean of four
independent experiments. Statistical significance denoted by * p≤0.05 based on
unpaired two-tailed t-tests.

The GABAergic receptor subunit GABAAR1 showed a delayed upregulation
expression profile in ventral-patterned cultures (Day 40-60) relative to dorsal neural cell
types, which showed a trend for lower gene expression at these later time points but an
earlier onset of receptor expression. Only at Day 40 of differentiation did ventral neural
cultures show a statistically significant increase of GABAAR1 expression compared to dorsal-
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patterned cell types (~4.6-fold higher). A more robust, early, and stable pattern of gene
upregulation was seen in both dorsal and ventral-cultures for GABABR1 expression from
Day 20 onwards. Again, there was a trend for higher relative expression in ventrallypatterned neural cells at each time point (Fig 3-20).
NMDAR1 subunit expression showed a steady expression profile in dorsal cultures
from Day 20, but a gradually increasing pattern within ventral cultures, which reached a
statistically significant difference at Day 60. A comparable expression profile over the
timeline of differentiation was seen for AMPAR1 gene expression in both dorsal and ventral
differentiation pathways, albeit with a slight increase in ventral cell types at later time
points. A peak in expression at Day 30-40 post induction was seen in both dorsal- and
ventral-patterned cultures that gradually lowered over the course of maturation (Fig 3-20).
However, the expression of AMPAR1 in ventral cultures at Day 60 was significantly higher
than that seen in dorsal-patterned cultures, mirroring the result of NMDAR1.
Finally, we wished to investigate the expression of genes related to glial cell
identity over the time course of neural differentiation, and to observe whether there was a
delay in the upregulation of glial-associated genes relative to neuronal markers. The
astroglial marker gene GFAP and the oligodendroglial marker GALC were monitored over
the same timeline of dorsal- and ventral-patterned neural differentiation (Fig 3-21).
Following the same pattern of delayed generation of astroglial cell types in CNS
development in utero (Hansen, Rubenstein and Kriegstein, 2011), both dorsal- and ventralpatterned in vitro neural cultures only showed detectable levels of GFAP gene expression at
later time points in differentiation: Day 40 in dorsally-induced cultures and Day 60 in
ventrally-induced cultures. This does suggest that a more protracted timeline of
differentiation and maturation would be necessary to generate an enriched population of
mature astroglial cell types. Surprisingly however, GALC expression did show initial early
upregulation and stable expression over the course of differentiation. Although GALC is not
completely specific to oligodendroglial lineages it is highly enriched within them, and it is
interesting that such robust gene expression is seen in these cultures that is not
recapitulated by the protein expression from the same induction protocol (Figs 3-10, 3-21).
It is possible that basal levels of GALC transcript are present in a subpopulation of cells
within each directed neural culture, but that true oligodendroglial lineage formation and
protein accumulation would take longer periods of maturation, as is seen for GFAP.
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Fig 3-21: Quantitative PCR analysis for astroglial marker (GFAP) and oligodendroglial
marker (GALC) expression within dorsal- and ventral-patterned hiPSC-derived neural
cultures over 60 days of differentiation. Data is shown as mean values ± standard error
of the mean of four independent experiments. Statistical significance denoted by *
p≤0.05 based on unpaired two-tailed t-tests.

3.3.5 Electrophysiological Analyses
Tracking the differentiation and maturation of hiPSC-derived neural cultures through the
molecular assays outlined above, generates a wealth of information about morphological
development as well as gene and protein expression during targeted differentiation.
However, electrophysiological functionality of hiPSC-derived neurons may be essential for
certain aspects of in vitro developmental- and disease-modelling. To this end, dorsally- and
ventrally-patterned neural cultures were assayed through patch clamp analysis to
determine the functional maturity of cells within each neural culture generated.
Current-clamp recordings of neuronal cells from each differentiation patterning
methodology after 95 days of differentiation are shown in Fig 3-22. The mean resting
membrane potential of all cells assayed was -46.6mV and a capacitance of 7.1pF. In
response to intracellular current injection both ventral- and dorsal-patterned neuronal cells
fired action potentials (Fig 3-22 B-C). The evoked action potentials were over 100mV in
both neural cell types with sharp narrow peaks. Ventrally-patterned neurons fired in
between one and four action potentials at threshold stimulation, with higher numbers of
action potentials initiated under lower current stimulation than supra-threshold values (Fig
3-22 B i-iii). Also, at supra-threshold stimulation levels a prolonged depolarisation was
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Fig 3-22: Current-clamp recordings of dorsally- and ventrally-patterned hiPSC-derived
neuronal cultures. (A) Bright field image of a patched cell. (B) Ventrally-patterned
neurons fired 1-4 large brief action potentials in response to current injection. Lower
stimulus levels (i-ii) evoked higher numbers of action potentials than supra-threshold
stimulation (iii) which elicited a sustained depolarisation before restoring holding
membrane potential (grey arrow). (C) Dorsally-patterned neurons fired only one action
potential regardless of stimulation level

recorded after the initiation of the action potential (Fig 3-22 B ii, grey arrow). Neurons from
dorsally-patterned cultures however, were only capable of firing one action potential
regardless of the current stimulus (Fig 3-22 C), and after firing the action potential also
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displayed sustained depolarisation before returning to resting membrane potential. The
action potentials seen within triggered dorsally-patterned neurons were also slightly
broader than those seen from ventral neuronal cultures.
Voltage-clamp recordings of the dorsally- and ventrally-patterned neuronal
cultures also showed differences in the maturation of functionality between the two
differentiation pathways (Fig 3-23).

Fig 3-23: Voltage-clamp recordings of dorsally- and ventrally-patterned hiPSCderived neuronal cultures. Both Ventral (A) and Dorsal (B) neurons displayed
fast transient inwards currents following stimulation (black arrows) followed by
sustained outward currents (asterisks). Both inward (sodium) and outward
(potassium) currents were larger in ventrally-patterned neurons.
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Neurons from both neural differentiation pathways displayed strong, transient
inward sodium currents after the onset of the stimulus. This inward current flux was
greater in neurons derived from ventrally-patterned cultures. Outward potassium currents
were also measured following sodium depolarisation, with larger currents being seen
within ventral-patterned neurons. From these data it appears as if the level of functional
maturity is delayed in the iPSC-derived forebrain dorsal neuronal cultures compared to
ventrally-patterned neurons.

3.4 Discussion and Conclusions
Many neural induction protocols from pluripotent stem cells have been generated for
obtaining neural subtypes of dorsal-forebrain & cortical lineages (Gaspard et al., 2008; Zeng
et al., 2010; Shi et al., 2012; Espuny-Camacho et al., 2013), and ventrally-derived inhibitory
GABAergic interneurons (Maroof et al., 2010; Danjo et al., 2011; Goulburn et al., 2012; Ma
et al., 2012; Arber and Li, 2013; Yan Liu et al., 2013; DeRosa et al., 2015) using signalling
morphogens derived from studying in vivo neural tube development (Jessell, 2000).
However, few studies have attempted parallel induction protocols to interrogate the
timings and mechanisms of in vitro neurological models from distinct brain regions. Mature
cortical tissue in vivo is derived from dorsal-anterior excitatory neural cell types combined
with migrating inhibitory interneurons generated in ventral-anterior regions of the neural
tube. Therefore, to fully model mature neural forebrain tissue in vitro, both neural cell
types must be generated and combined at developmentally relevant time frames to allow
for true recapitulation of neural tissue development.
We aimed to generate developmentally representative pools of excitatory cortical
neural cells and inhibitory GABAergic interneurons (displaying markers of the medial
ganglionic eminence transitory brain structure) from human iPSCs, and to investigate the
strength of neural induction, the molecular timings of genes and proteins involved in
differentiation, and the development of electrophysiological activity within the derived
cultures in vitro.
We used commercially available hiPSC cell lines that were shown to maintain high
levels of pluripotency marker expression throughout culture and expansion in a stable
fashion. The dual-SMAD inhibition mechanism of neural induction triggered a rapid
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reduction in pluripotency-associated cell markers, while vastly upregulating the gene and
protein expression of the forebrain neural precursor marker PAX6 over the course of 7
days. Flow cytometric analysis of cells undergoing differentiation revealed induction
efficiencies of >82% for PAX6-positive cells and >88% NESTIN-positive cells by Day 10.
Further refinement of the differentiation protocol was investigated with the use of a neural
proliferation media (NPM) and its effect on PAX6 and NESTIN expression. Stronger and
more penetrant NESTIN staining was seen under NPM treatment than with dual-SMAD
inhibition induction alone and was therefore adopted into the full long-term maturation
protocol.
Prevalent neural morphology and post-mitotic neuronal protein expression was
observed from Day 28 of the differentiation protocol. This was also studied after 60 days of
neural maturation; whereby extensive neuronal and glial protein marker expression
corresponded with widespread neuritogenesis. However, astroglial markers present at this
time, were displayed in cells with an immature morphology. Interestingly, oligodendroglial
lineage markers were not detected within neural cultures at this time point. This mirrors
other findings on neurological development, by which glial differentiation and maturation
is delayed relative to neuronal generation (Hansen, Rubenstein and Kriegstein, 2011;
Mallamaci, 2013; Anderson and Vanderhaeghen, 2014), such marker expression therefore
may be present after more protracted periods of differentiation and maturation. This
“default” neural differentiation pathway also upregulated proteins associated with cortical
(and therefore dorsal neural tube) neuronal cell identity. With noticeable expression of the
outermost layer I marker REELIN, the deep-layer neural markers TBR1 and CTIP2, and to a
lesser extent the upper-layer (II-IV) marker BRN2 in neural cultures differentiated for 60
days. This demonstrates that this level of differentiation and maturation of hiPSC-derived
neural cultures display representative markers of early- and late-born markers of
corticogenesis, and therefore recapitulation of neurodevelopmental processes in vitro.
Excitatory glutamatergic protein markers were present throughout the nonpatterned differentiated neural cultures, whereas markers of GABAergic differentiation
were not detected; again, suggestive of targeted dorsal-anterior cell populations. Other
protein markers of neuronal maturity, pre- and post-synaptic machinery, and glutamateand GABA-sensitive neurotransmitter receptor subunits showed high levels of protein
expression after 60 days of neural differentiation but were not present during early NPCenriched cultures nor undifferentiated hiPSCs. These results indicate a robust maturation
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process occurring within iPSC-derived neural cultures after 60 days of differentiation that
encompasses gene expression relevant to neurotransmitter release and response, which
are the foundation stones of functional network formation.
We then attempted to “pattern” the differentiating NPC cultures to one of ventralanterior lineages using the SHH signalling pathway agonist purmorphamine (Pur), in parallel
to the default dorsal-excitatory pathway. A strong nuclear presence of the early-cortical
marker TBR1 within cells in dorsal cultures, was in stark contrast to ventrally-patterned
ones which showed no such positive immunostaining. The presence of TBR1 was not only
localised to diffuse single cells throughout the dorsal culture, but also seen in the outer
layer of neural ganglia-like structures that had formed during maturation. A similar pattern
of staining was seen for the deep-layer cortical marker CTIP2 also within dorsal cultures,
suggestive of a possible organoid-like self-organisation into simplified versions of early
cortical structures (Kadoshima et al., 2013; Lancaster et al., 2013). However, CTIP2
immunostaining was also observed within subpopulations of ventrally-patterned neural cell
cultures. It is possible that this effect may be due to inefficient silencing of pathways
denoting default dorsal neural differentiation, and that upregulation of CTIP2 is more
sensitive to this. Another possibility is the inherent presence of CTIP2 in populations of
GABAergic interneurons, as has been reported in vivo (Nikouei, Muñoz-Manchado and
Hjerling-Leffler, 2016), and therefore the use of CTIP2 alone as a cortical localisation
marker should be used with caution.
Through Western blot analysis we report that the early and late cortical markers
REELIN and BRN2 follow the same divergent pattern as is seen with TBR1 expression
between dorsal- and ventral-patterned cultures; with the majority of protein expression of
these cortical markers found within dorsal-patterned cultures. From gene expression data
over the time-course of differentiation, early cortical markers peak to statistically
significant elevations in dorsal-patterned neural cultures by Day 30 of differentiation,
relative to ventrally-patterned cell populations. These upregulated genes continue to be
expressed throughout the maturation timeline in dorsal cultures, indicating that molecular
events driving early human corticogenesis can be detected as early as Day 20 of neural
induction and differentiation in vitro. The lower relative expression levels of the upperlayer cortical marker SATB2 over the full time-course however, does suggest that full
maturation of all late-born cortical cell types has not by this time point reached
completion, and that more protracted timelines of differentiation may be needed to obtain
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neural cell populations representative of layers II-IV of the prenatal cortex. Interestingly,
the gene expression level of CTIP2 in ventral cultures, although lower than dorsalpatterning at all time points measured, does show a gradual increase by Day 60 in culture,
which may explain the presence of the positive protein immunostaining at the end-point of
differentiation seen in a subpopulation of ventrally-patterned neural cells.
For assays of neuronal subtype specificity, immunostaining and Western blot
analysis of neural cultures after the full time-course of differentiation showed stark
differences in expression of glutamatergic and GABAergic neuronal markers from dorsallyand ventrally-patterned cultures. vGLUT1 and vGLUT2 protein levels were far higher in
dorsally-patterned cultures, whereas GAD65+67 expression showed exclusive upregulation
within ventrally-patterned neural cell types. Gene expression data also displays this strong
relationship to subtype marker expression and patterning methodology over the course of
differentiation. However, it is worthy of note that the upregulation of non-default ventral
GABAergic genes (GAT1 and GAD67) show far more striking and elevated levels within
differentiating ventral cultures, but still display basal levels of glutamatergic marker
expression (vGLUT1 and vGLUT2). This is suggestive of a system by which the upregulation
of non-default ventral-associated genes shows more distinct expression profiles than the
complete repression of genes of the default dorsal neural-lineage pathway. Hence the lack
of ventral-associated gene expression within dorsal-patterned cultures, but a “leaky”
expression of dorsal-associated genes within ventral-cultures. Even so, when the pattern
and strength of expression for each of these genes is assessed through robust regression
analysis over 60 days of differentiation: strong statistical divergence is seen between
dorsal- and ventral-patterned cultures for all of the markers assayed.
This segregation of neuronal subtype however did not disrupt comparable levels of
β-III-TUBULIN and TAU neuronal protein markers between the differentiation pathways.
This indicates that the timing of neuronal induction is maintained to equivalent levels
between the two pathways by this timepoint in neural maturation, and that only the
subtype of the neurons themselves show inherent differences. Interestingly, the
intermediate filament protein NF-L did show robust upregulation within dorsal- rather than
ventral-patterned neural cells, indicating a greater necessity of this gene within dorsalpatterned neural development. A slight upregulation of the canonical neuronal markers βIII-TUBULIN and TAU was seen within ventrally-patterned neuronal cultures at the
transcript and protein level at most time points, which suggests a slightly more enriched
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neuronal population of cells within these cultures. This pattern is also replicated when
observing the expression levels of the synaptic markers SYNAPTOPHYSIN and PSD95, which
again show slightly higher levels of protein expression in ventral-cultures, and a trend for
upregulation at the gene transcript level at most measured time points during
differentiation. These data could indicate a slightly higher proportion of mature neuronal
populations within GABAergic ventral cultures, which may equate to higher degrees of glial
differentiation within dorsal-patterned cell types or a higher retention of precursor cells
with a slightly delayed timescale of differentiation compared to ventrally-patterned neural
cells.
This postulated higher level of retention of NPCs in dorsal cultures however, is not
supported by the relative gene expression profile of the NPC marker NESTIN. No
statistically significant differences were recorded between dorsally- and ventrallypatterned neural cell cultures over the full time-course of differentiation, although there
was a slight trend of higher NPC marker expression within ventral-patterned cultures. As
with mature neuronal subtype markers, almost exclusive dorsal-NPC marker expression
(PAX6) and ventral-NPC marker expression (NKX2.1) was recorded that agreed with each
separate differentiation pathway. The statistically lower levels of PAX6 seen within
ventrally-patterned cultures may again be derived from the incomplete suppression of
default differentiation, but may also be related to Pax6’s role in neuroectodermal fate
determination and may be due to residual expression in early-NPC cell populations (Zhang
et al., 2010; Goulburn et al., 2011). All the NPC gene markers observed here however, show
the same pattern of early high relative expression before a decrease during neural
maturation. This would follow with the expected outcome of the neural differentiation
pathway by which high initial levels of NPCs would be generated from lineage restricted
hiPSCs which would decrease as post-mitotic neuronal differentiation takes place. Basal
retention of NPCs are indicative of the protracted neurological development of human
brain tissue, and are maintained throughout the differentiation culture, following intrinsic
developmental cellular timings (Espuny-Camacho et al., 2013).
The transcript expression of the glutamate receptor subunit NMDAR1 showed
comparable levels of expression throughout dorsal- and ventral-patterned differentiation
pathways, but with increased expression in ventral cultures by Day 60 of differentiation.
This increase is also reflected at the protein level. This pattern of gene upregulation in both
differentiation pathways is also mimicked by the glutamate neurotransmitter receptor
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subunit AMPAR1, which shows peak levels of expression in dorsal and ventral cultures at
Day 40 and Day 30 of differentiation respectively. Surprisingly, the cellular localisation of
AMPAR1 is not only within neuronal-marker-positive cell types, but also a subpopulation of
surrounding cells. This points to the conclusion that upregulation of AMPAR1 may precede
true post-mitotic neuronal differentiation and neuritogenesis, or that it may have other
developmentally relevant uses during early neural tissue generation.
The presence of GABA-sensitive neurotransmitter subunits GABAAR1 and GABABR1
did show protein level differences between dorsal- and ventral-cultures, with both of these
receptor subunits showing stronger upregulation in ventrally-induced neural cells. These
differences post-translationally are less pronounced when looking at gene expression levels
during neural differentiation. Although relative expression levels of both subunits were
consistently higher in ventrally-patterned cultures, they did not reach statistical significance
over the majority of assay time-points. Intriguingly, the localisation pattern of GABAAR1 and
GABABR1 show stark differences in neural cultures generated from both induction
pathways. GABAAR1 expression was restricted to cells displaying neuronal markers and
morphology, whereas GABABR1 showed strong expression within non-neuronal markerpositive cell types, to an even greater degree than was seen with AMPAR1. These results
indicate that the ionotropic GABA receptor subunit GABAAR1 shows a neuronal-specific
expression pattern that may be indicative of maturing receptor complexes necessary for
post-synaptic formation, whereas the metabotropic GABA receptor subunit GABABR1 may
have a NPC-specific role in GABA sensing or in other non-neuronal cell types during neural
induction and maturation.
Markers of gliogenesis, such as those found in astroglial lineages (GFAP and S100β)
and oligodendroglial lineages (GALC) were assayed over the time course of neural induction
and differentiation. Both astroglial markers were observed by Day 60 in dorsally-patterned
neural cultures in a subpopulation of cells. These markers co-localised with each other and
were separate from neuronal-marker-positive cell types. However, they displayed
morphology indicative of immaturity, which does follow the delayed gliogenesis seen
developmentally in vivo (Barateiro and Fernandes, 2014) and also from PSC-derived neural
cultures in vitro (Gaspard et al., 2008). This agrees well with the gene expression data of
GFAP which only displays upregulation at late time points over the course of this
differentiation. Oligodendroglial markers were not detected through protein analysis
within Day 60 neural cultures, but gene expression data did reveal consistent expression
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following NPC induction through both patterning pathways. This may be explained through
the presence of GALC in non-oligodendroglial lineages (albeit in less enriched amounts)
that were too low for detection through protein-based assays, or possibly indicate a strong
post-transcriptional silencing effect before the triggered onset of gliogenesis.
Electrophysiological assays of the hiPSC-derived neural cultures also uncovered
differences in functional maturation between the excitatory dorsal-patterned and
inhibitory ventral-patterned neuronal subtypes. Both dorsal- and ventral-patterned neural
cultures generated neuronal cells that were electrophysiologically active and could fire
action potentials under current-clamp stimulation. However, dorsally-derived neurons only
fired a single action potential after the onset of current stimulus whereas ventrally-derived
neurons fired in between one and four action potentials depending on the level of current
injection. This can be interpreted as a level of enhanced maturity of the ventrally-patterned
neurons relative to dorsally-patterned neurons. This advanced level of maturation is also
echoed in voltage-clamp recordings of each neuronal subtype. Larger sodium (inward) and
potassium (outward) currents were seen in ventrally-derived neurons following stimulation
than in the dorsally-derived counterparts. In both neuronal types however, extended
periods of depolarisation after stimulus withdrawal and lower potassium currents may be
indicative of a general immature neuronal phenotype relative to primary neurons. As
normal human brain development takes place throughout the protracted timeline of
gestation, it is plausible that true neuronal maturity and functionality of iPSC-derived
neural cultures would also need to take place over the course of many months in vitro if
the recapitulation of neurodevelopmental processes followed intrinsic timing mechanisms.
These preliminary findings show ventrally-patterned neural cultures display
hallmarks of advanced maturity compared to excitatory dorsally-patterned neurons at the
same time point. Although more research will be needed to verify this, it does reveal some
intriguing questions about the independent developmental timings of ventrally-derived and
dorsally-derived anterior neural cell types and how it would be best to combine them in in
vitro models to develop representative models of mature forebrain. Indeed, the higher
expression and protein profiles of neuronally-associated markers seen in ventrallypatterned cultures may reflect an enhanced maturing population of post-mitotic neuronal
cultures, that require extended timelines to be generated from dorsal-patterned cell pools.
In conclusion, we have demonstrated that efficient neural differentiation can be
elicited from hiPSCs in vitro and targeted to generate specific neuronal subtypes derived
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from dorsal-anterior and ventral-anterior regions of the neural tube. The maturity of these
patterned neuronal pools is displayed through comparable molecular markers of neuronal
cell identity, synaptic machinery, and appropriate dorsal/ventral identity markers.
Ventrally-patterned cells however show increased tendency for higher expression profiles
of many neural-associated markers and more mature electrophysiological properties,
suggestive of an accelerated maturation timeline of neural cells patterned in this way. All of
these data will inform future in vitro models of human forebrain cortical development.

3.4.1 Summary of Chapter Findings


hiPSCs undergoing neural induction via dual-SMAD inhibition pathways generate NPCs
with high efficiency over 7-14 days.



Further maturation of NPCs without exogenous signalling morphogens will derive
neuronal cells with extensive neuritogenesis after 28 days of differentiation and both
neuronal and glial-lineage cell types by Day 60 of maturation.



Neural cell cultures differentiated for 60 days will show markers of; cortical and
forebrain localisation; excitatory glutamatergic neuronal subtype; pre- & post-synaptic
components; and glutamate- & GABA-sensitive neurotransmitter subunits.



Ventral patterning of NPCs, through the use of a SHH-pathway agonist, generates
mature neurons of a predominantly inhibitory GABAergic cell type after 60 days of
differentiation and show heavily reduced cortical marker expression.



Robust regression analysis of neuronal subtype marker expression confirms the efficacy
of the patterning techniques and divergence of neural subtype differentiation.



Both neural induction pathways show upregulation of canonical neuronal markers over
the same timeline of differentiation.



Ventral-patterned neural cells show slight enrichment of neuronal associated markers
at the gene and protein level in comparison to the default (dorsal) induction pathway.



Glutamate-receptor subunits show comparable expression within neural cells from
both pathways of differentiation, but GABA-receptor subunits show elevated
expression in ventral-patterned cultures.



Astroglial lineage markers show highly delayed patterns of upregulation. Whereas
oligodendroglial protein markers were not detected in hiPSC-derived neural cultures
after 60 days.
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Both dorsally- and ventrally-patterned matured neuronal cells can fire an action
potential under intracellular current stimulation. Multiple action potentials can be
evoked from ventrally-patterned neuronal cells depending on the current stimulus
level, demonstrative of a more mature phenotype than is seen in dorsally-patterned
neurons.



Transient sodium and potassium currents are both present after stimulation of
dorsally- and ventrally-derived neurons. Both current levels are higher in ventrallypatterned cultures, indicative of a more mature ion channel composition phenotype.
However, potassium currents in neurons from both patterning methodologies are low,
showing an overall immature phenotype for all neurons assayed.
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3.5 Appendix
3.5.1 Matrigel Surface-Coatings for NPC Induction
Initial substrate testing for NPC induction and neural maturation also utilised Matrigel
coating, which was reported to show high rates of neuronal marker induction in PSCderived neural cultures (Muratore et al., 2014). However, preliminary data from the hiPSCs
used in this study showed high retention of NPC markers when cultivated on Matrigel
substrates but with low levels of neuronal maturation and marker expression (Appendix Fig
3-24). Therefore, we chose to complete all neural induction protocols using poly-L-lysine
and laminin coated surfaces that were conducive to neural maturation. Low levels of
neuronal morphology and marker development after 6 weeks of differentiation discounted
Matrigel coatings for assays into neural development and maturation of hiPSC-derived
cultures.

Appendix Fig 3-24: hiPSCs undergoing neural differentiation on Matrigel coated
surfaces displayed limited neuronal maturation but high rates of NPC marker retention
even after 4-6 weeks of differentiation. Scale bars represent 100μm.
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Chapter 4: Neural Differentiation of
hiPSCs in Three-Dimensional Biomaterial
Scaffolds

4.1 Introduction
The generation of mature neural cultures from human iPSCs (as described in Chapter 1 and
Chapter 3) follows that of embryological developmental timing and molecular signalling
(Gaspard et al., 2008), and can result in functional network formation (Odawara et al.,
2016). For the most part, these neural differentiation protocols are achieved in twodimensional (2D) adherent cell culture environments. Even so, crude elements of selforganised developmental structures can be seen within these 2D cultures that recapitulate
in vivo-like tissue. For example, early neural precursor structures termed “neural rosettes”
are self-formed multicellular patterns that were shown to be representative of a transverse
plane of neural tube cytoarchitecture (Watanabe et al., 2005; Eiraku et al., 2008). Further
development of more mature “brain-like” structures from hiPSCs has not been recorded
from planar culture but has been reported extensively since the advent of threedimensional (3D) organoid culture. By culturing neural precursors as free-floating
aggregates throughout differentiation and maturation, they generate histologically
accurate representations of early brain structures beyond those seen in rosette formation
(Kadoshima et al., 2013; Lancaster et al., 2013). The development of these 3D cerebral or
brain organoid cultures has been an incredible step forward in the field of in vitro-based
neuroscience as it illuminates not only the intrinsic timing of neural development that is
preserved in hiPSC differentiation, but also an inherent ability to self-organise into regionspecific complex structures (Meinhardt et al., 2014; Mariani et al., 2015; Muguruma et al.,
2015; Jo et al., 2016; Qian et al., 2016).
Although the potential of organoid tissue models for neurological research is
remarkable, there are limitations within this methodology that may impede specific aspects
of the research being undertaken. Firstly, continuous generation of single brain-like
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structures within the organoids (rather than multiple pseudo-structures within the same
aggregate) are dependent on high degrees of oxygen and nutrient diffusion, and therefore
require the use of spinning bioreactors to enable the generation of more representative
cytoarchitecture (Lancaster et al., 2013; Qian et al., 2016). However, this can still not
overcome the presence of necrotic cores within each organoid due to lack of vasculature
formation (Lancaster et al., 2013; Kelava and Lancaster, 2016). Furthermore, the
heterogeneity in the structure and cellular content of each organoid with high batch-tobatch variability may have repercussions in the reproducibility of experiments with more
subtle phenotypic outcomes (Brennand et al., 2015; Kelava and Lancaster, 2016).
Rather than free-floating organoid culture, 3D neural cultures from hiPSCs can also
be generated through encapsulation of differentiating neural cells within hydrogel scaffolds
that aim to mimic properties of the extracellular matrix microenvironment. The advantages
of 3D neural culture over 2D planar culture are apparent, even without the use of freefloating organoid formation. The enhanced degree of cell-cell interactions allowing for in
vivo-like cytoarchitecture and networking potential, whilst cell-matrix interactions would
allow for spontaneous cell migration throughout the scaffold, together with selforganisation reminiscent of neural organoids. It is also telling that the most successful
organoid culture protocols still embed cellular aggregates within droplets of hydrogel
scaffolds to enhance organoid formation (Lancaster et al., 2013), showing the great effect
that 3D neural cell encapsulation can generate. Although the same problems of nutrient
and oxygen diffusion exist in the generation of 3D encapsulated neural constructs, albeit to
a lesser degree compared to those found in organoid culture, these issues can be overcome
through control of cell density and scaffold geometry creation; variables that cannot be
controlled during organoid formation. An overview of some of the advantages and
disadvantages of 2D and 3D neural cell culture is shown in Fig 4-1.
Neural differentiation from pluripotent stem cells within 3D hydrogel environments
have shown promise throughout previous studies (Li et al., 2011; Lu et al., 2012; Kim,
Sachdev and Sidhu, 2013; Bozza et al., 2014) and in some instances have been shown to
enhance the efficiency and speed of neural maturation (Lu et al., 2012; Z.-N. Zhang et al.,
2016). However, little has been shown of this effect on the biomolecular process of
differentiation and maturation itself, and its effect on patterned neural subtypes that
undergo differential brain-region specific pathways of differentiation and development (as
outlined in Chapter 3). We have already shown the basis of generating both dorsal- and
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ventral-patterned neural subtypes from hiPSCs in planar culture with time-course analyses
of markers denoting post-mitotic neuronal generation, synaptic maturation, forebrain
localisation, neurotransmitter receptor generation, and gliogenesis. The downstream
neural maturation events of this hiPSC-derived NPC differentiation within 3D hydrogel
scaffolds however, remains largely unknown.

Fig 4-1: Overview of advantages and disadvantages of neural cell culture in
2D and 3D environments.
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This chapter will therefore focus on the timing of the molecular processes of neural
differentiation and maturation from hiPSCs in vitro and directly compare these markers
from neural cultures grown in 2D planar culture to those grown within a neuritogenicconducive 3D collagen hydrogel scaffold environment (as developed and assayed in
Chapter 2). The results of these assays will uncover any deviation in the efficiency of
derivation of dorsal- and ventral-patterned neural cultures in 3D compared to 2D
environments, as well as any effect of the 3D microenvironment on neural cell maturation
or neural tube patterning factors. This data will help inform future neural culture protocols
and elucidate the specific advantages (or otherwise) of neural differentiation from hiPSCs
within 3D hydrogel environments.
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4.2 Materials and Methods
4.2.1 iPSC Culture
All work in this chapter utilised the commercial human iPSC lines; ATCC-BXS0116 Human
Induced Pluripotent Stem (IPS) Cells (ATCC® ACS-1030™) and ATCC-DYS0100 Human Induced
Pluripotent Stem (IPS) Cells (ATCC® ACS-1019™). iPSCs were grown in feeder-free culture
conditions on Vitronectin XF (Stem Cell Technologies) coated 6-well tissue culture plates in
TeSR-E8 media (Stem Cell Technologies). iPSC colonies were passaged every 6-7 days with
Gentle Cell Dissociation Reagent (Stem Cell Technologies) and were re-plated with TeSR-E8
media containing the RHO/ROCK pathway inhibitor Y-27632 (10μM, Stem Cell
Technologies). Media was changed daily, except for the first day after a passage. Areas of
random differentiation within colonies were removed manually. All iPSC and neural
differentiation experiments used iPSCs below passage number 20.

4.2.2 Neural Differentiation
Dorsal neural induction of iPSCs was triggered using a monolayer dual SMAD-inhibition
protocol using commercially available STEMdiff Neural Induction Media (NIM) (Stem Cell
Technologies). Briefly, iPSCs were dissociated into single cells using Gentle Cell Dissociation
Reagent (GCDR) (Stem Cell Technologies) and plated at densities of 1 x 106 cells/well of a 6well tissue culture plate, coated with poly-L-lysine (0.01%, Sigma) & laminin (20μg/ml,
Sigma) (PLL), in 2ml NIM per well. Media was changed daily for the first 7 days of induction,
which also contained RHO/ROCK pathway inhibitor Y-27632 (10μM, Stem Cell
Technologies).
After 7 days of induction, media was changed to STEMdiff Neural Proliferation
Media (NPM) (Stem Cell Technologies) for another 7 days to trigger NPC maturation. NPCs
were passaged at Day 10 and seeded into Collagen Type I-based hydrogel scaffolds for
further differentiation and maturation within a 3D environment (see Section 4.2.3). At Day
14 post-induction, media was changed to a final neural maturation media (NMM) which
consisted of a 1:1 mix of “N2 media” and “B27 Media”. N2 media consisting of DMEM/F12
(Lonza), N2 Supplement (1x, Thermo Fisher Scientific), GlutaMAX (1x, Gibco), Non-essential
amino acid mixture (1x, Lonza), 100U/ml Penicillin and 100μg/ml Streptomycin (Gibco). B27
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media consisting of Neurobasal (Gibco), B27 Supplement (1x, Thermo Fisher Scientific), and
GlutaMAX (1x, Thermo Fisher Scientific). The combined maturation media was then
supplemented with BDNF (20ng/ml, PeproTech), GDNF (20ng/ml, PeproTech), and DAPT
(2μM, Stem Cell Technologies) to enhance neuronal differentiation and cell cycle
synchronisation of differentiating NPCs (Crawford and Roelink, 2007; Borghese et al.,
2010). Maturation media was changed every 2-3 days over the course of differentiation.
Ventral neural induction of hiPSCs followed the same protocol and media formulations as
above but with the addition of Purmorphamine (1.5μM, Stem Cell Technologies) from Day
2 to 14 post-induction. An overview of induction protocols can be seen in Fig 4-2.

Fig 4-2: Schematic representation of the protocols for parallel differentiation of
dorsal (excitatory) forebrain lineages and ventral (inhibitory) forebrain lineages
from hiPSCs. Both differentiation pathways include stepwise treatment with neural
induction media (NIM), neural proliferation media (NPM) and maturation media.
The maturation media also contained the neurotrophic factors; brain-derived
neurotrophic factor (BDNF), glial cell-derived neurotrophic factor (GDNF), and the
Notch signalling inhibitor N-[N-(3,5-difluorophen- acetyl)-l-alanyl]-S-phenylglycine
t-butyl ester (DAPT). In addition, the ventral differentiation pathway contained
purmorphamine (Pur) a small molecule agonist of the sonic hedgehog signalling
pathway.
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4.2.3 Three-Dimensional Hydrogel Encapsulation of NPCs
At Day 10 post-induction, NPCs were harvested from 2D culture plates prior to 3D hydrogel
encapsulation. NPCs were dissociated from the culture well surface with Accutase (Stem
Cell Technologies) for 5 minutes at 37⁰C. Cells were pelleted by centrifugation at 500xg for
5 minutes before resuspension in 1ml of media. Cell counts were performed using trypan
blue (Thermo Fisher Scientific) staining and quantified using a haemocytometer. Final cell
density for each cell-laden hydrogel was 1x105 cells/ml.
Collagen hydrogel scaffolds were formed with final concentrations of 0.4mg/ml
Collagen Type I from Rat Tail (Corning), 0.23x of the added collagen volume of 0.1M NaOH
(Sigma), and 1x HEPES Buffer (20mM HEPES [Sigma], 150mM NaCl [Sigma] pH 7.4), and
0.05mg/ml ECL Cell Attachment Matrix (Millipore). The working volume of the collagen
hydrogels was made up in sterile de-ionised water. Collagen and NaOH working volumes
were mixed (to trigger neutralisation) prior to addition to buffered cell suspensions. 250μl
of the hydrogel solution was added per well of a 48-well tissue culture plate to form each
scaffold for molecular analyses. 500μl of cell-laden hydrogel solution was added to a 60mm
x 15mm IVF One Well Dish (Falcon, Corning) for downstream fluorescent
immunocytochemical and confocal microscopy analyses. Scaffolds underwent gelation at
37⁰C for 30 minutes before addition of 0.5ml differentiation media per well, or 1ml media
per dish. Approximately 70% of media volume was changed every two days over the time
course of differentiation.

4.2.4 Fluorescent Immunocytochemistry and Epifluorescent/Confocal
Microscopy
Three-dimensional scaffolds for immunocytochemistry were fixed for 1 hour at room
temperature in 10% neutral-buffered formalin solution (Sigma) and permeabilised for 1
hour at room temperature in 0.5% Triton-X-100 in phosphate buffered saline (PBS) (137mM
NaCl, 10mM Phosphate, 2.7mM KCl, pH 7.4). Samples were blocked overnight at 4⁰C in 5%
goat or donkey serum (Millipore) in PBS before incubation with primary antibodies (also in
block solution) overnight at room temperature; anti-TUJ1 (Covance MMS-435P, 1:1000);
anti-MAP2 (Cell Signaling Technology 4542, 1:1000); anti-GAP43 (Millipore AB5220,
1:1000); anti-Synapsin I (Abcam ab64581, 1:1000); and anti-TBR1 (Abcam ab31940,
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1:1000). Constructs were washed three times for 1 hour each in PBS before addition of
secondary antibodies; goat-anti-mouse IgG AF488 (Invitrogen A11029, 1:2000); donkeyanti-rabbit IgG AF594 (Invitrogen A21207, 1:2000) in block solution overnight at room
temperature. Constructs were washed three more times in PBS before addition of DAPI
(Sigma) for 1 hour, for cell nuclei visualisation.
Epifluorescent images were acquired on an Olympus IX70 wide field microscope
with Spot RT Slider digital camera and Spot Advanced software, version 4.8 (Diagnostic
Instruments). Confocal image acquisition was performed using a Nikon Ti Eclipse
microscope equipped with a fully automated A1 confocal laser (A1R, Nikon) and processed
with NIS-Elements software (Nikon). Prior to acquisition, 3D constructs were transferred to
35mm Nunc Glass Bottom Dishes (Thermo Fisher Scientific).

4.2.5 Gene Expression Analysis
For cell extraction from collagen scaffolds, media was exchanged for 0.5ml maturation
media containing 0.05mg/ml Collagenase Type 1 (>125U/mg, Worthington Biochemical
Corporation) per well. Scaffold digestion took place at 37⁰C for 45 minutes prior to
trituration and centrifugation of cell pellets. Cells from five scaffolds were pooled to form
one pellet from each experimental setup. Cell pellets were stored at -80⁰C until RNA
purification.
Relative gene expression analysis was performed using quantitative polymerase
chain reaction (qPCR) methodology. Firstly, RNA was purified from frozen cell pellet
samples using the RNeasy Plus Mini Kit (Qiagen) as per the manufacturer’s instructions into
a total elution volume of 50μl nuclease free water. RNA concentration was determined
using an Ultraspec 2200 Pro Spectrophotometer (GE Healthcare Life Sciences) and RNA
integrity was confirmed by running samples on a 1% Agarose (w/v)-EtBR Tris-acetate (TAE)
buffered gel under electrophoretic conditions for 40 minutes at 80V followed by imaging
on a ChemiDoc MP (Bio-Rad) to show sharp ribosomal RNA banding.
cDNA was generated from 1μg of each RNA using the Omniscript Reverse
Transcription Kit (Qiagen) with 1μM oligo dTs (Thermo Fisher Scientific) and 1U/ml RNase
Inhibitor (Qiagen). Reverse transcription reactions took place at 37⁰C for 80 minutes in a
20μl reaction volume. On completion of the reaction, samples were further diluted with
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20μl of nuclease free water. cDNA samples were stored at -20⁰C until used in qPCR
reactions.
qPCR reactions were performed with SYBR Green PCR Master Mix (Qiagen) in 10μl
reaction volumes with 1μM of each primer set. De novo primer pairs were designed using
Primer-BLAST (NCBI) (Table 4-1). All amplicons were designed to be between 50-250bp in
length and have equivalent primer annealing temperatures.

Table 4-1: Primer pair sequences used for qPCR analysis of human iPSC-derived
neural cultures in 3D matrices.

Reactions were run on a RealPlex Mastercycler (Eppendorf) with the following
parameters: 95⁰C for 2 minutes, then 40 cycles of 95⁰C for 5s and 60⁰C for 10s, followed by
a melt curve recording. Amplicon specificity was determined via melt curve peak analysis.
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All relative expression data was normalised to HPRT1 housekeeping gene expression. Data
were analysed by the ΔΔCt method in Microsoft Excel and statistical analyses performed in
GraphPad Prism using multiple unpaired T-test analysis. Data is shown ± standard error of
the mean with significance denoted when the p-value ≤0.05. Four biological repeats were
completed for each differentiation type (dorsal/ventral) for each time point from both 2D
and 3D culture. Robust regression analysis of fold change expression data was performed in
Stata statistical software (version 15.1). Regression coefficients were maintained between
ordinary least squares (OLS) regression and those of the robust regression analysis. Raw
output tables are displayed in Section 4.5.1.
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4.3 Results
4.3.1 hiPSC-derived NPCs Differentiate and Undergo Neuritogenesis
within Three-Dimensional Collagen Scaffolds
We demonstrated in Chapter 2 that collagen (type I) hydrogel scaffolds allowed for
extensive neuritogenesis of encapsulated neural-like cells, as well as primary rat cortical
neurons (Appendix 2.5.2), in contrast to neural cells within alginate hydrogel scaffolds.
Therefore, we wished to observe whether these desired morphological changes in the 3D
collagen environment would also allow for neurite extensions during differentiation and
maturation of hiPSC-derived neural cultures.

Fig 4-3: Fluorescent immunocytochemistry of neuronal and synaptic markers of
hiPSC-derived neural cultures within 3D collagen hydrogel scaffolds after 60 days
of maturation. Cell nuclei are visualised through DAPI staining. Scale bars
represent 200μm (top three rows) and 100μm (bottom row)
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To this end, hiPSC-neural precursors were derived through adherent dual-SMAD
inhibition before seeding into collagen hydrogels at Day 10 of differentiation (see Methods
section 4.2.3). These 3D neural constructs were matured using the same maturation
protocol as 2D planar neural cultures over 60 days. Fluorescent immunocytochemical
staining of the neuronal markers β-III-TUBULIN, GAP43, and MAP2 reveal widespread
neuritogenesis and neuron-marker positive cells throughout the constructs (Fig 4-3). The
pre-synaptic marker SYNAPSIN I is also present throughout many of the derived neuronal
cells, which is suggestive of a successfully maturing neuronal population generating the
machinery necessary for functional synaptic formation.
However, simple epifluorescent microscopy is unable to capture the fully 3D nature
of the encapsulated cells and observed neuritogenesis. Therefore, confocal microscopy was
used to acquire images to show the full range of multi-planar neuronal extension and
prevalence throughout the scaffold (Fig 4-4). Dorsally-patterned neural differentiation of
hiPSCs was undertaken to generate neural cultures with a high prevalence of β-III-TUBULINpositive neuronal cells and TBR1-positive nuclei staining to better visualise the placement
of cell soma and neurites within the 3D scaffold (Fig 4-4 A). Robust neuronal cell
morphology and neurite extensions were observed throughout the cell-laden hydrogel
showing that this formulation of collagen hydrogel is conducive to neural tissue construct
formation with hiPSC-derived NPCs.
To better visualise the extent of neuritogenesis throughout the depth (Z-axis) of
the hydrogel; Z-depth colour coding of the matured hiPSC-derived neural culture was
generated to investigate the overall morphology of the neurite extensions and cell nuclei
within 3D space (Fig 4-4 B). Image stacks of approximately 40μm in depth are sufficient to
show that neurite growth occurs along all three-axes within the scaffold and that neuronal
soma are also dispersed throughout the structure.
It is also worthy of mention that although loose clusters of neural cells were
observed within the 3D constructs; tightly-packed ganglia-like structures seen throughout
planar culture of hiPSC-derived neural cells were not observed. Also, the pattern of
rounded cell aggregate formation seen within alginate hydrogels with neural cell lines
(Chapter 2), were not present within these scaffolds. Another indicator of the success of
this scaffold composition for allowing extensive neuritogenesis from hiPSC-derived
neurons.
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Fig 4-4: Confocal microscopy of dorsally-patterned hiPSC-derived neural cultures
encapsulated in 3D collagen hydrogels. (A) Immunostaining with the neuronal
marker β-III-TUBULIN (green) and the nuclei-localised early-cortical marker TBR1
(red). (B) Z-depth colour coding of the cell-laden scaffolds; β-III-TUBULIN (top row)
and TBR1 (bottom row) showing neurite extension and cell soma distribution along
all three axes. All image fields of view approximately 200μm x 200μm x 40μm.
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4.3.2 Neural Precursor Marker Expression in 2D and 3D Hydrogel
Scaffolds
To investigate whether hiPSC-derived NPCs within 3D collagen hydrogel scaffolds prompted
any differences in the propagation or maturation of the precursor population over the
time-course of differentiation, gene expression assays of NPC-specific markers were
undertaken. These assays were done to directly compare both dorsal- and ventralpatterned neural differentiation from hiPSCs in both 2D culture (from Chapter 3) and 3D
collagen hydrogel scaffolds.
The NPC marker NESTIN showed an early peak of expression (Day 20-30 of
differentiation) in all patterned neural cell populations in both 2D and 3D culture (Fig 4-5).
The levels of expression were comparable at all time points between 2D Dorsal, 2D Ventral,
and 3D Dorsal cultures. Only 3D Ventral cultures showed statistically significant increases in
NESTIN expression at Day 14 and Day 20 post-neural induction compared to the other
three culture conditions. This pattern indicates that in both 2D and 3D culture conditions,
early NPC marker expression occurs prior to a decrease over the time course of neuronal
maturation and post-mitotic differentiation. The initial induction or preservation of NESTIN
marker expression however, is much higher under ventral-patterning conditions within a
3D hydrogel environment.
The dorsal-forebrain precursor marker PAX6 displays robust upregulation in 2D
dorsal-patterned differentiation. This peaks at Day 20 of differentiation before slightly
lower but stable expression for the rest of the maturation time course. These levels of
expression were consistently and significantly higher than was seen in the ventrallypatterned neural cultures from both 2D and 3D differentiation. Interestingly, the level of
PAX6 expression within 3D Dorsal cultures did show the same early peak of upregulation,
but to a much lower level than was maintained within 2D dorsal inductions. Also, this burst
of PAX6 expression was not maintained throughout maturation, suggesting that a drop in
the number of dorsal-forebrain precursors may be taking place within 3D scaffolds (Fig 45).
The ventral-forebrain precursor marker NKX2.1 displayed almost exclusive
upregulation within ventrally-patterned neural cultures, and this ventralisation signal was
unaffected through differentiation within 3D scaffolds compared to planar culture. The
exception being a very high upregulation of NKX2.1 in 3D Ventral cultures compared to 2D
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Fig 4-5: Quantitative gene expression analyses of neural precursor markers in dorsallyand ventrally-patterned hiPSC-derived neural cultures differentiated in 2D planar
cultures and 3D hydrogel scaffolds over 60 days of differentiation. ND; Not Detected.
Data is shown as means ± S.E.M of four independent experiments. Statistical
significance is displayed relative to; 2D Dorsal (*), 2D Ventral (#), and 3D Dorsal (α). *,#,α
p≤0.05, **,##,αα p≤0.01, ***,###,ααα p≤0.001 based on unpaired two-tailed t-tests.
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Ventral cultures at Day 14 post neural induction (~8-fold higher), which mirrored the
concurrent significant upregulation of NESTIN at the same point (Fig 4-5). Ventral
patterning and propagation of ventral-forebrain precursors over the time course of neural
differentiation for the most part was unaffected and certainly not inhibited by maturation
within 3D culture environments.

4.3.3 Comparison of Neuronal and Synaptic Marker Expression
Profiles in 2D and 3D Scaffolds
To further investigate and understand the effect of neural differentiation and maturation
within 3D scaffold environments we next sought to observe the expression profiles of
canonical neuronal and axonal markers as well as pre- and post-synaptic functional
components (Fig 4-6).

Fig 4-6: Quantitative gene expression analyses of neuronal and synaptic markers in
dorsally- and ventrally-patterned hiPSC-derived neural cultures differentiated in 2D
planar cultures and 3D hydrogel scaffolds over 60 days of differentiation. Data is shown
as means ± S.E.M of four independent experiments. Statistical significance is displayed
relative to; 2D Dorsal (*), 2D Ventral (#), and 3D Dorsal (α). *,#,α p≤0.05, **,##,αα p≤0.01,
***,###,ααα p≤0.001 based on unpaired two-tailed t-tests.
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The neuronal structural marker β-III-TUBULIN displayed robust expression after 20 days of
neural differentiation, in both 2D ventrally- and dorsally-patterned neural cultures. At later
time-points this level of expression was significantly enhanced within ventral cell
populations. This pattern of increased expression under ventral-patterning was also seen
within the 3D encapsulated cultures, however, the overall level of expression was
significantly lower in cells within hydrogel scaffolds than in planar culture by later timepoints of differentiation (Day 30-60) (~3.3- to 7-fold lower) (Fig 4-6).
This difference between expression levels within 2D and 3D differentiation
strategies was less pronounced at earlier time points, suggesting that the onset of postmitotic neuronal maturation was not inhibited within 3D cultures, although further
maturation or development of increased neuronal cell numbers may be negatively
affected.
The axonal marker TAU displayed consistent upregulation over the course of
differentiation in both 2D Dorsal and 2D Ventral neural cell cultures, but again with a trend
for higher upregulation in ventral-patterned cultures. In contrast to the expression profiles
of β-III-TUBULIN in 3D Dorsal cultures, which showed restricted expression compared to 2D
Dorsal cultures; the level of TAU in 3D Dorsal culture showed a trend for constant increase
over the course of differentiation. At later time points this level of expression exceeded
that seen within 2D Dorsal differentiation (~1.7-fold higher at Day 60) but did not reach
statistical significance. Conversely, the level of TAU expression within 3D Ventral
differentiation displayed its highest peak of expression by Day 20 (significantly above dorsal
culture conditions) before showing a gradual decreasing pattern of expression until Day 60
when it became significantly lower (~3.5-fold lower than 3D Dorsal conditions), breaking
the pattern of gradual upregulation seen in other experimental conditions. This low level of
TAU expression in 3D Ventral cultures was also significantly lower than the level of
transcript obtained from 2D Ventral cultures. These data suggest that markers of
axonogenesis follow a comparable pattern and level of gene expression in 2D Dorsal, 2D
Ventral and 3D Dorsal neural cultures, but show divergently lower levels within 3D Ventral
setups, possibly indicating an inhibitory effect of axonal generation within these cultures or
retention of NPC characteristics.
The pre-synaptic marker SYNAPTOPHYSIN (SYN) from Day 30 of differentiation
onwards showed stable expression within 2D Dorsal and 2D Ventral neural cell cultures,
with a trend for higher expression under ventral-patterning. Overall expression levels of
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SYN in 3D Dorsal cultures however, were lower than their 2D counterparts at the majority
of later time points, and significantly lower at Day 30 of differentiation. From Day 30 of
differentiation onwards SYN levels in 3D Dorsal cultures were significantly lower than those
seen within 2D Ventral differentiations. After a very high peak of SYN expression at the
early Day 20 time point in 3D Ventral cultures, that was significantly higher than that seen
in any of the other experimental conditions, this too reduced to a low basal level
comparable to that seen within 3D Dorsal cultures. By Day 40-60 post neural induction, SYN
levels in both dorsal- and ventral- patterning methodologies in 3D scaffolds were
significantly lower than those seen from 2D Ventral culture (Fig 4-6).
A very similar pattern was seen when assaying the post-synaptic marker PSD95
across all 2D and 3D experimental conditions. 2D Dorsal expression levels were robustly
present after Day 20 of differentiation and remained stable over the course of
differentiation. This was also true of PSD95 gene expression levels within 3D Dorsal
cultures but with a relative expression level approximately half of that seen within 2D
Dorsal cultures, although not to a statistically significant degree. 3D Ventral cultures
showed an early expression peak of PSD95 (Day 14-20) as was seen with SYN expression,
but which lowered after 30 days of differentiation to levels comparable to those seen in 3D
Dorsal inductions. This peak of synaptic machinery transcript expression was also seen
within 2D ventrally-patterned cultures (Day 30), which may indicate a conserved
upregulation of such genes in ventralised cultures compared to those undergoing dorsal
patterning. Again however, significantly lower levels of relative PSD95 expression were
seen within 3D neural cultures than in 2D ventral cultures at more mature time points (Fig
4-6).

4.3.4 Preservation of Neuronal Subtype Patterning within 3D Hydrogel
Scaffolds
It is possible that cell-matrix interactions occurring within 3D cell-laden hydrogel
environments may have an impact on the efficacy of neural subtype patterning utilised in
this study. To observe whether the 3D cellular microenvironment influenced the
development of mature excitatory or inhibitory neuronal subtype markers (from dorsal-
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and ventral- patterning respectively) we assayed the expression profiles of markers
indicative of glutamatergic and GABAergic neuronal cell fates (Fig 4-7).
The glutamatergic marker vGLUT1 was strongly expressed from Day 20 post neural
induction in 2D Dorsal cultures demonstrating the presence of excitatory neuronal cell
populations. Expression was also seen within 3D Dorsal cultures from Day 20 of neural
induction although with a trend for lower expression levels than was seen from the default
2D induction pathway, but still significantly higher than both 2D and 3D ventral
differentiations at Day 40-50 of maturation. Basal low-level expression of vGLUT1 was
observed within both 2D and 3D Ventral cultures showing an incomplete inhibition of the
excitatory neuronal differentiation pathway, but still with significantly lower excitatory
neuronal marker expression than dorsally patterned cultures. This excitatory neuronal
marker was further suppressed within 3D Ventral cultures compared to the 2D Ventral
differentiation pathway.

Fig 4-7: Quantitative gene expression analyses of excitatory (vGLUT1 and vGLUT2) and
inhibitory (GAD67 and GAT1) neuronal markers in dorsally- and ventrally-patterned
hiPSC-derived neural cultures differentiated in 2D planar cultures and 3D hydrogel
scaffolds over 60 days of differentiation. ND; Not Detected. Data is shown as means ±
S.E.M. of four independent experiments. Statistical significance is displayed relative to;
2D Dorsal (*), 2D Ventral (#), and 3D Dorsal (α). *,#,α p≤0.05, **,##,αα p≤0.01, ***,###,ααα
p≤0.001 based on unpaired two-tailed t-tests.
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However, adherence to this divergent pattern of expression is exhibited less in the
expression level of the excitatory marker vGLUT2. The upregulation of this marker showed
more robust segregation between 2D Dorsal-patterned and 2D Ventral-patterned cultures,
with higher expression found within the former experimental condition. However,
expression levels within 3D Dorsal cell populations were lower than their 2D counterparts
and were more comparable to levels seen within ventrally-patterned cultures, although
these lower levels of expression did not reach statistical significance. Intriguingly, the Day
20 level of expression seen within 3D Ventral cultures, was comparable to that seen within
both dorsally-patterned differentiation pathways and significantly higher than the level
seen within 2D ventrally-patterned cultures. However, this high spike of vGLUT2
glutamatergic marker expression in 3D ventral cultures is not paired with an equivalent
upregulation of vGLUT1 expression (which was not detected at the same time point) (Fig 47). This is suggestive of either a transient upregulation of vGLUT2 expression in ventral
cultures that does not denote intrinsic pathway divergence or possibly the generation of an
early glutamatergic neural subset that is not maintained throughout the culture. Overall
the divergent nature of ventral- and dorsal-patterning is more apparent through vGLUT1
expression patterns than was seen with vGLUT2 expression.
The inhibitory GABAergic neuronal marker GAD67 within 2D Ventral cultures
displayed a steady upregulation during neural differentiation and maturation over 60 days.
Upregulation was also seen within the 3D Ventral-patterned cultures, albeit to a
significantly lower level than was observed in 2D (~13-fold relative expression versus ~3fold relative expression at Day 60 of differentiation). Within both 2D and 3D Dorsal cultures
the level of GAD67 was at a consistently low basal level that was significantly lower than
the expression level within the ventrally-patterned cultures throughout the latter half of
the neural differentiation pathway (Fig 4-7).
GAT1 (a GABA re-uptake transporter and GABAergic marker) expression levels
showed robust upregulation from Day 30 onwards of 2D ventrally-patterned neural
differentiation that was not observed in either the 2D Dorsal nor 3D Dorsal differentiation
pathway cultures. Unlike GAD67 expression however, 3D Ventral cultures showed almost
no GAT1 gene expression at any time-point during the differentiation process. This more
mature marker of GABAergic neuronal function may therefore be inhibited within the 3D
growth conditions of this experiment.
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As in the previous chapter, regression analysis of marker gene expression pattern
and strength can be used to determine overall comparisons between divergent growth
conditions for each marker. In this case when comparing the neuronal subtype specific
markers vGLUT1, vGLUT2 and GAD67 it can be seen that between 3D Dorsal and 3D Ventral
cultures a significantly divergent pattern of expression is recorded for both the dorsal
marker vGLUT1 and the ventral marker GAD67 (Table 4-2). However, this is not true of the
vGLUT2 regression data which shows a similar pattern between 3D Dorsal and 3D Ventral
cultures (mirroring the point-by-point t-test data above).

3D Dorsal vs 3D Ventral

Table 4-2: Table of full time-course robust regression analysis of dorsal and ventral
markers for 3D Dorsal vs 3D Ventral neural cultures. Statistical significance denoted
by * p≤0.05, ** p≤0.01, *** p≤0.001.

These data reinforce the conclusion that although patterning bias is preserved
within dorsal and ventral 3D neural culture, the overall expression of mature neuronal
subtype markers are lower in 3D growth cultures compared to 2D differentiation. This drop
in overall neuronal maturation is reflected in the lower degrees of significance seen in the
regression tables of 3D patterned cultures (Table 4-2) than is seen in 2D patterned cultures
(Fig 4-7, Table 3-2).
To better visualise the effect of the 3D growth environment on the extent of
neuronal subtype marker expression (and therefore patterned differentiation) within each
neural culture; robust regression analysis was also performed on the 2D/3D Dorsal
expression data (Table 4-3) and 2D/3D Ventral expression data (Table 4-4).
For dorsally-patterned differentiations there is no upregulation in ventrally
associated gene expression (GAD67) when growth occurs within the 3D hydrogel
environment compared to 2D planar culture (Table 4-3). This confirms that the hydrogel
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scaffold itself does not impose any ventralising factors to the embedded cells and thereby
triggering inhibitory neuronal subtype development.

2D Dorsal vs 3D Dorsal

Table 4-3: Table of full time-course robust regression analysis of dorsal and ventral
markers for 2D Dorsal vs 3D Dorsal neural cultures. Statistical significance denoted
by * p≤0.05, ** p≤0.01, *** p≤0.001.

However, the strength of induction of dorsal-specific neuronal gene expression is
inhibited within 3D Dorsal environments (Table 4-3), as is seen with the difference in
expression patterns of the dorsal markers vGLUT1 and vGLUT2. This difference is not
derived from a breakdown in the patterning events per say, but instead is reflective of
lower overall neural maturation/differentiation within this 3D environment, of which these
subtype markers are also indicative (see section 4.3.3).
This is also true when comparing the patterned 2D Ventral and 3D Ventral
expression data, which also preserve the same extent of dorsal-gene inhibition (i.e. the
same efficacy of neural patterning) but combined with an overall significantly lower
expression of ventral associated markers GAD67 and GAT1 (Table 4-4).

2D Ventral vs 3D Ventral

Table 4-4: Table of full time-course robust regression analysis of dorsal and ventral
markers for 2D Ventral vs 3D Ventral neural cultures. Statistical significance
denoted by * p≤0.05, ** p≤0.01, *** p≤0.001.
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Taken altogether this regression analysis confirms the preservation of patterning
methodologies during differentiation within the hydrogel scaffolds, and that the scaffold
itself does not elicit any patterning influence over the embedded cells. However, there is a
strong consistent repression of neuronal subtype marker expression within both dorsal and
ventral 3D cultures, which is also reflected in canonical neuronal marker expression.
Therefore, under these 3D conditions; neuronal patterning is preserved but tied to
inhibition of neural maturation.

4.3.5 Cortical Marker Expression Profiles in 2D versus 3D Culture
Neural morphogen patterning of hiPSC-derived NPCs does not generate specific neuronal
subtypes in isolation, but instead does so by recapitulating temporo-spatial coordinates of
neural tube localisation. Therefore it is necessary to uncover whether the maturation
events of dorsal-forebrain identity (corticogenesis) are preserved, accelerated or altered
under maturation in 3D hydrogel scaffolds. To this end, gene expression profiles of the
early-to-late born cortical markers REELIN, TBR1, CTIP2 and SATB2 were analysed in all four
neural differentiation conditions (Fig 4-8).
REELIN expression is a marker of the pioneer outer layer I of the cortex and an early
marker of cortical development. The greatest upregulation of this gene was seen within 2D
Dorsal cultures with peak expression after 30 days of neural differentiation but with
maintenance of expression up until Day 60. It also showed upregulation within 3D Dorsal
cultures although to a much lower extent. At Day 30 the relative expression in 2D was 8fold higher than expression in 3D Dorsal cultures, but by Day 40 to 50 of differentiation this
difference in expression dropped to below 2-fold. Expression of REELIN in both 2D and 3D
ventral-patterned cultures was consistently lower than is seen in the dorsal inductions,
especially after protracted periods of neural maturation, but expression was not
suppressed entirely. Even within positively expressing dorsal cultures, high variability of
expression between biological repeats was prevalent.
This overall pattern was repeated when observing the expression of cortical preplate and layer VI cortical marker TBR1 over the course of differentiation (Fig 4-8). Robust
gene expression was limited to 2D Dorsal cultures with a significant peak around 30 days of
differentiation followed by a steady decrease until Day 60. Recorded expression of TBR1 in
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3D Dorsal culture was consistently lower than in 2D, ranging from approximately 8.5-fold to
5.4-fold reduced relative expression across the course of differentiation. As with REELIN,
ventrally-induced neural cultures (both 2D and 3D) showed the lowest expression levels of
TBR1, although did maintain a minimal expression level.

Fig 4-8: Quantitative gene expression analyses of early and late cortical-specific markers
in dorsally- and ventrally-patterned hiPSC-derived neural cultures differentiated in 2D
planar cultures and 3D hydrogel scaffolds over 60 days of differentiation. ND; Not
Detected. Data is shown as means ± S.E.M. of four independent experiments. Statistical
significance is displayed relative to; 2D Dorsal (*), 2D Ventral (#), and 3D Dorsal (α). *,#,α
p≤0.05, **,##,αα p≤0.01, ***,###,ααα p≤0.001 based on unpaired two-tailed t-tests.

Intriguingly, the expression profiles of the layer V cortical marker CTIP2 and the
late-born upper layer II-IV cortical marker SATB2 break from the pattern described above
and showed enhanced levels of expression within 3D Dorsal cultures compared to the 2D
Dorsal inductions (Fig 4-8).
CTIP2 expression in 2D and 3D Dorsal cultures were at approximately equivalent
levels over Days 20-40 of differentiation, but increased by Day 60 within the 3D Dorsal
populations to a level over 7-fold higher than that seen in 2D Dorsal cultures at the same
time point. Levels of CTIP2 gene expression within either of the ventrally-patterned culture
conditions remained lower than those seen within dorsal cultures at every measured time
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point. However, the low relative transcript expression increases only reached significance
after 60 days of differentiation relative to 3D Dorsal cultures (Fig 4-8).
At all assayed time points the upper-layer late-born neuronal cortical marker SATB2
displayed a trend for higher relative expression levels in 3D Dorsal rather than 2D Dorsal
cultures (~2 to 4-fold higher) (Fig 4-8). No noticeable upward trend of expression level was
discernible along this timeline of neural maturation that would follow with the expected
timeline of late-born cortical neuron generation. As with the majority of dorsal-anterior
cortical markers, the expression level of SATB2 within both 2D and 3D Ventral cultures
were barely detectable at any of the time-points assayed. The high variability of expression
levels within dorsally patterned biological repeats hints at the possible stochastic nature of
the development of these subpopulations of cortical cell types between differentiations.
However, regardless of this spread of cortical marker strength, for all four markers
analysed, all showed stronger expression profiles in the dorsally-patterned neural cultures.
To confirm the separation of cortical localisation markers between the 3D Dorsal
and 3D Ventral growth environments, we once again used regression analysis of the gene
expression data to compare overall pattern divergence (Table 4-5).

3D Dorsal vs 3D Ventral

Table 4-5: Table of full time-course robust regression analysis of cortical localisation
markers for 3D Dorsal vs 3D Ventral neural cultures. Statistical significance denoted
by * p≤0.05, ** p≤0.01, *** p≤0.001.

For all of the early-to-late cortical markers analysed, strong significant differences
in expression pattern are maintained between 3D Dorsal and 3D Ventral cultures. All of
these markers are indicative of cortical or pre-cortical neuronal localisation and dorsal
forebrain development. Therefore the strong presence of these cortical markers in
dorsally-patterned, but not ventrally-patterned, 2D and 3D neural cultures (Fig 4-8, Table 45) confirm the preservation of dorsal identity within the hydrogel environment, and that
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the 3D scaffold itself does not infer any localisation specification onto the encapsulated
cells.
To observe whether the 3D environment itself has a negative impact on cortical
marker expression (as was seen with neuronal subtype genes in Section 4.3.4) we repeated
the robust regression analysis of cortical localisation gene markers between 2D Dorsal and
3D Dorsal differentiations (Table 4-6).

2D Dorsal vs 3D Dorsal

Table 4-6: Table of full time-course robust regression analysis of cortical localisation
markers for 2D Dorsal vs 3D Dorsal neural cultures. Statistical significance denoted by
* p≤0.05, ** p≤0.01, *** p≤0.001.

Intriguingly, the “early” cortical markers REELIN and TBR1 do show significant
differences in the magnitude and pattern of expression between 2D and 3D Dorsal
differentiation. This is also seen with the “late” cortical marker SATB2. No significant
difference was observed in the expression pattern of the “mid”-onset cortical marker
CTIP2. These differences in expression pattern between 2D and 3D Dorsal inductions are
not simply a reduction in each overall gene transcription, as was seen for the neuronal
subtype markers. Instead the expression of the “early” markers are lower in the 3D
cultures, whereas the “late” cortical marker is significantly enhanced.
To ascertain whether the repression of anterior-dorsal cortical markers is
maintained in 3D encapsulated ventrally-patterned cultures, we reproduced the regression
analysis above for 2D Ventral and 3D Ventral neural cultures (Table 4-7). For all of the
cortical regionalisation genes, with the exception of TBR1, no significant differences in
cortical marker upregulation is seen in the 3D Ventral cultures. The differences flagged by
this analysis for TBR1 expression denotes higher expression within 2D Ventral cultures than
3D, which still confirms the conclusion that the hydrogel scaffold does not enhance dorsal
gene expression patterns or limit the ventral patterning efficacy. Instead this difference,
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although significant, is still based on expression levels far below those seen within planar
dorsally-patterned cultures (Fig 4-8).

2D Ventral vs 3D Ventral

Table 4-7: Table of full time-course robust regression analysis of cortical localisation
markers for 2D Ventral vs 3D Ventral neural cultures. Statistical significance denoted
by * p≤0.05, ** p≤0.01, *** p≤0.001.

The combination of all cortical marker regression data does reinforce the
conclusion that dorso-ventral regionalisation is strongly maintained within the 3D
patterning differentiation methods utilised here. In addition to this, no evidence of
repressed ventralisation within the hydrogel scaffold was observed in the pattern of
cortical-specific genes. There were however differences in the magnitude of cortical gene
expression from planar dorsal cultures and 3D Dorsal cultures showing that hydrogel
embedding may elicit an effect on cortical cell maturation rates.

4.3.6 Effect of 3D Culture on Neurotransmitter Receptor Expression
Another aspect of neural cell maturation that may differ between planar and 3D
encapsulated neural inductions is the prevalence of neurotransmitter receptor
development, as a precursor to excitatory and inhibitory synaptic function.
The ionotropic GABA receptor subunit GABAAR1 showed a late-onset upregulation
of expression in both 2D Dorsal and 2D Ventral neural cultures, with a bias of elevated
expression within the latter (Fig 4-9). However, this pattern was not preserved with 3D
Dorsal and Ventral neural inductions which displayed reduced expression in 3D Dorsal
cultures relative to both 2D culture types with a 4-fold and 7.5-fold decrease in expression
compared to 2D Dorsal and 2D Ventral cultures respectively. The upregulation of this
receptor subunit was seen strongly within 2D Ventral inductions but were barely
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detectable in 3D Ventral cell populations at any time point during differentiation (Fig 4-9).
At Days 40-60 of differentiation, the GABAAR1 expression level in 3D Ventral cultures was
significantly lower than that observed in 2D Ventral cultures at equivalent timepoints.
In contrast, the metabotropic GABA receptor subunit GABABR1 displayed
upregulation earlier in the time-course of neural differentiation than GABAAR1. Consistent
and robust expression of GABABR1 was observed in both 2D Dorsal and 2D Ventral cultures
with a trend for approximately double the expression within ventrally-patterned cultures
than in dorsal ones from Day 30 onwards (Fig 4-9). Spikes of GABABR1 expression at Day 14
and 20 of differentiation were seen within 3D Ventral cultures that at the latter time point
were 3- to 5-fold higher than in the other three culture conditions (p≤0.01 to p≤0.001). This
early increase, at the time-point indicative of initial neuronal formation, then lowered to
comparable levels seen within 2D induction conditions (and even lower by Day 60).
Following the same pattern of 2D Ventral and Dorsal cultures, 3D Dorsal expression of
GABABR1 was consistently lower than that seen in 3D Ventral cell populations.

Fig 4-9: Quantitative gene expression analyses of GABA and glutamate neurotransmitter
receptor subunit markers in dorsally- and ventrally-patterned hiPSC-derived neural
cultures differentiated in 2D planar cultures and 3D hydrogel scaffolds over 60 days of
differentiation. ND; Not Detected. Data is shown as means ± S.E.M. of four independent
experiments. Statistical significance is displayed relative to; 2D Dorsal (*), 2D Ventral
(#), and 3D Dorsal (α). *,#,α p≤0.05, **,##,αα p≤0.01, ***,###,ααα p≤0.001 based on unpaired
two-tailed t-tests.
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The overall relative expression level observed within 3D Dorsal cultures did remain steady
over the course of differentiation, but at a level constantly lower than the other three
neural induction conditions (Fig 4-9).
When assaying the gene upregulation of the ionotropic glutamate receptor
subunits NMDAR1 and AMPAR1, the same spike of high expression within 3D Ventral
cultures after 20 days of differentiation is observed, similar to that seen with GABABR1
expression. For both AMPAR1 and NMDAR1 expression this early spike rapidly dropped
over the time-line of differentiation to levels significantly below that seen in 2D culture
conditions for NMDAR1 expression, or comparable to 2D culture conditions in the case of
AMPAR1 (Fig 4-9). NMDAR1 expression levels within 2D Dorsal cultures remained stable
over every time-point from Day 20 of neural maturation, while a gradual upregulation over
time was observed with 2D Ventral cultures (from 4-fold less than 2D Dorsal expression at
Day 20 up to a 2-fold significantly higher expression by Day 60). 3D Dorsal expression levels
of NMDAR1 followed a similar pattern to that seen with GABABR1 expression, with gene
expression levels 2- to 10-fold less than those recorded in 2D Dorsal cell populations. By
Day 60 of differentiation, both 3D patterned neural cell cultures showed significantly lower
expression of NMDAR1 than 2D Ventral cultures (Fig 4-9).
This same pattern was seen with AMPAR1 expression but less starkly than was
observed in NMDAR1 expression analyses. By Day 50-60 of differentiation, similar levels of
AMPAR1 expression was observed in 2D Dorsal, 3D Dorsal and 3D Ventral cultures, with an
approximate 2-fold elevation in 2D Ventral cell populations. Earlier in the differentiation
timeline (Day 20-30), the level of 3D Dorsal expression again remained stable but lower
than that recorded in 2D Dorsal populations. Both 2D and 3D Ventral patterned cultures
displayed slight trends for elevated AMPAR1 glutamate receptor expression than neural
populations undergoing dorsal-patterning.

4.3.7 Gliogenesis within 3D Scaffolds
Gliogenesis in utero is delayed relative to neuronal differentiation, and this pattern is
recapitulated in neural differentiation pathways from pluripotent stem cells in vitro. To
study whether neural differentiation of hiPSCs within 3D hydrogel environments affects the
induction strength of astroglial and oligodendroglial cell lineages, or the timing of such
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molecular events relative to 2D, we studied the gene expression profiles of the astrocytic
marker GFAP and oligodendroglial lineage marker GALC (Fig 4-10).
The astrocytic marker GFAP did indeed display a robust delay of upregulation in
comparison to the neuronal-specific markers analysed above, with detectable expression
levels only later in the maturation timeline (Day 50 to 60 of differentiation). The level of
GFAP expression was increased within both 3D Dorsal and 3D Ventral cultures relative to
both 2D neural induction cell populations, with statistically significant higher levels of
expression in 3D Ventral cultures. By Day 60, 3D Dorsal neural populations displayed
significantly higher levels of GFAP expression compared to 2D dorsally-patterned cell types.

Fig 4-10: Quantitative gene expression analyses of astroglial (GFAP) and
oligodendroglial (GALC) markers in dorsally- and ventrally-patterned hiPSC-derived
neural cultures differentiated in 2D planar cultures and 3D hydrogel scaffolds over
60 days of differentiation. ND; Not Detected. Data is shown as means ± S.E.M. of
four independent experiments. Statistical significance is displayed relative to; 2D
Dorsal (*), 2D Ventral (#), and 3D Dorsal (α). *,#,α p≤0.05, **,##,αα p≤0.01, ***,###,ααα
p≤0.001 based on unpaired two-tailed t-tests.

Interestingly, the expression of the oligodendroglial lineage marker GALC did not
appear to be affected by neural differentiation strategies in either 2D or 3D environments
and showed relatively stable expression levels over the full time-course of differentiation
(Fig 4-10). Only in 3D Ventral cultures did the level of GALC expression show maintenance
at significantly lower levels than 2D differentiation pathways. This is surprising, as the
development of oligodendrocytes would logically follow the same pattern as astroglial
generation, with a protracted (and intrinsic) delay following neuronal differentiation.
However, this stable expression profile may represent basal levels of GALC within nonoligodendroglial cell types (including neurons), and extended maturation times may be
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necessary to show strong gene upregulation indicating true oligodendrocyte formation. The
trend of overall lower levels of expression in 3D Ventral cultures may indicate an increased
population of neuronal rather than glial subtypes compared to other differentiation
strategies, or an inhibition of oligodendroglial precursor identity within the 3D culture.

4.4 Discussion and Conclusions
To fully model neurological development and in vivo-like cytoarchitecture in vitro, many
studies have focused on the generation of various 3D environments for neural cell
encapsulation. These aim to mimic the biophysical and biochemical properties of native
neural tissue. The reported advantages of such 3D neural cell culture systems would allow
for enhanced cell-cell contacts ( e.g. synapse formation) along all three axes, as well as
greater degrees of cell-matrix interaction allowing for cell migration and possible selforganisation (LaPlaca et al., 2010). Differentiation of iPSCs into neural lineages in various
3D hydrogel environments has been linked with enhanced markers of differentiation, and
has been successfully used for migration-defect modelling of neurons from neurological
pathologies (Z.-N. Zhang et al., 2016; Gu et al., 2017). However, direct comparisons of
neural differentiation between 3D and 2D planar culture, and the effect of 3D hydrogel
environments on dorsal- and ventral-patterned encapsulated NPCs in parallel, has not been
explored.
In this chapter we have shown that hiPSC-derived NPCs differentiated in 3D
collagen hydrogel scaffolds undergo extensive neuritogenesis. This is consistent with the
finding detailed in Chapter 2; with neurite formation from neural-like cells encapsulated
within collagen scaffolds. These neurites extend in all three-axes of the hydrogel
environment and display markers of post-mitotic neuronal identity and pre-synaptic
molecular machinery. Previous studies have shown that neural cell electrophysiological
activity is preserved within collagen hydrogel matrices (O’Connor et al., 2000; Ma et al.,
2004), so such neuritogenesis as described here is integral for the maturation of functional
synapses between neuronal cells in this microenvironment.
The NPC marker NESTIN, shows comparable levels of expression when hiPSCderived neural cultures are differentiated in 2D Dorsal, 2D Ventral and 3D Dorsal
environments over 60 days. However, NESTIN expression early in differentiation (Day 14176

20) within 3D Ventral cultures is significantly higher than is observed in all other
experimental conditions (~3.6-fold higher at Day 14 and ~2.4-fold higher at Day 20). This
suggests a higher level of NPC induction within 3D encapsulated ventrally-patterned neural
cultures. This early spike of NPC induction is reflected by higher levels of the ventral
forebrain precursor marker NKX2.1 at early time points within 3D Ventral cultures relative
to 2D Ventral conditions. This pattern is not seen for dorsal-patterned cultures, in which
PAX6 levels are not enhanced within cells cultured in a 3D environment. This suggests that
this 3D environment enhances ventral NPC generation, but does not enhance default
dorsal precursor cell pools. Importantly, the effect of 3D collagen encapsulation did not
appear to alter the patterning of encapsulated cells. That is to say, the effect of the
patterning molecule purmorphamine is not inhibited through cell growth and
differentiation in hydrogels. Also, the biophysical composition of the hydrogel itself does
not appear to adversely affect the dorsal/ventral NPC developmental pathway. This is in
opposition to primarily Matrigel-based hydrogel scaffolds that can alter downstream
neuronal subtype composition through inherent signalling molecule content (Shimada et
al., 2012; Ni et al., 2013).
When observing markers of neuronal maturation such as β-III-TUBULIN; 2D and 3D
growth environments appear to elicit comparable levels of this marker at early time points
of neural differentiation (Day 14-20). However, this level drops to significantly lower levels
in both 3D Dorsal and Ventral cultures relative to 2D inductions for the remainder of neural
maturation. This may be due to either an inhibition of maturation of post-mitotic neuronal
cells within the 3D environments or a possible inhibition of the NPC-to-neuronal transition
event, leading to a retention of immature NPC characteristics. This 2D and 3D segregation
is less defined when looking at the axonal marker TAU, in which only 3D Ventral cultures
show lower expression levels by later timepoints of maturation. Interestingly, the pre- and
post-synaptic markers SYN and PSD95 display early peaks within 3D Ventral cultures (Day
14-20) that dissipate over the remainder of neural maturation to levels below those
recorded in 2D culture. This may be indicative of an initial acceleration of ventral neural
differentiation in 3D culture that is not maintained for the time course of differentiation
and maturation. This effect, however, is limited to ventrally-patterned 3D cultures as no
such early peak (or indeed elevation) of neuronal or synaptic markers is observed in 3D
Dorsal neural cultures at any assayed time point. It may then be possible that these 3D
hydrogel environments may elicit both enhancing and diminishing effects on hiPSC-derived
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neural maturation dependant on the early patterning and neural tube regionalisation of the
starting NPC pool.
As with NPC patterning specificity, dorsal- and ventral-derived forebrain
localisation markers are also preserved within 3D hydrogel environments. The early- and
late-born cortical markers REELIN, TBR1, CTIP2 and SATB2 are all present in 2D and 3D
Dorsal cultures. REELIN and TBR1 expression levels however, were lower in 3D Dorsal
cultures compared to 2D differentiation, whereas CTIP2 and SATB2 (late born cortical
markers) showed higher expression profiles. Limited expression of these dorsal markers
was seen in either 2D or 3D Ventral neural cultures. The segregation of these dorsalassociated cortical markers between the dorsal and ventral patterned cultures is also
confirmed through regression analysis of each pattern of marker expression for the whole
time-course of differentiation. It is interesting to note that the raw patterning segregation
of these dorsal regionalisation markers is preserved within 3D dorsally-patterned cultures,
but that differences in early- and late-born cortical markers are apparent. It is possible that
the enhanced upregulation of CTIP2 and SATB2 within 3D microenvironments may be due
to biophysical interactions with the hydrogel itself, or a possible acceleration of late-born
cortical neurogenesis at the expense of prolonged early-born cortical cell identity (REELIN
and TBR1). In either case, the patterning of dorsal and ventral neural cell localisation
identity appears preserved within this 3D hydrogel system.
Excitatory and inhibitory neuronal subtype patterning was also shown to be
unaffected by differentiation within the hydrogel environment through robust regression
analysis of marker gene expression patterns between all of the growth conditions. The
excitatory neuronal subtype marker vGLUT1 is highly expressed in 2D Dorsal neural culture
but shows more restricted expression within neural cells in 3D Dorsal culture. Even so, the
level of expression in dorsally-patterned neural cultures is still higher than that observed
under ventral patterning, showing the preservation of excitatory/dorsal neuronal identity.
This is also reflected in the upregulation of the GABAergic ventral neuronal marker GAD67,
which shows steady upregulation in 2D Ventral cultures during maturation. GAD67
expression is also observed within 3D Ventral neural cultures although, as with vGLUT1, to
a lower level than is recorded from 2D planar culture. This is much more apparent with the
GABAergic marker GAT1 which shows significantly lower levels of expression in 3D Ventral
cultures compared to 2D. A possible explanation of this finding may be related to ideas
discussed above, by which the 3D environment appears to be having an inhibitory effect on
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the rate of neural maturation. This may be due to an interaction with the biomaterial itself,
or possibly an issue related to relative cell densities between 2D and 3D environments. Cell
seeding densities within this study were selected on the basis of maximising construct size
without generating scaffolds that would have a negative impact on cell viability through
restrictive diffusion of oxygen and nutrients. However, a truer in vivo-like developmental
environment would require higher cell densities to be more neural tissue-like, which may
positively impact neural cell differentiation. To overcome this, other studies have utilised
restricted construct size to counterbalance cell death from high cell densities (Frampton et
al., 2011), cultured 3D constructs within perfusion devices to keep pace with the metabolic
demands of encapsulated cells (Cullen et al., 2007), and generated 3D bioprinted
constructs that enable higher surface area exchange of oxygen and nutrients (Gu et al.,
2017).
This restriction of maturation within 3D environments was also observed when
looking at molecular markers of neurotransmitter sensitivity. By later time points of neural
differentiation and maturation, cells cultured within both 3D environments displayed
generally lower levels of the neurotransmitter receptor markers GABAAR1, GABABR1,
NMDAR1, and AMPAR1. Although this restriction was most pronounced in the expression
profiles of GABAAR1 and NMDAR1. Interestingly, after 20 days of differentiation, 3D Ventral
cultures displayed the same strong peak of expression for NMDAR1, GABABR1 and AMPAR1
as was seen for SYN and PSD95 expression. It is surprising that both pre- and post-synaptic
machinery transcripts seem to be preferentially upregulated in 3D Ventral environments
rather than 3D Dorsal ones early in neural differentiation. This initial burst of expression
may be related to an accelerated differentiation profile, before cessation during more
protracted timelines of differentiation, and one that appears specific to ventrally-patterned
NPCs within 3D hydrogels. However, this does not hold true for markers of
neurotransmitter generation and uptake (GAD67 and GAT1) which conversely show more
restricted expression in 3D Ventral environments than 2D Ventral counterparts. It may be
concluded therefore that 3D encapsulation in biomaterial scaffolds can have differential
effects on separate elements of neural differentiation and maturation, rather than
complete enhancement of all neural differentiation markers. This effect also appears
dependent on the type of patterned NPC pool, as ventrally- and dorsally-patterned
precursors responded differently to the same 3D environment.
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Finally, the generation of astrocytic glial lineages does appear to be influenced
through 3D hydrogel encapsulation compared to planar culture. Both 3D Dorsal and Ventral
neural cell types displayed higher levels of the astrocyte marker GFAP by Day 60 of
differentiation than is seen in either 2D culture. It is also possible that the 3D environment
elicits a pro-glial environment for NPC differentiation, or may even accelerate intrinsic
developmental timings that regulate the gliogenesis in vivo.
In conclusion, we have shown that 3D collagen hydrogel environments are
conducive to neural cell neuritogenesis of encapsulated hiPSC-derived NPCs. Neural
differentiation and maturation markers are expressed during this 3D differentiation, but in
many cases, are directly comparable or reduced relative to 2D planar differentiation. 3D
Ventral differentiation did appear to show accelerated markers of neural maturation
through early expression spikes of canonical neuronal and synaptic markers, that were not
seen in 3D Dorsal culture. From these data, it appears as though differentially patterned
pools of NPCs demonstrate differing effects on gene expression from growth in the same
3D environment. This would impact the formation of neural tissue constructs derived from
dorsal and ventral lineages within these 3D scaffolds, with such discrepancies influencing
the formation of any representative native tissue cellular composition.
The lack of sustained expression of maturation markers observed may be due in
part to lower cell densities within the 3D culture system resulting in reduced overall cellcell contact number than when compared to dense 2D neural cultures. Thus, high cell
densities may be key to recapitulate and enhance neural differentiation in 3D but must
overcome limitations in maintaining cell viability through restricted diffusion of oxygen and
nutrients. Therefore, methods of generating bioprinted neural-tissue constructs (using
biomaterials utilised in Chapters 2 and 4) that can maintain high neural cell densities, will
be the focus of the next chapter.

4.4.1 Summary of Chapter Findings


hiPSC-derived NPCs differentiating within 3D collagen type I scaffolds undergo
neuritogenesis in all three axes throughout the hydrogel over 60 days of
differentiation.
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3D encapsulated neural cultures express protein markers of post-mitotic neuronal
generation as well as pre-synaptic machinery.



Neural differentiation in 3D collagen hydrogel scaffolds does not affect the efficacy of
patterning morphogens to generate dorsal- and ventral-derived neural lineages.



Enhanced NPC marker expression was seen within ventrally-patterned neural cells but
not with dorsally-patterned neural cultures when encapsulated in 3D hydrogel
environments.



3D Ventral cultures show early peak expression of neuronal and synaptic markers
significantly above the levels of 2D cultures and 3D Dorsal neural cultures.



By later time points of differentiation: neuronal, axonal and synaptic marker expression
are lower in 3D microenvironments than in 2D planar culture, suggesting an inhibition
of maturation.



Excitatory and inhibitory neuronal subtype marker expression are preserved in
dorsal/ventral patterning in 3D environments, but with lower levels of expression than
is seen in planar differentiation.



Dorsal cortical localisation markers are observed in both 2D and 3D Dorsal neural
cultures. In 3D scaffolds however, early-cortical markers (REELIN, TBR1) display
expression profiles lower than in 2D differentiation, and late-cortical markers (CTIP2,
SATB2) show enhanced expression relative to 2D Dorsal cultures.



The ionotropic GABA-receptor GABAAR1 shows limited expression in both 3D Dorsal
and 3D Ventral neural cultures.



3D Ventral neural cultures show significantly high expression spikes of GABABR1,
NMDAR1 and AMPAR1 neurotransmitter receptor subunits, not seen in 3D Dorsal
differentiation. By later time points of maturation, these markers tend to show lower
expression in 3D cultures compared to 2D differentiation.



Neuronal generation is not limited within 3D hydrogel scaffolds, but functional
maturation does appear to be restricted under these experimental conditions.



Astrocytic gliogenesis is enhanced in 3D differentiation environments compared to 2D
cultures.
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4.5 Appendix
4.5.1 Robust Regression Analysis Output Tables
To further statistically verify the segregation of neural subtype patterning markers between
dorsally-patterned and ventrally-patterned cultures (in both 2D and 3D) we undertook
robust regression analysis for the pattern and magnitude of each subtype marker gene
(Sections 3.3.4, 4.3.4, and 4.3.5). The raw output statistical tables for each pair-wise
comparison and each gene marker are displayed in the figures below.

Appendix Fig 4-11: Robust regression analysis output tables for glutamatergic (dorsal)
neuronal cell identity genes vGLUT1 and vGLUT2. Data set being compared to in each
table is displayed on the left-hand side. Highlighted rows contain outputs used in
compiled results tables in Chapters 3 and 4.
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Appendix Fig 4-12: Robust regression analysis output tables for GABA-ergic (ventral)
neuronal cell identity genes GAD67 and GAT1. Data set being compared to in each table
is displayed on the left-hand side. Highlighted rows contain outputs used in compiled
results tables in Chapters 3 and 4.
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Appendix Fig 4-13: Robust regression analysis output tables for early cortical-specific
regionalisation (dorsal) neuronal cell identity genes REELIN and TBR1. Data set being
compared to in each table is displayed on the left-hand side. Highlighted rows contain
outputs used in compiled results tables in Chapters 3 and 4.
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Appendix Fig 4-14: Robust regression analysis output tables for late-born corticalspecific regionalisation (dorsal) neuronal cell identity genes CTIP2 and SATB2. Data set
being compared to in each table is displayed on the left-hand side. Highlighted rows
contain outputs used in compiled results tables in Chapters 3 and 4.
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Chapter 5: Development of Bioinks for
Neural Tissue Bioprinting

5.1 Introduction
Many potential advantages of in vitro neural tissue development within 3D culture systems
have been outlined above (Chapter 4) and are well documented across other sources
(LaPlaca et al., 2010). The construction of natural or synthetic cellular microenvironments,
such as those within hydrogel scaffolds, allow for the recapitulation of in vivo-like spatial
geometry, cell-cell communication and cell-matrix interactions. However, the use of simple
hydrogel encapsulation of neural cells has implicit limitations. Cell densities within the
constructs must not exceed the rate of oxygen and nutrient diffusion available, and
therefore the more “tissue-representative” the cellular content, the smaller the size of the
construct must be to avoid cell death. As is seen in Chapter 4, this critical cell density may
be necessary for adequate neural cell maturation and development of function. Certain
techniques have been utilised to overcome this limiting factor through the use of perfusion
devices (or so-called “brain-on-a-chip” devices) by which to maximise the available
concentrations of nutrients and the removal of metabolic waste products (Cullen et al.,
2007; Pamies, Hartung and Hogberg, 2014; Moreno et al., 2015).
As well as issues with controlling nutrient diffusion, the cytoarchitecture within
hydrogel scaffolds is difficult to modify manually, with the cells, in many cases, distributed
evenly throughout the construct prior to gelation. Therefore, controlled deposition or
assembly of different cellular pools is extremely difficult in basic encapsulation methods.
Neural organoid culture can show incredible recapitulation of early-neurological structures
derived from intrinsic self-organisation, and do so strongly when embedded within
hydrogel scaffolds (Lancaster et al., 2013; Kelava and Lancaster, 2016), however, the same
issue of low diffusion rates of nutrients (even within bioreactors) leads to the formation of
necrotic cores and inherent size limitations of each organoid.
To retain the intrinsic advantages of 3D neural cell culture, but to overcome the
disadvantages of limited nutrient diffusion (or small construct size) and tighter control over
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cell subtype segregation and placement, many research projects are now focused on the
development of additive fabrication technologies to generate neural tissue in vitro (Thomas
and Willerth, 2017; Knowlton et al., 2018). This process, termed “bioprinting”, is based
around the use of 3D-printing technology by which to accurately generate 3D
cytocompatible tissue-like structures in a controlled temporo-spatial manner.
The scaffolds used for such bioprinting techniques are termed “bioinks”, which may
also be a class of hydrogels, but are distinguished through the bioink’s ability to form and
retain a filamentous morphology during the printing process. The ability to retain such
shape fidelity allows for the design of custom topologies and complex structural elements.
Unlike simple hydrogel encapsulation, which may only form a solid block of tissue-like
scaffold, bioprinting can generate complicated geometries, may be formed from multiple
bioinks, and contain structural elements to enhance the construct’s tissue-like properties
(Kang et al., 2016). Certain aspects of cell positioning and placement within simple hydrogel
in vitro neurological models, such as the layering of the cortex using hydrogel moulds and
microfluidic devices, have been elegantly accomplished (Kunze et al., 2011; Odawara,
Gotoh and Suzuki, 2013). However, the level of tailoring of construct parameters through
these methods suffers from low resolution and require long periods of development.
Scaffold designs for bioprinting, on the other hand, can be developed in silico and redesigned extremely quickly. An example of an in silico designed output and a 3D-printed
product can be seen in Fig 5-1.

Fig 5-1: An example of an in silico 3D-printable design (left) that can generate
complex structures from hydrogels through 3D printing technology (right).
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By creating specific geometries within the bioprinted construct, it is also possible to
generate patterns of pseudovasculature that not only allow for improved access of
encapsulated cells to oxygen and nutrients, but by doing so, allow for the scaling-up of
hydrogel scaffolds into sizes relevant for human tissue research or regenerative therapy
(Kang et al., 2016). The use of bioprinting therefore combines the advantages of basic 3D
hydrogel culture with the ability to generate larger and more cell-dense in vitro models.
A critical aspect of any bioprinting methodology is the selection (and potential
modification) of bioinks to make them amenable to the 3D-printing extrusion process as
well as being tolerated by encapsulated neural cells. Cytocompatibility is of paramount
importance when generating 3D cell-laden constructs and so not only in the base state
must a bioink be non-cytotoxic to cells, but any associated cross-linking gelation processes
must also be non-damaging (Knowlton et al., 2018).
Methacrylate groups are a common additive to polymer backbones as a way of
inducing controlled covalent crosslinking and gelation of hydrogels. This process
predominantly utilises photoinitiator compounds that generate free radicals under
exposure to ultraviolet (UV) light that consequently react and chemically-bond adjacent
methacrylate moieties. Such crosslinking has been used extensively with the biomaterials
methacrylated gelatin (GelMA) (Thomas and Willerth, 2017) and hyaluronic acid (HAMA)
(Z.-N. Zhang et al., 2016). Hydroxyphenylpropionic acid (HPA) conjugated gelatin (GelHPA)
also crosslinks in the presence of free radicals, but rather than UV-activated
photoinitiators, can be catalysed through the reaction products of hydrogen peroxide and
horse radish peroxidase (M. Hu et al., 2009). Care must be taken however when optimising
the exposure of cell-laden bioinks to UV irradiation and free radical generation as both are
known to have pronounced cytotoxic effects (Williams et al., 2005; Mironi-Harpaz et al.,
2012). Bioinks derived from non-mammalian polysaccharides also have precedent as
scaffolds for bioprinted neural tissue engineering, with ionic crosslinking either following or
as a continuous process during bioprinting (Lozano et al., 2015; Gu et al., 2017), with no
discernible negative effect on encapsulated cell types.
As well as the cytocompatibility of biomaterials for 3D tissue-engineering, bioinks
should display an array of physical characteristics, that in broad terms, combine to define
the “printability” of the material. Multiple methodologies of biomaterial printing have
shown promise in generating cell-laden biomaterial scaffolds, although the main three
techniques are inkjet-based printing, laser-assisted printing, and extrusion printing
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(Knowlton et al., 2018). By far the most common however, is extrusion-based printing. This
involves the mixing of cells and bioink prior to deposition through pressurised nozzles or
needles. This fabrication technique allows for the rapid and large-volume deposition of cellladen and/or acellular biomaterial scaffolds. For extrusion-based bioprinting to be
successful, the printability of bioinks is dependent on various material characteristics. The
physical traits necessary for the generation of extrudable bioink formulations include;
appropriate viscosity; non-Newtonian shear-thinning or thixotropic qualities; and retention
of filament fidelity prior to crosslinking.
The viscosity of bioinks allows for the retention of design fidelity following
extrusion from the nozzle. Therefore, extrudable bioinks must have viscosities that are high
enough to maintain a free-standing shape, as well as being necessary for multiple layers to
be printed and stacked on top of each other to generate 3D topographies. Candidate
bioinks with too low a viscosity will lose shape resolution and be unable to form true 3D
scaffolds. Another desired trait of extrudable-bioinks is for the biomaterial to display shearthinning or thixotropic qualities. This is a non-Newtonian pseudoplastic behaviour by which
viscosity decreases under shear strain. In essence, this can be seen as transitioning the
bioink to a more liquid-like state during the pressure-driven extrusion process, but after
deposition, rapidly regains highly viscous characteristics. A bioink with high degrees of
shear-thinning will result in lower levels of shear stress being generated under extrusion,
which is advantageous for cell-laden bioinks, where high degrees of shear stress can have
negative effects on cell survivability (Blaeser et al., 2016). Bioink compositions can also be
modified to alter properties of viscosity; such as the addition of glycerol to modify the
extrusion characteristics (Kang et al., 2016); as well as controlling the temperature of
extrusion apparatus which can directly affect bioink printability (Chung et al., 2013).
This Chapter will focus on the development of bioinks and bioprinting techniques
that allow for extrusion-based bioprinting of neural cells. The biomaterials used as a basis
for these bioinks will be those assayed previously in Chapters 2 and 4, namely alginate and
collagen type I. From Chapter 2 we demonstrated that neural cells encapsulated in alginate
scaffolds retain high cell viability, but restricted neuritogenesis, whereas collagen type I
hydrogels were conducive to neuritogenesis and hiPSC-derived neural differentiation
(Chapter 2 and 4). This section of research will explore methods of utilising alginate within
acellular components of a neural construct, with collagen forming the cell-laden and
neuritogenic-conducive elements of the bioprinted scaffolds. After preliminary
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development of biomaterial formulations, we also investigate the use of coaxial bioprinting
as a mechanism of segregating structural and cell-laden components of the bioink scaffold.
This mechanism of coaxial bioprinting is based on previously reported hand-held
bioprinting of precursor cartilage tissue (Duchi et al., 2017).
This Chapter therefore aims to combine the findings from all previous chapters and
to derive a usable neural-conducive bio-printable scaffold system by which to generate
neural-tissue constructs from in silico designs.
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5.2 Materials and Methods
5.2.1 Preparation of Bioinks
The biomaterials used in this chapter are; Sodium alginate (Sigma); Collagen Type I
(Millipore); Hyaluronic acid (HA, Xi’an Rongsheng Biotechnology); Gelatin from bovine skin
(Sigma); and CELLINK Start (CELLINK) as a “gold standard” extrusion printable material. For
acellular extrusion assays, all dry-mass biomaterials were reconstituted in distilled water
with percentages denoting w/v measurements. Samples were kept at 37⁰C until fully
dissolved and mixed through trituration to ensure even dispersal. Fully dissolved materials
were stored at 4⁰C until used. Acellular collagen bioinks were composed of a 0.4mg/ml final
concentration derived from a commercially available stock solution, working
concentrations were generated through dilution in distilled water.

5.2.2 Bioprinting
Bioprinting design G-Code was written de novo in a basic word processing software and
visualised using an online G-Code simulator (https://nraynaud.github.io/webgcode). All
bioprinting utilised the INKREDIBLE+ printer system from CELLINK (Fig 5-2). Bioinks were
loaded into 3cc dispensing cartridges and extruded through a 25-gauge (0.25mm internal
diameter) nozzle tip (Nordson EFD).

Fig 5-2: Image of the INKREDIBLE+ Bioprinter utilised for
all bioprinting experimental work outlined in this
chapter.
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Extrusion pressure for each bioink formulation was adjusted to maximise a smooth
extrusion of material. Extrusion pressures varied from 5kPa for low viscosity materials up to
140kPa for highly viscous bioinks. All materials were printed at room temperature, with the
bioinks allowed to equilibrate to room temperature prior to printing. The printing substrate
surfaces used were 25mm x 75mm standard microscope slides, as a simple way to handle
and image the printed structures. All macroscopic images were captured with a Nikon
D3400 DSLR camera and processed in ImageJ software (NIH).
Shape fidelity assays were qualitative assessments of each bioink to recapitulate an
in silico spiral design (20mm x 16mm) and therefore a measure of the viscosity and bioprintable qualities of each bioink. String test assays were used as an indirect measure of
printability by examining not only the base bioink viscosity, but also the cohesive nature of
the material relating to shape fidelity (Schuurman et al., 2013). Biomaterials that formed a
droplet under extrusion were said to have failed the test, whereas materials that formed
strings over 10mm long during extrusion were more likely to generate better formed
printed constructs. The layer stacking test is another measure of a biomaterial’s ability to
stack upon itself following extrusion, as a precursor to fully realised multi-layer 3D scaffold
printing. Bioinks that failed to adequately stack layered filaments of a 15mm x 15mm
square were discounted from further testing.

5.2.3 Coaxial Bioprinting
For coaxial bioprinting, a specialised coaxial extrusion nozzle, previously developed for
cartilage tissue engineering (Cornock et al., 2014; O’Connell et al., 2016; Duchi et al., 2017)
was utilised. This nozzle was attached to two of the 3cc bioink cartridges used above, and
was then fastened to the INKREDIBLE+ print stage. An image of the coaxial system used is
seen in Fig 5-8.
For the shell material, a mixture of alginate (3%): gelatin (5%) was found in monoaxial tests to generate a bioink with acceptable shape fidelity, string printability and
filament stacking attributes under acceptable extrusion pressures. Both components were
mixed together vigorously within a 5ml syringe (BD Biosciences) attached to the 3cc bioink
cartridge, after warming to 37⁰C to minimise viscosity. The cell laden core material was
composed of final concentrations of 0.4mg/ml collagen type I (neutralised with 0.23x of the
added collagen volume of 0.1M NaOH, Sigma), 1% (w/v) HA, and 1x HEPES (20mM HEPES
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[Sigma], 150mM NaCl [Sigma] pH 7.4). The remaining volume was composed of growth
media containing neural cells. Final cell density within the core bioink was 2x106 cells/ml.
For acellular core/shell testing, the cells were replaced with fluorescent red latex beads
(0.5μm) (Sigma) used at 10μl per ml of core material, and with DMEM (Gibco) used in place
of growth media. All manipulation of materials was done under aseptic conditions in tissueculture facilities and sterile laminar flow hoods. Extrusion pressures for core and shell
material components were 12kPa and 50kPa respectively.
The crosslinking of alginate components of the shell material was done post-print
with a sterile 200mM CaCl2 solution (Sigma). Scaffolds were left to crosslink at room
temperature for 3 minutes, prior to scaffold transfer to 6-well tissue culture plates with 3ml
of growth media per well. Cells were then cultured at 37⁰C and 5% CO2 in standard cell
culture incubators. Differentiation within the printed scaffolds was monitored over 7 days,
with differentiation media changed every 2 days.

5.2.4 Cell Culture
The murine NSC-34 neural cell line (obtained courtesy of the Intelligent Polymer Research
Institute) was used for the assessment of cell survival and neural differentiation within
bioprinted structures generated in this chapter. The short time-frame of induced
differentiation enabled rapid assessment of the cell-laden bioprinted structures. Briefly,
cells were cultured in a proliferation media composed of DMEM (Gibco), 10% FBS (Gibco),
2mM L-Glutamine (Gibco), 100U/ml Penicillin and 100μg/ml Streptomycin (Gibco). Cells
were cultured in 75cm2 tissue culture coated flasks and were passaged using a 0.025%
Trypsin Dissociation Buffer for 5 minutes at 37⁰C. Differentiation of NSC-34s was triggered
using a differentiation media composed of DMEM (Gibco), 2% Horse Serum (Gibco), 2mM
L-Glutamine (Gibco), 100U/ml Penicillin and 100μg/ml Streptomycin (Gibco),
For cell harvesting prior to addition to the core bioink, cells were harvested
through trypsin dissociation (as above) and pelleted at 400xg centrifugation for 5 minutes.
Cells were resuspended in 1ml proliferation media, with an aliquot utilised for manual cell
count estimation using trypan blue dye (Thermo Fisher Scientific) on a haemocytometer.
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5.2.5 Viability Assay
For assays of cell viability, the fluorescent dyes Calcein-AM (Life Technologies) and
Ethidium Homodimer (Life Technologies) were used to establish the proportion of living
and dead cells respectively, within printed cell-laden scaffolds. Briefly, media around the
constructs was exchanged for DMEM containing 1μM Calcein-AM and 1μM Ethidium
Homodimer. The constructs were left to incubate at 37⁰C and 5% CO2 for 1 hour. The dyeladen media was then exchanged for differentiation media prior to imaging.

5.2.6 Fluorescent and Live Cell Imaging
Live cell imaging was achieved through visualisation on an EVOS XL Cell Imaging System
(Thermo Fisher Scientific), with images processed with ImageJ software (NIH).
Imaging acquisition of fluorescent bead-loaded core constructs and fluorescentlylabelled cell viability assays was performed on an Olympus IX70 wide field microscope with
Spot RT Slider digital camera and Spot Advanced software, version 4.8 (Diagnostic
Instruments).
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5.3 Results
5.3.1 Assessment of Unmodified Alginate and Collagen Hydrogels as
Bioinks
Previous work has shown that neural cells encapsulated within collagen hydrogels of low
mass content, will undergo extensive neuritogenesis during differentiation (Chapters 2 and
4). Cell-laden alginate hydrogel scaffolds retain many cytocompatible characteristics,
display storage moduli comparable to native neural tissue, but are non-conducive to
neurite extensions under assayed conditions (Chapter 2). However, the generation of a
multimodal neural tissue construct whereby the support structure is supplied by one
biomaterial and the cell-laden component by another, would allow for more complex
scaffolds to be formed.
Using unmodified alginate and collagen in the concentrations known to be
cytocompatible with encapsulated neural differentiation in cast-gel scaffolds, these
biomaterial formulations were assayed for their printability in comparison to a
commercially available 3D printable water-soluble ink.
Compared to the programmed print design, both alginate and collagen candidate
bioinks at these formulations failed to maintain any filament integrity during the printing
process (Fig 5-3). Each biomaterial displayed a viscosity similar to that of water, and as
such, after printing were unable to maintain a filamentous shape, and instead combined
into an amorphous pool of biomaterial. When compared to the Cellink Start material,
which demonstrated high pattern fidelity and retention of filament shape, these basic
alginate and collagen formulations would be unsuitable for the generation of free-standing
neural tissue scaffolds.
Under extrusion from the bioprinting nozzle, both the alginate and collagen
hydrogels formed only droplets, whereas the viscous cohesive nature of the Cellink Start
generated a flowing “string” that reached over 10mm in length. This string test has been
used previously as a qualitative measure of a bioink’s propensity to form free-standing
filamentous structures (Schuurman et al., 2013). Under these assay conditions, again the
alginate and collagen formulations evaluated here would fail to demonstrate appropriate
printability markers as usable bioinks.
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Fig 5-3: Pattern fidelity and string test assays of collagen and alginate bioinks at low
concentrations. When compared to the Cellink Start material, both alginate and
collagen hydrogels fail to retain the printed filamentous design or generate flowing
“strings” under extrusion (black arrow head). Scale bars represent 10mm.

As well as shape fidelity and string formation, another useful assay is the
demonstration of multi-layer stacking properties of bioinks.
An in silico designed 15mm x 15mm four-layered square was used as a basic assay
of filament stacking properties. The Cellink Start ink formed a strong recapitulation of the
programmed design shape, and demonstrated the ability to stack filaments in ordered
layers (Fig 5-4). However, as with the pattern fidelity assays, both collagen and alginate
hydrogels at these concentrations failed to form not only the basic shape pattern, but could
not stack on themselves vertically, akin to other non-viscous fluids (Fig 5-4).
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Fig 5-4: Layer stacking assay of collagen and alginate bioinks at low concentrations.
Cellink Start-based inks form a faithful recapitulation of input design (top panel) and
allow for true 3D stacking of multiple printed layers. Collagen and alginate hydrogels
simply pool after printing and do not display any layer stacking properties. Scale bars
represent 10mm.

5.3.2 Modification of Alginate and Collagen Bioinks to Improve
Printability
We have shown above that collagen and alginate bioinks in the formulations necessary for
in vitro neural tissue formation in solid cast-gel formats, are unsuitable for bioprinting
purposes. However, certain concentrations and formulations of these inks may have
positive effects on printability characteristics without negatively impacting
cytocompatibility and permissiveness to neural tissue generation.
Using alginate as simply a structural support hydrogel in downstream neural tissue
construct fabrication would utilise its strengths of cytocompatibility and inert cellular
interactions, but not rely on encapsulated neural cell differentiation and neuritogenesis.
For this reason, multiple alginate concentrations were assayed for the printability assays
outlined in the previous section. Alginate hydrogels at 2% (w/v) displayed higher viscosities
than the lower 0.5% (w/v) concentrations and as such maintained a better, although still
poor, filamentous pattern fidelity after extrusion printing (Fig 5-5). However, this
concentration of alginate still failed to generate a “string” under free-standing extrusion.
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When concentrations of alginate were increased to 8% (w/v) the recapitulation of the
printed pattern design was far greater than was seen with lower concentrations. However,
even at this very high alginate hydrogel solution, an incomplete string formation was
observed and layer stacking tests tended to collapse shortly after printing has completed
(Fig 5-5). It is also worth noting that manipulations of this high concentration alginate
hydrogel were difficult due to its high level of viscosity as a solution, hence increasing
alginate concentrations beyond 8% (w/v) was not possible.

Fig 5-5: Pattern fidelity, string test, and layer stacking assays of multiple
alginate hydrogel concentrations. Increasing concentrations of alginate have
positive effects on pattern fidelity, but are unable to form continuous strings
or stack adequately during printing. Scale bars represent 10mm.

Collagen scaffold production with increased levels of collagen concentration may
allow for enhanced bioprinting characteristics, however, these higher concentrations may
have detrimental effects on neural differentiation and neuritogenesis within the scaffolds,
as reported previously (O’Connor et al., 2001). Composite hydrogels formed from other
soluble mammalian polymers however, may allow for the formation of a bioprinted
construct but elicit a non-damaging effect on encapsulated neural cells and the gelation of
the collagen fibrous network.
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Fig 5-6: Pattern fidelity, string test and layer stacking assays of hyaluronic acid (HA)
and collagen composite hydrogels. (A) Increasing the concentration of HA
generates greater shape fidelity and string formation compared to base collagen
hydrogels. (B) Layer stacking even with higher concentrations of HA shows limited
height and compression of printed layers. Scale bars represent 10mm.

The addition of the mammalian anionic glycosaminoglycan hyaluronic acid (HA) to collagen
hydrogels did dramatically increase all measures of printability (Fig 5-6). Composite
hydrogels of 2% (w/v) HA and collagen showed much stronger pattern fidelity than was
seen with collagen hydrogels alone, although such a blend did not generate an extruded
string of over 10mm and retained droplet-like morphology during extrusion. When the
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concentration of HA was increased to 4% (w/v), a noticeable increase in the sharpness of
the printed pattern was seen and the extruded bioink did form a free-standing string (Fig 56 A).
Layer-stacking of multiple filament layers was also improved by the addition of
higher concentrations of HA (Fig 5-6 B), although neither of these formulations generated
stacked structures to the same degree as was seen with Cellink Start ink (Fig 5-4). Printed
structures derived from HA and collagen hydrogel composites are a promising source of
modifying collagen bioinks to make them more amenable to bioprinting technologies.
However, the non-crosslinked and soluble nature of the HA component of the ink, together
with low stacking characteristics would necessitate the use of a secondary structural
element by which to contain and protect and collagen scaffold undergoing gelation in an
aqueous environment.
As base alginate bioinks, even at high concentrations, have poor string formation
and layer stacking qualities, other strategies must be developed to generate printable
forms of this biomaterial. As HA was used to modify the viscosity and printing
characteristics of collagen hydrogels, we next demonstrated the use of gelatin composites
within alginate hydrogels to modify bioink traits (Fig 5-7). Gelatin is a hydrolysed form of
collagen type I, and the use of gelatin as a component of bioinks, has widespread
precedent throughout the literature (Chung et al., 2013). Even small amounts of gelatin
were shown to have profound effects on bioink printability and the extrusion pressure
necessary to print the bioinks. 2% alginate and 2% gelatin composite inks showed low
pattern fidelity and droplet formation during extrusion, but both parameters were slightly
improved when alginate concentration was increased to 4% (Fig 5-7 A). The pressures
necessary to extrude these materials increased only slightly from 8kPa to 13kPa. A vast
improvement in print fidelity and string formation was seen with bioinks composed of 4%
alginate and 4% gelatin, although with considerable lag in the extrusion deposition of the
material and lag after the ceasing of the extrusion pressure. This was seen by the absence
of bioink filament in the lower left point of the spiral design (the print origin point) and the
slight pooling of material in the centre of the spiral design (the print endpoint) (Fig 5-7 A).
This increase in bio-printable characteristics with increased gelatin concentration was also
accompanied with an increased necessary extrusion pressure (56kPa).
Further increasing the gelatin concentration to 6% with 2% alginate did increase
the resolution of the printed design, and demonstrated string formation during extrusion.
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However, this bioink lost characteristics of smooth filament formation and demonstrated
traits of over-gelation that required high extrusion pressures to print (~140kPa). This stiff
gel-like bioink did perform very well in the layer stacking assay (Fig 5-7 B), but its inability to
print smoothly and consistently would be disadvantageous in downstream neural tissue
engineering applications. A composite blend of 3% alginate and 5% gelatin bioink
demonstrated high print pattern fidelity, string formation and relatively good layer stacking
properties, and as such was chosen as the candidate structural alginate bioink formulation
for a component of coaxial neural tissue bioprinting.

Fig 5-7: Bioprinting characteristics of alginate and gelatin composite bioinks.
(A) Pattern fidelity and string test assays of each blended material. (B) Layer
stacking assays of each biomaterial composition. Scale bars represent 10mm.
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5.3.3 Formation of Neural Tissue Constructs Using Coaxial Bioprinting
As well as mono-axial bioprinting techniques, where a single material is deposited in a
single filament; coaxial printing methodologies can combine two separate bioink
formulations into a single extruded strand. Its applicability to neural tissue engineering
relates to the generally low viscosity, low modulus hydrogels conducive to neural cell
differentiation being unsuitable for the majority of free-standing extrusion bioprinting
processes shown above. However, by separating a neural cell-laden “core” material that
maintains the appropriate modulus and biophysical interactions to allow for neural
differentiation to take place, and surrounding it concentrically with a “shell” material that
maintains the structural support and pattern fidelity of the bioprinted scaffold, then de
novo neural tissue scaffolds can be designed.
To accomplish this, we utilised a coaxial printing nozzle that was generated through
selective laser melting of titanium 6Al4V alloy. This coaxial system was developed internally
and has been utilised for precursor cartilage bioprinting (O’Connell et al., 2016; Duchi et al.,
2017). The “shell” material chosen for coaxial printing tests was a 3% alginate and 5%
gelatin composite bioink (A3G5), as determined by the positive printability characteristics
displayed in Section 5.3.2. Initial “core” material tests for bioprinting capabilities used a
coloured water solution in place of a bioink to assess the stability and sealed nature of the
core/shell structure. However, the low viscosity core continuity was easily disturbed
through the printing process (data not shown) and so future experiments utilised a collagen
(0.4mg/ml) and 1% HA core material in order to represent the true printing format of
neural cells and increase the viscosity of the core to a level that would not be disrupted
through the bioprinting process (Fig 5-8).
These bioink formulations extruded through the coaxial nozzle maintained
segregation of core and shell components and could generate free standing string
formations (Fig 5-8 A). Furthermore, this process could derive coaxial printed scaffolds to a
pre-determined two-layer print design and maintained the core/shell separation (Fig 5-8 B).
Following in situ crosslinking, the printed scaffold could be handled easily. This was also
seen after 24 hours in cell culture conditions at 37⁰C. This retention of integrity was due to
the alginate component of the shell bioink which retained ionic crosslinking properties in
cell culture media, whereas the non-crosslinked nature of the gelatin component would
undergo gel-sol transition at physiological temperatures. Steric entanglement of gelatin
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molecules within the alginate scaffold however, may act to retain some gelatin
composition.

Fig 5-8: Coaxial bioprinting of 3% alginate/5% gelatin shell materials and collagen/HA
core materials. (A) Coaxial separation of core and shell is maintained throughout the
printing process together with string formation. The geometry of the coaxial nozzle is
also shown. (B) Bioprinting of the coaxial bioink formulations can be made to specific
design patterns that maintain structural integrity. Scale bars represent 10mm.

To further demonstrate the segregated nature of the core and shell elements after
the printing process, the core material was combined with fluorescently-labelled beads
while the shell material was left “empty”. Fig 5-9 shows that 24 hours after printing and
maintenance in cell culture conditions, fluorescent beads were present only in the core of
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each coaxial filament. The total filament size ranged from 1-2mm in diameter with the core
representing approximately 500-750μm of this width. This process has therefore generated
a construct in which the core biomaterial composition could not ostensibly be generated
into a multi-layer bioprinted construct using conventional mono-axial printing alone. But
through the combination of a non-cytotoxic structural support material and coaxial design,
successful generation of a large-scale scaffold can be generated.

Fig 5-9: Demonstration of core/shell filament formation from coaxial bioprinting.
The core material was mixed with fluorescently-labelled beads (Red) to show
separation of core and shell bioinks. Images were taken 24 hours post-print. Scale
bars represent 500μm.

The next element of study for coaxial neural tissue bioprinting was to assay
whether encapsulated neural cells retained viability after the formation of bioprinted
scaffold or underwent irreparable damage in the extrusion process. A neural cell line was
encapsulated in physiologically buffered core material of the same composition as assayed
above. Coaxial bioprinting of the cell-laden core and shell material was completed to the
same design as seen in Fig 5-8. A Calcein-AM and Ethidium homodimer cell viability dye
assay demonstrated a very high proportion of viable cells four days post-print (Fig 5-10,
Green), whereas cells displaying positive ethidium homodimer fluorescence (dead cells)
were barely present throughout the construct. This illustrates that the coaxial printing
process itself, crosslinking process, and maintenance in neural cell differentiating
conditions does not have detrimental effects on cell survival.
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Fig 5-10: Cell viability assay of encapsulated neural cells in coaxial bioprinted
structures. Calcein-AM staining of viable cells are shown in green, whereas
ethidium homodimer staining (red) highlights dead cells. All cells were loaded
in the core of the construct. BF; Bright field. Scale bars represent 500μm.

Finally, after demonstrating high retention of neural cell viability within the core of
the bioprinted construct, it was necessary to determine whether neural differentiation
characteristics such as neuritogenesis was also preserved within this collagen-based core
material. Live cell imaging of the scaffolds after one week of neural differentiation
displayed widespread neuritogenesis of cells within the construct (Fig 5-11). The neurites
extended into the core biomaterial itself and were not restricted to cellular aggregates,
displaying the successful interaction between the neural cells and the encapsulating matrix.
This not only demonstrates the efficacy of bioprinting a structurally sound neuraltissue construct from multiple bioinks, but that principles of neural cell differentiation,
within conducive hydrogel scaffolds in simple cast-gel formats, can be translated into
bioprinting methodologies.
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Fig 5-11: Live cell imaging of encapsulated neural cells undergoing
neuritogenesis within the bioprinted core material after 7 days of
differentiation. The neural cells displayed widespread propensity for neurite
extensions (white arrow heads). Scale bars represent 50μm.

5.4 Discussion and Conclusions
The rise of bioprinting technology as a catalyst for tissue-engineering and regenerative
medicine studies in recent years has generated much hope for the future of personalised
medicine (Zhang et al., 2017). Compared to standard 3D encapsulation-based cell culture,
bioprinting of cells in tailored biomaterials has many advantages to its use. Through the
printing of cell-laden filaments in particular arrangements it has been shown that a
pseudovasculature-like system can be generated that allows for extensive nutrient and
oxygen diffusion in large, clinically-relevant sized 3D constructs (Kang et al., 2016). This is
an inherent limitation in simple cast-gel cell culture techniques where an increase in
scaffold volume limits the surface area by which to adequately diffuse nutrients. This also
limits possible cell densities within these constructs, as cell density is increased to tissuelike levels, so does the demand for oxygen and metabolic components. To obtain 3D neural
cell cultures with cell densities approaching that of native tissue, the only way of achieving
this in static culture is to limit construct size (Frampton et al., 2011).
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The ability to design and control bioprinted scaffold complexity not only allows for
tissue-like cellular composition and increased overall size of the scaffolds, but can also form
complex structures that recapitulate elements of native-tissue morphology. For the printing
of neural tissue, this has included the laminar layered composition of the cortex (Lozano et
al., 2015). As well as the ability to mimic tissue composition and structure, such bioprinting
techniques could be used to segregate or combine specific neural cell types within the
same construct, but in a controlled manner. This would mirror the mixing of glial and
neuronal lineages in iPSC-derived neural functionality assays (Odawara et al., 2016).
Successful reports of neural tissue extrusion-bioprinting are beginning to increase
in frequency, with a wide array of polysaccharide- and protein-based polymers utilised in
the production of neural tissue constructs (Thomas and Willerth, 2017; Knowlton et al.,
2018). However, the biomaterials used within these positive reports tend to lack high
filament resolution or display limited interaction between embedded neural cells and the
hydrogel scaffold i.e. low neuritogenesis. Here we have shown that biomaterial
formulations shown to be conducive to positive neural differentiation and neuritogenesis in
simple cast-gel formats (Chapters 2 and 4) were not amenable to the generation of freestanding bioprinted neural constructs. As such, we focused on the modification of these
materials by which to attempt to maintain positive neural cell viability and differentiation
but also allow for the printability of the scaffolds.
Low concentration alginate and collagen scaffolds failed all used printability tests
including pattern fidelity, string formation and multi-layer stacking. Even at very high
alginate concentrations (8% w/v) this material failed to adequately generate a freestanding string under extrusion and was unable to stack layered filaments without collapse
and pooling. Pattern fidelity in a single layer did show promise, although this is not enough
to conclude that base alginate alone is a suitable bioink. This mirrors similar methods of
alginate bioprinting that form either composite blends with gelatin (Chung et al., 2013) or
other polysaccharide polymers (Gu et al., 2017).
Preliminary tests of blending the mammalian glycosaminoglycan hyaluronic acid
(HA) within collagen hydrogel formulations, did improve markers of printability. Pattern
fidelity and string formation was greatly improved with 4% w/v addition of HA, albeit with
lower multi-layer stacking outcomes. However, the soluble and non-crosslinked nature of
HA within these scaffolds and the inherent increase in viscosity generated may adversely
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affect scaffold stability under long term cell culture conditions and the ability of neural cells
to undergo neuritogenesis in this modified collagen-based biomaterial.
To overcome this limitation, we employed the use of coaxial bioprinting, by which
to segregate a neural-conducive inner core collagen-based biomaterial, and an outer shell
support material based on alginate hydrogel formation. This coaxial technology has already
been utilised to generate precursor cartilage tissue through separation of stabilising
supporting material and the cell-laden biomaterial cargo, although with different bioink
formulations (O’Connell et al., 2016; Duchi et al., 2017). Composite blends of alginate and
gelatin bioinks were assayed for their printability characteristics and a final formulation
that appeared promising for bioprinting applications was deduced (3% alginate and 5%
gelatin concentration). This was combined with a modified collagen-based core material,
that contained a 1% HA concentration to slightly increase bioink viscosity, to make it more
amenable to the flow characteristics of coaxial extrusion bioprinting.
Assays of the combined coaxial printing process demonstrated clear separation of
shell and core during extrusion, and a maintenance of free-standing string formation.
Coaxial printing of an in silico designed two-layer grid pattern was recapitulated by the
printing process, and the core/shell segregation was maintained throughout the printed
construct. Ionic crosslinking of the alginate polymer within the shell material, through
addition of calcium cations, resulted in a construct that could be handled and manipulated
easily by hand. The gelatin component of the shell bioink was non-crosslinked into the
hydrogel itself and undergoes sol-gel transition at physiological temperatures. However,
after 24 hours within cell culture growth conditions (37⁰C, 5% CO2) the structural integrity
of the construct was maintained. This demonstrates that the alginate component of the
shell is widespread and robust enough after crosslinking to maintain scaffold shape fidelity,
even after the possible solubilisation of the gelatin portion of the shell bioink. It is also a
possibility that some level of gelatin retention is enabled through steric entangling of the
gelatin and alginate chains during crosslinking. Either outcome is non-detrimental, as
residual gelatin components would add to the stability of the construct, whereas any
solubilised gelatin may increase the porosity of the shell hydrogel and allow for increased
levels of nutrient diffusion. That being said, further work will need to be undertaken to
ensure the stability of the scaffold during differentiation assays of hiPSC-derived neurons,
that takes place over the course of months and not days. However, this initial data is a
promising result in this endeavour.
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The maintenance of core/shell separation was further shown after printing through
the use of fluorescently-labelled beads that indicated the location of core printed material.
This result demonstrates the limited mixing and of core and shell components during the
printing process and shows the limited turbulence generated under this method of coaxial
bioprinting.
To determine how these bioink formulations and the coaxial printing process itself
affected encapsulated neural cell viability, bioprinted constructs containing a neural cell
line were produced to the same specifications as the bead-loaded scaffold. After four days
post-printing, an assay of cell viability of the encapsulated neural cells revealed almost
complete retention of living cells within the core bioink. This demonstrates that not only is
the printing process itself amenable to high levels of cell survival, but as is the crosslinking
process and the diffusion level of nutrients within the scaffold. Such a result is integral for
forming constructs of increased cell density approaching that of native neural tissue.
Another implication of this result is that the level of shear stress imposed on the
encapsulated cells during the extrusion printing process is well tolerated. High shear stress
has previously been shown to have detrimental effects on cell survival (Blaeser et al.,
2016), which is not seen under these bioprinting conditions.
Finally, to ensure that the collagen-based core bioink retained its ability to support
neuritogenesis of encapsulated neural cells under differentiation conditions, we assayed
whether neurite extension occurred after 7 days of neural differentiation within the
coaxially printed scaffold. Live cell imaging did reveal neuritogenesis throughout the core of
the scaffolds which indicates the favourable neural differentiation conditions within this
core bioink formulation. Comparing this outcome to other published (although limited)
neural-tissue bioinks would give valuable information on the practicality and efficacy of this
bioink for neural tissue engineering.
Taken together, these data show the development of a coaxial format of
generating self-supporting 3D bioprinted neural tissue scaffolds. Each element of the core
and shell bioinks could further be tailored depending on design specifications or desired
printing resolution, but form a strong foundation stone on which future bioprinted neural
constructs can be fabricated. The retention of neural cell viability and the ability to undergo
neuritogenesis within these scaffolds are a key factor in the progression of these
techniques and must be at the forefront of future bioink formulations. The cell-based
functionality of the desired tissue type is the true goal of experiments such as these, and so
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a bioink that retains highly printable characteristics but loses cell functionality is an
unacceptable outcome.
Projected future work from these experimental findings would be far reaching, but
ultimately crucial to the development of higher resolution neural tissue models. Long term
culture of such scaffolds must be shown to maintain sufficient integrity for confluent neural
tissue formation to take place. The effect of temperature controlled extrusion can have
striking repercussions on the printing characteristics of bioinks (Chung et al., 2013) and may
be yet another method of modifying scaffold formation and resolution.
Furthermore, assessing the limits of cell densities possible within designed
scaffolds such as this, will allow for the formation of more brain-tissue representative in
vitro modelling practices. By combining this technology with long-term differentiation of
hiPSC-derived neural cultures it will begin to be possible to generate more tailored and
representative tissue morphologies that ultimately will push forward the frontiers of
modern neuroscience.

5.4.1 Summary of Chapter Findings


Low concentration collagen and alginate hydrogel solutions show poor bioprinting
traits.



Increasing alginate concentrations has positive effects on pattern fidelity of a single
printed layer but displays limited string formation and poor filament stacking
properties.



Composite bioinks of collagen and hyaluronic acid show improved bioprinting traits,
although the soluble nature of hyaluronic acid and increased viscosity of the bioink
would make them poor single component bioink for neural tissue engineering.



Alginate and gelatin composite bioinks show differential printing characteristics heavily
dependent on concentration and ratio to each other. A 3% alginate and 5% gelatin mix
was found to have promising properties for a bio-printable material.



Coaxial printing of a collagen-based core material designed to be amenable to neural
cell differentiation, and an alginate-gelatin shell bioink surrounding the core adding to
the structural integrity of the scaffold, was developed.
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Core/shell separation was conserved throughout the printing process and could form
two-layer in silico designed grid structures.



Acellular versions of the scaffold construct could be handled manually, and maintained
structural integrity after storage under physiological conditions.



Separation of core and shell biomaterial components was demonstrated through
fluorescent-bead loading of the core material, which displayed continued core/shell
separation after maintenance at 37⁰C.



Neural cell encapsulation and growth within the bioprinted core component of the
coaxial scaffold demonstrated the retention of high cell viability by day four postprinting.



Neuritogenesis was prevalent by day 7 of differentiation post-print within the coaxial
scaffold. Demonstrating conduciveness to neural differentiation within the core
collagen-based bioink.
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Chapter 6: Overall Conclusions and
Future Directions
The broad aim of this thesis was to study and develop multiple aspects of in vitro threedimensional forebrain neural tissue constructs from human stem cells. The main
components of this goal were to; assay and analyse candidate biomaterial hydrogels as
potential cell carriers for neural cell differentiation; to successfully differentiate and
compare markers of neural maturation of dorsal and ventral forebrain neural cell identities
from hiPSCs; to demonstrate the effects of a pro-neuritogenic hydrogel scaffold on hiPSCneural differentiation; and lastly, to modify and develop bioprinting techniques that allow
for the generation of 3D neural tissue constructs through additive fabrication technologies.
Stem cell lineage specification is known to be driven strongly by the substrate
stiffness of the materials in contact with the cells (Engler et al., 2006). Neural tissue
modelling applications have therefore benefitted from matching the moduli of cell culture
substrates to those of native brain tissue (Banerjee et al., 2009; Teixeira et al., 2009;
McKinnon, Kloxin and Anseth, 2013). In this body of work, both alginate- and collagen type
I-based candidate hydrogels displayed storage moduli lower than that recorded for native
brain tissue, and both preserved cell viability of neural cells after encapsulation and over
the course of differentiation. However, only collagen-based scaffolds allowed for
neuritogenic events to occur. Alginate hydrogels covalently modified with neural matrix
metalloproteinase (MMP)-cleavable motifs and laminin-binding moieties also failed to
induce neurite extension morphology, although did elicit changes in neural marker protein
expression, demonstrating a direct effect of hydrogel composition and modification on
protein expression during neural differentiation. As a further direction of research, it would
be valuable to assay whether other functionalisation groups (such as other MMP-sensitive
motifs) elicit a similar effect on encapsulated neural cells, or whether modified reaction
conditions, that would generate higher degrees of functionalisation, may overcome the
steric hindrance imposed by the alginate environment and allow neuritogenesis to occur. In
a similar vein, it would be crucial to understand whether this process is indeed relative to
the covalently-bonded peptide moieties themselves, or whether the loss of carboxyl-
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groups used for the carbodiimide chemistry, impacts polymer chain ionic-crosslinking. It is
possible that this effect mimics the sub-stoichiometric conditions seen in recent positive
polysaccharide hydrogel neural tissue studies (Palazzolo et al., 2015). Indeed, it is entirely
possible that a synergistic effect between restricted ionic cross-linking sites and native
peptide motifs may take place.
Some canonical neuronal marker expression profiles did show upregulation during
the differentiation of encapsulated neural cells, but this upregulation did not reflect the
level of neuritogenesis within the scaffold. This is an intriguing finding, as the upregulation
of many standard neuronal markers has been used to demonstrate the success of a
hydrogel scaffold’s composition for neural tissue engineering purposes in many published
studies. This thesis shows however, that with a panel of cytoskeletal-associated markers,
striking differences can be seen within protein marker expression profiles from neural cells
in pro-neuritogenic and non-neuritogenic environments. However, it should be noted that
the patterns of marker expression from pro-neuritogenic environments do not intrinsically
follow those of planar culture differentiation. This suggests a strong interplay between the
three-dimensional environment itself on neural differentiation kinetics and the ability to
generate neurites within the hydrogel scaffold, that differs to planar culture. Further
investigation to see if this holds true with other neural cell types, and with extended panels
of markers will allow improved resolution of early neural differentiation responses in threedimensional environments.
A possible limitation in the analytical power of the alginate and collagen hydrogel
assays outlined in Chapter 2 relates to the constitutively high gene expression of many
neuronal markers even under proliferative conditions of the neural cell line. Although
protein marker expression showed clear and distinct patterns between culture conditions,
gene marker expression fold-changes were very low over the course of differentiation. This
may be related to the type of neural cell line used, which may employ post-transcriptional
regulation of differentiation-associated genes to generate the neuritogenic phenotype
(Lindenbaum et al., 1988; Perrone-Bizzozero, Cansino and Kohn, 1993). Other primary cells
or neural cell lines may therefore show more robust gene expression changes during
differentiation, but would also require longer periods of time in culture to generate a
mature neural phenotype. As Chapter 2 was primarily based on biomaterial-suitability for
future three-dimensional culture of iPSCs-derived neural cells and less an understanding of
a specific neural cell line differentiation processes: the accelerated speed of differentiation
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and neuritogenesis of PC12s under differentiating conditions was advantageous. From
these results, the collagen-based hydrogel scaffold as a pro-neuritogenic environment was
selected as the scaffold for downstream three-dimensional iPSC-based neural
differentiation (Chapter 4).
Accurate in vitro human forebrain modelling, be it for developmental or diseasebased study, requires the accurate recapitulation of in vivo cellular content. Forebrain
cortical tissue is derived from both dorsal- and ventral-neural tube structures, with the
development of complete cortical tissue driven by the tangential migration of ventrallyderived cells into dorsal regions. In vitro “patterning” of iPSC-derived forebrain neural
cultures however would predominantly generate either dorsal or ventral neural cell types.
Therefore, to understand the timings and maturation events of ventrally-patterned and
dorsally-patterned neural cell types derived from hiPSCs, we undertook parallel
differentiation strategies to directly compare molecular and functional components of the
differentiation process. Understanding the details of these processes will lead to more
accurate and representative combinations of cell types from both pathways as is seen in
vivo. The work in this thesis demonstrated that NPC pools from both patterned
differentiation strategies were generated in comparable amounts early in the
differentiation timeline, but that stark differences in expression existed between the
dorsal-specific and ventral-specific NPC markers (PAX6 and NKX2.1 respectively) between
neural cells from dorsal and ventral patterned differentiation pathways in planar culture.
This separation of dorsal and ventral identity widened over the time-course of neural
maturation with the segregated expression of pre-synaptic ventral-GABAergic markers and
dorsal-glutamatergic markers dependent on the differentiation strategy. Interestingly,
there was a consistent trend of upregulated neural marker gene and protein expression in
ventrally-patterned hiPSC-derived neural cultures compared to dorsal-cultures. This may be
indicative of an accelerated level of differentiation of cells derived from this pathway or a
possible enrichment of neuronal cells. However, preliminary functional assays of neuronal
electrophysiological activity demonstrated a more functionally-mature phenotype in
ventrally-patterned neural cells, verified by higher numbers of induced action potentials
following current stimulation, and larger sodium and potassium currents during invoked
activity. Initial experiments to observe spontaneous activity of neural cell cultures via
extracellular recordings, displayed activity in a subset of ventrally-patterned hiPSC-neural
cultures that was not seen in cells from dorsal inductions. However, this induction of
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functionally mature behaviour was only achieved through the use of media formulations
previously shown to enhance electrical maturation of various neuronal cell types (Bardy et
al., 2015). This reveals the potential for acceleration of other maturation processes within
hiPSC-derived neural cells through media composition alone, and may be another tool by
which to generate and modulate derived neuronal cell activity.
This difference in neuronal marker expression and functional maturity can now act
as a guide to understand how different combinations of these patterned neural cell types
will interact when matured together in controlled mixed differentiation cultures. Perhaps
through substrate patterning or other segregation methods, co-culture models based on
these induction strategies can then generate truly representative models of complete
human forebrain cytoarchitecture.
To understand whether differentiation within pro-neuritogenic three-dimensional
hydrogel environments had positive or negative effects on the efficiency or speed of neural
maturation, hiPSC-derived NPCs (both dorsally- and ventrally-patterned) were
encapsulated in collagen-based scaffolds. As was seen in Chapter 2 with differentiation
studies on PC12s, hiPSC-derived neural cells were able to undergo extensive neuritogenesis
throughout collagen scaffolds in all three directional axes. Early significant peaks of both
NPC and mature neural marker expression were recorded from ventrally-patterned threedimensional neural cultures, whereas this accelerated maturation was not observed in cells
from dorsally-patterned inductions. This accelerated upregulation of neural differentiation
markers was also significantly higher than that seen from planar ventrally-patterned
inductions. This is suggestive of a system by which the same scaffold environment may
elicit differing effects on neural maturation depending on neural subtype specificity. It was
also demonstrated that the hydrogel environment itself did not alter the patterning of
differentiating neural cells themselves, and the morphogen driven separation of ventral
and dorsal lineages was preserved within the three-dimensional scaffolds.
However, markers of maturation at later time points in differentiation appeared
lower in neural cells in three-dimensional scaffolds than was seen in planar culture. One
possible explanation is the necessity of high neural cell densities by which to trigger the
expression of genes associated with neuronal and synaptic maturation. The cell densities in
this study were utilised to minimise cell death derived from low diffusion rates of oxygen
and nutrients into the solid cast-gel constructs. This compromise to maintain cell viability
may have negative effects on functional neural network formation. Other studies using
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more tissue-representative cell densities, but employing smaller construct sizes or
bioprinted grid structures to maintain viability, have shown promising results from threedimensional neural scaffolds (Frampton et al., 2011; Gu et al., 2017).
Therefore, to overcome issues of cell density limitation within cast-formed threedimensional scaffolds, bioprinting strategies for additive fabrication of neural tissue
formation were developed. The low biomaterial content of the hydrogels that show
successful pro-neuritogenic neural differentiation results in low pre-gelation viscosities
which make them unsuited for use as free-standing bioprinting inks or “bioinks”. To
overcome this, a coaxial system using a pro-neuritogenic cell-laden collagen-based “core”
and a structurally reinforcing outer “shell” of alginate and gelatin composite hydrogel, was
developed to generate multilayered printed structures. These structures allowed for the
successful segregation of cell-laden and acellular supportive elements that maintained a
protected core structure of consistent diameter. Neural cell lines printed within this core
retained high cell survival rates and displayed neurite extensions after 7 days of neural
differentiation.
Although in this instance only a two-layered grid structure was formed, this
methodology can be further developed to generate much more complex tissue construct
designs in a multi-layered fashion. The modification of grid-like print designs to introduce
elements of pseudovasculature would also enable the increase of neural cell densities
within bioprinted culture systems. To this end, the scaling up of in vitro neurological models
to sizes relevant for human clinical translation may be possible. Further tailoring and
refinement of the shell bioinks used in this study may also aid with the porosity of the
scaffold, as the gelatin component of the bioink used was non-crosslinked with the alginate
polymer, other than steric retention. It would therefore be necessary to observe the longterm stability of such constructs and to modulate this with the alginate network forming
the shell structure.
Another advantage of using multiple bioink printing capabilities is the ability to
localise and place specific neural cell types in known three-dimensional arrangements.
Precise neurological models could then be developed to mimic specific brain tissue
morphologies and cellular content. However, enhanced printing resolution would need to
be developed to ensure that cellular placement and fibre arrangement was on the scale
seen in vivo. Current methodologies of cellular placement and arrangement are quite crude
by comparison. The refinement of these models could then easily be analysed through
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assays of neural network formation and functionality and be used as the basis for highly
representative neurological-disease models that stem from hiPSC-based modelling. In
combination, the synergy of bioprinting methodologies and hiPSC-modelling of human
neural development make a potent toolkit to further the study of neuroscience through
purely in vitro study.
In conclusion, this thesis has covered the development and biological assays of
candidate biomaterials for neural tissue engineering. The major cellular subtype
components of human forebrain formation have been generated from hiPSCs and the timelines of maturation and functionality directly compared. The same processes were
modelled within three-dimensional environments that elicited changes in neuronal
maturation rates dependent on subtype composition. Finally, pro-neuritogenic hydrogel
scaffolds were adapted to bioprinting methodologies in order to increase the complexity of
neural tissue architecture, and as a method of maintaining high cell viability with higher cell
densities. This body of work will help inform the next generation of in vitro neurological
modelling studies, with the hope of better understanding human brain development and
disease.
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